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You cannot hope to build a better world without improving the individuals. To that end, 
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SUMMARY 
 
One of the most fundamental challenges in analytical mass spectrometry (MS) is 
the efficient conversion of neutral molecules into intact gas-phase ions. In this thesis, I 
investigate the capabilities of various new and established ionization techniques including 
(a) the Array of Micromachined UltraSonic Electrosprays (AMUSE), (b) Direct Analysis 
in Real Time (DART) and (c) Electrospray Ionization (ESI) for bioanalytical and 
biomedical analysis purposes. 
The AMUSE is a MicroElectroMechanical System (MEMS)-based device that 
was created as an alternative, and more sensitive approach for ion generation in an array 
format. In the AMUSE, the processes of droplet formation and DC droplet charging are 
separated allowing ionization of liquid samples using low charging voltages and a wide 
variety of solvents. Our analytical characterization work with the AMUSE showed that 
ion generation with this device was indeed possible, and that incorporation of a Venturi 
device increased signal stability and sensitivity due to enhanced droplet desolvation and 
increased ion transfer efficiency. A detailed investigation to determine the optimal source 
parameters for ionization of aqueous solutions of model compounds including reserpine, 
leucine enkephalin and cytochrome C was carried out and it was found that ionization 
was possible even without the application of a DC charging potential. Subsequent 
experiments using the thermometer ion method to characterize the AMUSE from a more 
fundamental point of view, showed that AMUSE ions are lower in internal energy than 
ESI ions, opening interesting possibilities for the mass spectrometric study of labile 
species. Furthermore, it was found that it was possible to manipulate the internal energy 
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of the ion population by varying the parameters that most strongly affect desolvation and 
focusing. 
Our studies with DART were directed at investigating its analytical potential. 
DART was applied to the identification of active ingredients (AIs) in low quality 
combination medicines that are used for the treatment of fever, the first clinical symptom 
that is observed for malaria. As these drugs are commonly sold in regions of the world 
(particularly Southeast Asia) where drug resistant malaria is endemic, their use may 
engender increased resistance against the few remaining effective antimalarials. The 
analytical utility of DART was further extended to the screening of counterfeit 
pharmaceuticals to determine their chemical composition and to aid in a collaborative 
forensic investigation aimed at identifying the sources of these fakes. 
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This chapter describes some of the advantages and limitations of established 
ionization methods and introduces two ionization techniques that attempt to improve the 
performance of previous approaches to ion generation. The chapter begins with an 
overview of early ionization techniques that operated under vacuum and then describes 
the gradual shift towards techniques capable of operating at atmospheric pressure (AP). A 
review of AP spray-based ionization techniques leading to the development of chip-based 
ion sources is presented followed by a review of the explosive new trend towards 
developing ionization techniques that operate under ambient conditions. 
 
1.2. Early Ionization Techniques – Ionization Under Vacuum 
The efficient conversion of neutral molecules into low-internal energy gas-phase 
ions is one of the most fundamental challenges in mass spectrometry (MS).2, 3 The most 
traditional mass spectrometers combine an ionization source with a mass analyzer and 
detector all operating under medium or high vacuum. Ionization in these early 
instruments was typically accomplished using either electron ionization (EI) or chemical 
ionization (CI). EI, introduced in 1918 by Dempster, is a “hard” ionization method that 
produces fragmentation spectra from ions generated by collisions between gas-phase 
analyte molecules and energetic electrons (70 eV).4 CI, developed by Munson and Field 
in 1966, is a “softer” ionization techniques that provides complementary information 
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about the analyte of interest.5 In CI, intact molecular ions are generated via low-energy 
(~5–10 eV) collisions between gas-phase analyte molecules and reactive ions produced 
from the preferential ionization of reagent gas molecules (i.e. methane) during EI. This 
preferential ionization can be attributed to the large excess of reagent gas in the ion 
source, which increases the probability of hard collisions occurring between the reagent 
gas and energetic electrons, and leads to the formation of an excess of reactive ions. 
These reactant ions then interact with the less abundant gaseous analyte molecules to 
form analyte ions. Despite the analytical utility of EI and CI, which enabled the creation 
of massive spectral databases allowing routine identification of compounds by comparing 
experimental fragmentation spectra with reference spectra (EI) and allowed for the facile 
determination of a compound’s molecular weight from relatively simple spectra (CI), 
these techniques are limited to the analysis of volatile compounds which are stable in the 
gas phase (i.e. low molecular weight organic compounds). 
Since the introduction of EI, a plethora of other ionization techniques has been 
introduced to extend the capability of MS to non-volatile, thermally labile compounds of 
higher molecular weight. These ionization techniques differ in the types and phases of 
analyte molecules that can be probed and also differ in the methods by which analyte 
desorption and ionization occur. In thermal ionization (TI, 1923),6, 7 sample coated onto a 
metal ribbon is thermally desorbed and ionized via electron transfer from the analyte to 
the metal while in secondary ion mass spectrometry (SIMS, 1931),8 a surface is 
bombarded by a primary ion beam causing the ejection of secondary ions from the 
sample surface. In spark ionization (SI, 1936),9 a high-voltage arc between two electrodes 
ionizes analyte incorporated into the tips of the electrodes while in field ionization (FI, 
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1954),10 ionization occurs via the removal of electrons from analyte vapors introduced 
into a high electric field. In photoionization (PI, 1956),11, 12 absorption of incident 
photons causes the emission of ions from a solid sample while in field desorption (FD, 
1969),13 analyte coated onto a metal emitter is heated and exposed to a high potential 
causing desorption and ionization of low-vapor pressure compounds. In glow discharge 
(GD, 1971),14 a discharge gas causes sputtering of analyte from a cathode and ionization 
occurs via electron transfer or Penning ionization while in electrohydrodynamic 
ionization (EHD, 1972),15 an interaction between a strong electrostatic field and liquid at 
the end of a capillary causes the liquid to form a sharp point at which field ionization 
occurs. In plasma desorption (PD, 1974),16 ions are generated from a sample deposited on 
foil by the bombardment by beta particles while in fast atom bombardment (FAB, 
1981),17 analyte is mixed with a liquid matrix (such as glycerol) which prevents sample 
damage as ions are sputtered from the surface due to bombardment by a beam of 
energetic atoms (i.e. argon). Table 1.1 lists these techniques in chronological order 
according to when they were first reported and describes the operating principles, 
analytical figures of merit, and some of the advantages and disadvantages for each.18-25 
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- Transfer 2 000 u femtomole
+ Produces reproducible fragment spectra.
+ Provides structural information.
- Sample must be volatile.







e- Transfer 400 picogram
+ Produces simple spectra.
+ Stable ion beam.
- Limited to volatile compounds.








Energy Transfer 12 000 u ppm
+ Sensitive analysis of organic compounds.
+ Allows imaging and depth profiling.
- Ion beam induces chemical changes.







e- Transfer 300 u ppb
+ Useful for analytes of any state.
+ High sensitivity analyses.
- Difficult sample preparation.
- Limited to low-mass compounds.
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FI
(1954) Field Ionization e
- Transfer 1 000 u ppm
+ Allows observation of molecular ions.
+ Useful for volatile organic compounds.
- Source is subject to arcing and is fragile.










+ Amenable to analysis of labile compounds.
- Complex source setup and operation.











2 000 u picomole
+ Produces simple spectra containing M+..
+ Operates in positive or negative ion mode.
- Limited to volatiles species.







e- Transfer / 
Protonation / 
Cationization
10 000 u picograms
+ Useful for volatile & nonvolatile compounds.
+ Produces simple spectra containing M+..
- Fragile emitter.





Ionized by GD 
Plasma
Penning / e- 
Transfer
300 u ppb
+ Sensitive method for analysis of solids.
+ Useful for elemental analysis.
- Limited to low-mass analyses.











4 000 u nanomole
+ Useful for volatile & nonvolatile compounds.
+ Self-replenishing analyte (external pump).
- Generally uses low vapor pressure solvent.








Energy Transfer 45 000 u nanograms
+ Useful for detection of large molecules.
+ Useful for nonvolatile & labile compounds.
- Difficult sample preparation.









Deprotonation 24 000 u nanomole
+ Useful for detection of large molecules.
+ Useful for nonvolatile & labile compounds.
- Exhibits significant chemical background.
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All of these techniques are amenable to the analysis of non-volatile compounds to 
some degree. However, TI is limited to the ionization of compounds having low 
ionization potentials (primarily inorganic compounds). SIMS provides sensitive analysis 
of organic compounds and is becoming increasingly popular today in imaging mode, 
however, the energetic primary ion beam can cause changes in the chemical composition 
of the sample and the upper mass limit of the technique is 12,000 Da, showing mass-
dependent ion yields.26 SI can be used to analyze samples in any state but produces a 
large number of fragment ions and ions having a large distribution of kinetic energy; 
thus, it was typically coupled to expensive, high resolution mass analyzers such as 
double-focusing magnetic sector mass analyzers. Both FI and FD produce simple spectra 
from volatile compounds generally containing the intact molecular ion and FD can be 
applied to the analysis of non-volatiles species. However, both techniques are limited by 
the presence of arcing in the source and exhibit compound-dependent sensitivity. PI can 
be used to analyze thermally labile organic compounds but is difficult to operate and is 
not amenable to the direct analysis of solids. However, PI can be considered a precursor 
to modern laser desorption-based techniques such as matrix-assisted laser 
desorption/ionization (MALDI, 1988),27, 28 which differs from PI primarily in the use of 
an organic acid as a matrix which greatly enhances desorption and ionization of analyte 
molecules. Although MALDI, along with electrospray ionization (ESI) 29-31 an 
atmospheric-pressure (AP) spray-based technique that is described in more detail below, 
has revolutionized the field of MS by allowing the soft ionization of large biomolecules, 
the utility of MALDI at lower mass ranges is somewhat hindered by intense chemical 
background due to the crystalline matrix. GD provides sensitive analysis of solid surfaces 
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and is particularly useful for elemental analyses but is only useful at low mass ranges and 
exhibits a low sample throughput. EHD, a progenitor of modern spray-based ionization 
techniques such as ESI, has been applied to the analysis of non-volatile, polar compounds 
but requires a volatile solvent having a high conductivity, incorporation of a stabilizer 
such as glycerol, high needle voltages (8-13 kV) and very low flow rates (<10 μL min-1). 
PD, FAB and a variant of FAB known as continuous-flow FAB (CF-FAB)32 have been 
successfully applied to the analysis of high mass (up to 45 kDa), non-volatile 
compounds,33 however, spectra obtained using these techniques typically show 
significant chemical background. 
Although some of these techniques, specifically, EI, CI, MALDI, FAB, and 
SIMS, are still routinely used for MS analyses, all of these ionization methods share one 
distinct limitation – in their early versions all had to be operated under vacuum. As such, 
operation of mass spectrometers was limited to one ion source at a time if vacuum was to 
be preserved. It is also clear from a review of the literature that none of the previously-
described ionization techniques can be considered universal in terms of the kinds of 
compounds that can be analyzed. Furthermore, these techniques, with the exception of 
CF-FAB and EHD, are not easily applied to on-line or continuous flow analyses, as 
would be preferred for coupling MS with chromatographic techniques. To that end, a 
paradigm shift towards the development of AP ionization sources, including an AP 
version of MALDI (AP-MALDI),34 progressively occurred allowing for modularity in the 
design of modern mass spectrometers, enabling the performance of complementary 
analyses using different ionization techniques with a single mass analyzer, and 
facilitating the coupling between MS and liquid chromatography (LC) and capillary 
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electrophoresis (CE). Development of these ionization techniques is described in detail in 
section 1.3. 
A more recent theme in ion generation technology development is the progressive 
trend towards ambient ionization techniques35, 36 which are capable of directly 
interrogating samples of odd shapes in their native state, without sample preparation. The 
development of new ambient ionization sources has skyrocketed in recent years catalyzed 
by the introduction of desorption electrospray ionization (DESI) by Cooks and 
coworkers37 and direct analysis in real time (DART) by Cody and coworkers38 and 
leading to the development of twenty-two new ionization techniques (as of May 2009) 
since 2004. These devices, which are capable of conducting direct analysis (i.e. probing 
the surfaces of solid or liquid samples directly), are ideal for use in high-throughput 
screening experiments which are described in section 1.4. 
 
1.3. Atmospheric Pressure Ionization Techniques 
AP ionization sources are characterized by operation at atmospheric pressure 
outside of the vacuum system of the mass spectrometer. Typically, these apparati are 
coupled to mass analyzers via an interface that provides differential pumping to aid in ion 
transmission as ions are transported through a pressure reduction on the order of 105-1012 
Torr. One of the central motivations for the development of AP ionization techniques was 
to find a means of coupling LC with MS. Prior to the 1980’s, gas chromatography 
(GC)-MS was well developed and routinely enabled the analysis of low molecular weight 
compounds via EI or CI ionization. However, LC-MS was thought to be impossible due 
to the large flow rates used with LC at that time (1-3 mL min-1) and the need to vaporize 
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the LC effluent prior to MS analysis to prevent overloading of the vacuum system.39, 40 
Despite these challenges, there was considerable interest in using MS as a detector for LC 
separations to provide improved resolution of overlapping components in the 
chromatograms obtained from nonspecific detectors, such as UV-Vis, which were largely 
prevalent at the time. Successful merging of these analytical techniques was ultimately 
accomplished by the development of AP ionization sources that now routinely enable the 
generation of gas-phase ions from neutral molecules emanating from a liquid stream. 
The first reported bioanalytical LC-MS coupling was by Horning and coworkers 
in 1974 who introduced atmospheric pressure chemical ionization (APCI) as an interface 
for LC-MS.41, 42 In APCI, a mixture of solvent and analyte is vaporized using a heated 
nebulizer and is ionized through ion/molecule reactions with reagent ions present in the 
area surrounding a corona discharge needle. Due to the use of heat, analytes are subject to 
thermal degradation, thus, APCI is not considered suitable for the analysis of thermally 
labile species. In addition, APCI has been shown to preferentially ionize low-mass 
(<1200 u) nonpolar compounds. 
In 1979, Thomson et al. introduced AP Ion Evaporation (APIE), which used a 
pneumatic nebulizer to create a spray of droplets that were ionized by being placed in 
close proximity to an electrode held at 3.5 kV.43 Using this technique, Thomson and 
coworkers were able to obtain mass spectra for 30 cations and anions from salts such as 
NaCl and some small drugs but their work was limited to small molecules due to the low 
mass range of the mass analyzer they used. Because no heat was used, solvent-ion 
clusters were also commonly observed in their experiments. In 1983, Thomson and 
coworkers introduced the Heated Nebulizer Probe (HNP), which used a pneumatic 
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nebulizer to create a stream of droplets sprayed from a heated metal capillary.44 In this 
technique, ionization occurred as desolvated droplets passed near a corona discharge 
needle. This technique was fundamentally the same as APCI, differing primarily in probe 
design and the method by which heat was used to desolvate the droplets, and produced 
APCI-type spectra while suffering from the same limitations as conventional APCI 
experiments. 
This strategy of decoupling aerosol generation from ionization was also used by 
Willoughby and Browner who introduced the Monodisperse Aerosol Generator Interface 
for Chromatography (MAGIC) in 1984.45 In MAGIC, highly uniformly-sized droplets 
(12 – 20 μm diameter) are formed from a liquid effluent (0.1-0.5 mL min-1) flowing 
orthogonal to a nebulizing gas stream. The droplet stream is desolvated in a heated, AP 
desolvating chamber and the volatilized sample is ionized externally using EI. Despite 
the clear advantage of using this probe, namely the ability to couple it to most types of 
mass spectrometers and ionization sources, the relatively complicated setup hindered 
widespread acceptance of MAGIC. 
At the same time, Vestal and coworkers introduced Thermospray (TS), a 
technique in which aqueous mobile phase was vaporized as it passed through a stainless 
steel capillary located in a heated ion source.46 Unlike the previously-mentioned 
techniques, no external field or charging was used to induce ionization. Rather, this 
apparatus took advantage of the statistical partitioning of charges within the droplet 
population, which included some positively charged droplets and an equal number of 
negatively charged droplets in the overall neutral bulk distribution. However, a discharge 
needle was commonly integrated into the apparatus to allow for the generation of APCI-
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type spectra when operation in thermospray mode produced insufficient signal. Vestal et 
al. used TS to analyze peptides and drugs but the technique suffered from poor interday 
reproducibility and analyte ion intensities exhibited a strong dependence on variations in 
the sample flow rate and composition.46 
Despite the success of these techniques, the coupling of LC with MS did not 
become routine until the introduction of ESI as an ionization method for biomolecular 
MS analysis by Fenn and coworkers30, 31, 47 and Aleksandrov and coworkers48 in the early 
1980’s as discussed in the following section. 
 
1.3.1. ESI-Based Ionization Techniques 
The usefulness of ESI for MS analysis was first demonstrated by Dole and 
coworkers in 1968 who used it to produce charged gas-phase polystyrene ions29 by 
passing solution through a hypodermic needle held at -10 kV. The analytical utility of 
ESI was further extended in 1984 by Fenn and coworkers who characterized the behavior 
of a slightly modified ESI ion source,30 later demonstrating the ability to analyze proteins 
having molecular weights up to 180,000 Da in 1989.31 A schematic showing the basic 
principle of a conventional ESI analysis is shown in Figure 1.1. 
 









































Figure 1.1. ESI Schematic. Charged droplets are ejected from a metal capillary. 
Solvent evaporates until droplet fission occurs leading to the formation of 
desolvated ions. (Adapted from Gaskell, et al.49) 
 
In conventional ESI, a potential is applied to the exterior of a capillary inducing 
charge separation in the solution flowing through. Charge builds up at the tip of the 
capillary forming a Taylor cone and causing the forcible ejection of a charged droplet. 
Due to the application of a concurrent flow of nitrogen (N2) through the evacuated 
chamber in Dole’s apparatus or a countercurrent N2 flow in Fenn’s apparatus, solvent 
evaporates from the droplet as it transits through the evacuated chamber until the droplet 
reaches the Rayleigh limit and undergoes Coulombic explosion to form desolvated ions.50 
Early on it was recognized that spray stability and desolvation varied widely in 
conventional ESI experiments, thus a variant of ESI, pneumatically-assisted ESI (pESI), 
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was introduced by Henion and coworkers.51 This ionization source (Fig. 1.2) was later 
trademarked by PE/Sciex (Perkin Elmer, Concord, Ontario, Canada) and is currently the 
most widely used ESI-based ion source today. 
 
Nebulizing Gas
(0.1 – 1 L/min)
Sample
(5 – 1000 μL/min)
Charging Potential
(2 – 6 kVDC)  
 
Figure 1.2. Schematic of pESI technique. Average droplet diameter is 5 – 12 μm.51 
 
In ESI, desolvated ions are formed via one of two proposed models: (1) the 
charged residue model29 which proposes that electrospray droplets repeatedly evaporate 
and explode as the charge on the surface exceeds the Rayleigh limit forming successively 
smaller droplets containing a portion of the charge and ultimately leading to ions and (2) 
the ion evaporation model52 which proposes that ions are ejected directly out of the 
droplet due to the high electric field strength on the surface. It has been observed that the 
charged residue model appears to dominate when analyzing high mass compounds 
(> 3300 u) while the ion evaporation model dominates when analyzing low mass 
compounds, however, ESI mechanisms are still the subject of active discussion.53 Despite 
this ongoing debate, it is clear that the power of ESI lies in its ability to generate and 
make amenable to analysis ions from non-volatile compounds spanning a large mass 
range, which can be attributed to the tendency to create multiply-charged species, and its 
flow-through nature allowing facile coupling to LC and other liquid phase separation 
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techniques. However, ESI does suffer from some limitations that are inherent to the 
electrospray process itself. 
One of the limitations of Taylor cone liquid atomization is that the high voltage 
required for effective ionization sets a minimum to the distance between the sprayer and 
other instrument components that can be used for operation without electrical discharges. 
This minimum distance limits the efficiency with which highly-charged droplets can be 
collected and transmitted into the mass spectrometer via the AP interface. These high 
voltages can also cause an increase in background signal due to the increased rate of 
solvent oxidation54 and because of possible ionization of volatile contaminants present in 
the laboratory air55. In addition, the Taylor cone behavior is highly influenced by the 
surface tension of the sprayed solution, and thus, improvement of signal stability is 
generally achieved by addition of organic solvents. However, these solvents may modify 
the native conformation of the solutes thus distorting, to an unknown extent, the 
correlation between solution-phase and gas-phase conformations,56-58 important in 
techniques such as ion mobility-MS. Also the variable purity of organic solvents can 
introduce contaminants into the spray causing degradation of the signal.59 In addition, 
conventional pESI requires the use of high flow rates (5-2000 μL min-1) due to the 
relatively large internal diameter of the metal capillary through which the sample flows49 
causing the consumption of large amounts of sample. 
Moreover, in scenarios where analytes with largely disparate concentrations are 
present in the sprayed solution, the intrinsic limitation in the total current that can be 
supported by Taylor cone electrospray can seriously limit dynamic range, and 
concomitantly, the relative peak intensities (ion suppression effect).60-62 Furthermore, it is 
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well-known that variations in gas phase acidity and basicity,63, 64 as well as differences in 
hydrophobicity,65 can significantly affect the ionization efficiency of some analytes by 
ESI, which preferentially ionizes hydrophobic analytes having high proton affinities (for 
positive mode ESI). Finally, the throughput of conventional ESI is limited by ion source 
geometry, as most commercial sources are limited to containing only one or two sprayers.  
Some of these limitations have been overcome by the introduction of 
(microelectrospray ionization) μESI66 and (nanoelectrospray ionization) nESI,67-69 which 
aim to reduce ion suppression effects in ESI and improve signal intensities by reducing 
the initial droplet size which increases droplet charge density. Ultrasonically-assisted 
electrospray (UA-ESI),70, 71 which aims to increase the range of mobile phase 
compositions amenable to spray-based ionization techniques and also to reduce ion 
suppression has also been reported. Despite the improvements offered by these 
approaches, these still suffer from limited throughput, poor reproducibility (in the case of 
pulled nESI capillaries) and cross-contamination. Conversion of these techniques into 
chip-based format by making use of miniaturized devices72-76 was attempted to further 
improve their figures of merit. 
 
1.3.2. Miniaturized Ion Sources 
Ionization using the nESI format is one of the preferred techniques for proteomic 
workflows. Typically, nESI (Fig. 1.3) is conducted using pulled or tapered glass 
capillaries, to which charging voltages between 900 VDC and 1500 VDC are applied, 
resulting in sensitivities that are 10–100 times greater than that of conventional ESI.69 
 




(< 2.5 kVDC)  
Figure 1.3. Schematic of nESI technique. Average droplet diameter is < 200 nm.67, 68 
 
A wider linear dynamic range (102 increase in upper concentration limit) has also 
been observed in nESI and is attributed to the higher charge density of nESI droplets. The 
higher charge density allows for a reduction in charge competition between analytes in 
mixtures making more charge available to each analyte and causing a concomitant 
reduction in ion suppression effects.62 nESI is particularly amenable to miniaturization 
and spray nozzles with internal diameters of a few microns have been successfully 
fabricated with techniques normally used for the manufacturing of semiconductor 
microchips.77 Microfabricated nanospray (microchip ESI) devices offer a number of 
advantages for mass spectrometric analysis, including reduced sample consumption and 
cross-contamination, improved sprayer reproducibility, high-throughput and automation 
capabilities, and the potential for integration with on-chip solid-phase extraction, and 
chromatographic or electrophoretic separations.78, 79 
To date, reported miniaturized nanospray infusion devices fall into four main 
categories: (1) devices using fused silica capillary emitters attached to a chip,80-91 (2) 
devices using a microchannel exiting the edge of a wafer,92-105 (3) monolithic devices 
using etched ESI tips,61, 106-118 and (4) integrated miniaturized nESI devices comprising 
enrichment columns, reverse-phase separation channels and micromachined nanospray 
emitters.73, 119-123 Although all of these devices have been shown to successfully generate 
gas-phase ions from small sample volumes (nL–µL), they still rely on the generation of a 
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Taylor cone for liquid atomization, which can only be overcome via the use of a 
fundamentally different approach to the ionization process. 
 
1.3.3. Ultrasonic Electrospray Ion Sources - Decoupling Droplet Formation and 
Droplet Charging 
To overcome some of the innate limitations of Taylor cone electrospray mass 
spectrometry, several reports on the use of acoustic liquid ejection for ESI purposes have 
been reported. Unlike droplet ejection in conventional ESI which relies on charge 
repulsion to force ejection of liquid from a capillary, acoustic liquid ejection, which is 
commonly used in inkjet printing technology,124, 125 relies on the use of an ultrasonic 
pulse to focus acoustic energy on a portion of the liquid sample, forcing the ejection of a 
droplet from the liquid surface. In 1994, Banks et al. introduced UA-ESI, which uses a 
piezoelectric transducer to produce a continuous droplet stream by Rayleigh vibrational 









(< 200 VDC)  
Figure 1.4. Schematic of UA-ESI technique. Average droplet diameter is 10 – 20 μm.70 
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The underlying motivation for this approach was to decouple the spray formation 
and ionization processes. This enables efficient and stable ionization of analytes from 
solutions containing little or no volatile solvents. However, the proposed UA-ESI device 
suffered from instabilities due to temperature variations that affected the resonant 
frequency needed for optimum ejection. 
Shiea et al. also recognized the potential of ultrasonic nebulization and coupled an 
ultrasonic nebulizer to an array of seven electrospray nozzles to which a charging voltage 
of 4000 VDC was applied, showing the feasibility of generating multiply charged protein 
ions.126 Smith et al. later utilized drop-on-demand technology in conjunction with ESI, 
with charging voltages of up to 4900 VDC to sensitively ionize insulin samples dissolved 
in 1:1 methanol/water, 1% acetic acid.74 In this approach, a single droplet is released 
from the end of a capillary because of a rapid pressure pulse generated by a radially-
contracting piezoelectric element. Droplet bursts or continuous trains are ejected from 
this capillary by application of a corresponding pulse burst or sine wave to the cylindrical 
piezoelectric actuator surrounding the electrospray capillary. In a related experiment, 
Murray et al. demonstrated the feasibility of performing MALDI-MS on aerosol particles 
derived from discrete droplets produced using a piezoelectric dispenser.127 More recently, 
Muddiman and coworkers used RF actuation to cause desorption of analyte (ubiquitin 
and a peptide, brain natriuretic peptide-32) from a quartz crystal microbalance. These 
analytes were ionized via interaction with an ESI spray, demonstrating the utility of this 
technique for the analysis of biomolecules.128 
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1.3.4. Overcoming Challenges in AP Ion Generation – AMUSE Ionization 
To overcome some of the limitations inherent to current spray-based technologies, 
we demonstrated the successful generation of ions from a MEMS device first 
conceptualized by Fedorov and coworkers,129 the Array of Micromachined UltraSonic 
Electrosprays (AMUSE). This ion generation technique is based on the concept of 
decoupling the processes of droplet formation and droplet charging by acoustically 
driving the ejection of droplets using the mechanical oscillations of a piezoelectric crystal 
and charging the droplets via the application of an additional DC potential of only a few 
hundred volts to the sample reservoir.76, 130-135 Part I (Chapter 2-4) of this thesis describes 
our advances made towards the development of the AMUSE as a stable ion source for 
analytical mass spectrometry and its applications, as well as our efforts to characterize 
and reduce the internal energy deposition of AP ionization techniques in general. Chapter 
2 presents efforts to couple the AMUSE with MS and characterize the device by 
comparing results for the analysis of standard compounds, including a drug, peptide and 
protein, to results obtained by ESI and nESI.76, 133 Chapter 3 describes extensive 
experiments to measure and modulate the internal energy deposited on ions by both ESI 
and AMUSE135 while Chapter 4 describes our proof-of-principle efforts to couple LC to a 
quadrupole ion trap LC-MS detector via AMUSE. 
 
1.4. Ambient Ionization Techniques 
The revolution in time-of-flight (TOF) instrumentation following technological 
advances in reflectron technology, collisional cooling, orthogonal ion acceleration and 
analog-to-digital data acquisition,136 as well as the introduction of novel mass analyzers 
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such as linear ion traps137 and the Orbitrap,138, 139 and the development of new hybrid 
instruments such as the quadrupole ion trap-fourier transform (QiT-FT),140 linear ion 
trap-Orbitrap (LiT-Orbitrap),141 and quadrupole-ion mobility-time-of-flight (Q-IMS-
TOF)142 mass spectrometers has put exquisitely powerful mass analysis tools in the mass 
spectrometrist’s fingertips, enabling the simultaneous non-targeted detection, 
identification and quantitation of hundreds of analytes. This has translated the 
performance bottleneck to the front end of the mass spectrometer. The need to dissolve, 
extract and/or filter the sample prior to analysis and for placing it under vacuum constrain 
the type and shape of materials that can be investigated. The recent introduction of 
ionization techniques that operate under ambient conditions aims to address these 
limitations and has further expanded the toolbox of analytical methodologies available 
for drug discovery, metabolomics, forensics, and quality control applications by enabling 
the rapid screening of chemical systems of medium complexity35 with sample 
throughputs of up to 45 samples min-1.143 
Ambient ionization sources are characterized by operating at AP, and by being 
able to probe the surface of samples of any size, shape and texture/morphology. Ions are 
created outside of the instrument, in the open air. Whereas in conventional mass 
spectrometric experiments the sample is generally dissolved prior to analysis, in ambient 
MS the sample is interrogated in its native state, accelerating the analytical pipeline, 
preserving spatial chemical information, avoiding dilution, and maximizing sensitivity. 
The breadth of the new field of ambient MS is reflected by the explosive appearance of a 
multitude of new ionization approaches, spearheaded by DESI,37 and soon followed by 
DART.38 These new ionization techniques can be separated into five categories based on 
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their respective desorption mechanisms and include techniques exhibiting desorption due 
to the action of a spray or jet, laser, heat, gas, or resonance. 
Ionization techniques utilizing spray- or jet-based desorption include DESI, easy 
ambient sonicspray ionization (EASI, formerly known as desorption electrosonic spray 
ionization (DeSSI)),144 and fused droplet ESI (FD-ESI),145 while techniques that rely on 
laser-assisted desorption include electrospray-assisted laser desorption ionization 
(ELDI),146 matrix-assisted laser desorption electrospray ionization (MALDESI),147 laser 
ablation-electrospray ionization (LAESI),148 infrared laser-assisted desorption ESI (IR-
LADESI),149 AP-laser desorption/chemical ionization (AP-LD/CI)150 and laser-induced 
acoustic desorption/ESI (LIAD/ESI).151 Ambient ionization techniques that use thermal 
desorption include DART, atmospheric pressure thermal desorption/ionization 
(APTDI),152 atmospheric-pressure solids analysis probe (ASAP),153 desorption 
atmospheric pressure chemical ionization (DAPCI),154 desorption atmospheric pressure 
photoionization (DAPPI),155 plasma-assisted desorption/ionization (PADI),156 and low 
temperature plasma (LTP).157 Ambient techniques that rely on desorption via gas flow 
include extractive electrospray ionization (EESI),158, 159 neutral desorption sampling 
extractive electrospray ionization (ND-EESI),160 dielectric barrier discharge ionization 
(DBDI),161 and flowing atmospheric pressure afterflow (FAPA).162 Finally, techniques 
relying on ultrasonic desorption include ultrasonically-assisted EESI (UA-EESI),163 and 
radio frequency acoustic desorption/ionization (RADIO).128 
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1.4.1. Spray- or Jet-Based Ambient Ionization Techniques: DESI, EASI, and FD-ESI. 
DESI was first introduced by the Cooks group in 200437 and uses a 
pneumatically-assisted high-velocity electrospray jet that is directed onto the surface of a 
sample to bring about analyte desorption. Following desorption the analyte is “picked-
up” by impacting droplets and subsequently ionized via either the ion evaporation or 
charge residue mechanism.164, 165 Recently, computational fluid dynamics simulations 
have confirmed this “droplet pick-up mechanism” showing that the DESI process 
contains three consecutive stages: 1) the formation of a thin liquid film on the sample 
surface, 2) extraction of solid-phase analytes into this thin film, and 3) collision of 
primary droplets with this thin film, producing secondary droplets which take up part of 
the analyte-containing liquid.166 
Like DESI, the EASI ionization process also uses a high velocity spray to probe 
the sample, but in EASI, no voltage is applied to the sprayed solution. It is believed that 
droplet charging in EASI occurs as a result of statistical fluctuations of the charge spatial 
distributions within the sprayed droplets.167, 168 It has also been speculated that desorption 
and ionization in this technique, which has been shown to be useful for the direct analysis 
of pharmaceuticals,144 probably follow the DESI mechanisms described above. 
One particularly interesting and somewhat unexplored DESI aspect is its 
“reactive” mode, which allows for specific chemical reactions to occur via introduction 
of various reagents into the DESI spray solution.169-171 Cooks and coworkers were the 
first to demonstrate the potential of reactive DESI for the rapid, sensitive detection of 
explosives from a wide variety of surfaces by selective adduction with chloride, 
trifluoroacetate and methoxide anions introduced into the DESI spray.169 In reactive 
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DESI, the mass spectrometric detection of specific products formed as a result of these 
in-situ chemical reactions can be used to increase the selectivity of the technique and may 
also provide increased sensitivity as in some cases, the chemical species produced are 
better able to survive transport through the mass spectrometer’s ion optics.171 
In FD-ESI, a pneumatic nebulizer is used to create a sample aerosol which is 
carried to the tip of a capillary where the neutral sample aerosols fuse with charged 
methanol droplets generated by electrospraying an acidified methanol solution.172 This 
ionization technique has been shown to provide high quality mass spectra from biological 
samples such as myoglobin prepared in Tris buffer and containing detergent, as the 
solubility of the unwanted components can be decreased by changing the electrospraying 
solvent.145 
 
1.4.2. Laser-Assisted Desorption/Ionization Techniques: ELDI, MALDESI, LAESI, 
IR-LADESI, AP-LD/CI, and LIAD/ESI. 
Laser-assisted desorption/ionization techniques include techniques combining 
laser desorption with ESI (ELDI, MALDESI, LAESI, and IR-LADESI) or with corona 
discharge ionization (AP-LD/CI). Shiea et al. used ELDI coupled to a Q-TOF to directly 
detect the active ingredient (AI) in drugs using UV irradiation to desorb methaqualone 
from a tablet followed by ESI.146 MALDESI, which Muddiman et al. coupled to FT-ICR 
to obtain high resolution spectra from peptides and proteins, is similar to ELDI but uses 
an organic acid matrix to improve ion signal.147 LAESI,148 which was introduced by 
Vertes, et al., and IR-LADESI,149 which was introduced by Rezenom, et al., both use a 
mid-IR laser to irradiate water-rich samples, causing desorption of analyte from the 
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surface. However, the sources used by Vertes and Rezenom have different geometries 
whereby the laser source in LAESI is orthogonal to the sample surface while the laser in 
IR-LADESI is oriented 45º with respect to the sample surface. In the latter, lower pulse 
energies were also used which resulted in both ablation and desorption of surface 
neutrals.149 In AP-LD/CI, a laser pulse is used to desorb intact neutral molecules that then 
undergo chemical ionization via interaction with reactive ions produced by the corona 
discharge. Preliminary experiments comparing the results of these experiments using 
model compounds with those by AP-IR-MALDI yielded a 150-fold increase in signal 
intensity, indicating the benefit of incorporating multiple ionization processes into 
techniques that include desorption steps that produce a large number of neutral species.150 
In LIAD/ESI, a sample solution deposited on a metal foil is irradiated with a 
pulsed laser that creates acoustic waves that propagate through the foil and enable 
desorption of the sample from the foil. Following desorption, ionization via interaction 
with the charged ESI solution occurs. One unique feature of LIAD desorption is that 
there is little excitation of intramolecular vibrational states, thus a wide variety of 
molecules can be desorbed as intact neutral species.151 
 
1.4.3. Heat-Assisted Ambient Ionization Techniques: DART, APTDI, ASAP, DAPCI, 
DAPPI, PADI, and LTP. 
In DART, which was first introduced in 2005 by Cody et al., a stream of heated 
helium gas flows past a glow discharge region within the source leading to the production 
of metastable helium atoms of 19.8 eV.38 When analyte-containing samples are placed in 
the region between the DART ionization source and the mass spectrometer inlet, analyte 
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is desorbed, or possibly sputtered, from the surface and ionization is accomplished via 
one of the mechanisms described in detail in section 5.3.1.38, 173, 174 
In addition to DART, several other discharge-based ambient ionization techniques 
have been reported in the literature. The first report of APTDI was by Cooks and 
coworkers in 2006 who observed that heating organic and inorganic salts led to the 
production of reagent ions that generated analyte ions via proton transfer similar to what 
occurs in CI.152 In ASAP, a solid sample probe is introduced directly into the corona 
discharge region of an enclosed APCI ion source via a custom built sample port.153 The 
heated gas stream from an APCI probe desorbs the analytes, which are ionized by 
interaction with the corona discharge plasma. ASAP has been applied to a variety of 
analytical problems, including the analysis of biological tissue, pharmaceuticals, 
polymers, currency,153 and inhibitors of the ergosterol pathway.175 
DAPCI was originally implemented using toluene as the reagent gas flowing 
through the annular gas flow of a modified DESI sprayer in which the spray capillary was 
replaced by a sharp stainless steel tip.154 Unlike DESI, DAPCI has been shown to be 
effective at ionizing compounds of moderate to low polarity.176 In DAPCI, the sample is 
directly introduced into the corona discharge region generated between a sharp needle 
and the capillary inlet of a mass spectrometer. Qiao et al. recently demonstrated the 
feasibility of using ambient air as the CI reagent in DAPCI.177 
In DAPPI, a heated jet of vaporized solvent is directed towards the surface of a 
sample causing thermal desorption of analyte(s) which is then ionized by photons emitted 
by a photoionization lamp (10 eV photons). Unlike the previously described techniques, 
DAPPI is well-suited to the analysis of polar, non-polar and neutral compounds. Thus, 
Hampton, C. Y.  25 
DAPPI can provide complementary information to what would be obtained via other 
ambient methods.155, 178 
A related method, PADI156 has also been recently reported and is carried out by 
generating a non-thermal RF plasma into which the sample is placed directly, as in ASAP 
and DAPCI. In the LTP, helium (0.5 L min-1) flowing through a plasma generated by a 
small probe is directed at the surface of a sample. In these experiments, the sample is 
heated to provide thermal desorption and ionization most likely occurs via the same 
mechanisms as those described for DART. This ionization technique has been 
successfully applied to the detection and quantitation of melamine in milk powder and 
whole milk.179 
 
1.4.4. Gas-Assisted Ambient Ionization Techniques: EESI, ND-EESI, DBDI, and 
FAPA. 
EESI, introduced by the Cooks group in 2006, uses a gas stream to desorb 
compounds from a solid or liquid surface generating a neutral aerosol mixture that is 
subsequently ionized by interactions with an electrospray solution.158 Zenobi et al. 
recently demonstrated the rapid profiling of complex biological samples such as frozen 
meat, vegetation and human skin samples using ND-EESI160 on a hybrid quadrupole-
time-of-flight (Q-TOF) mass spectrometer. Mass accuracies of 10 ppm or better with 
detection limits as low as 10 femtograms histamine/cm2 were achieved using this 
ionization technique with an analysis speed of 1-2 s. 
Zhang et al. reported DBDI in 2007161 which was employed for the direct analysis 
of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX), 2,4,6-trinitrotoluene (TNT), and 
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pentaerythritol tetranitrate (PETN) from explosives-contaminated surfaces, and for amino 
acids. In DBDI, a needle–plate electrical discharge generates energetic species, such as 
electrons, and these species launch desorption and ionization of the analyte from a solid 
surface used as a dielectric barrier, where the sample is deposited. In negative ion mode, 
DBDI was observed to form the typical [TNT]−, [TNT−H]−, [RDX+NO2]−, 
[PETN+ONO2]−, and [RDX+ONO2]− anions. For amino acids in positive ion mode, the 
[M+H]+ protonated molecules were observed.161 
FAPA, which was recently reported by Hieftje and coworkers,180-182 uses a beam 
of energetic helium metastable species to create a high flux of reagent ions such as 
protonated water clusters, nitrogen dimer ions and oxygen ions. In this source, gas-
assisted analyte desorption likely occurs while ionization most likely follows CI 
mechanisms.162 
 
1.4.5. Ultrasonically-Assisted Desorption/Ionization Techniques: UA-EESI, RADIO. 
Ultrasonic desorption can generally be achieved using a piezoelectric transducer. 
In UA-EESI, a small droplet of sample (~3 μL) is deposited on an ultrasonic transducer 
and nebulized. The neutral sample aerosol then undergoes extraction via interaction with 
a droplet stream from an ESI sprayer. This method has been successfully applied to the 
detection of melamine in various food matrices including raw milk, wheat gluten, and 
milk powder.163 RADIO was recently reported by Dixon et al. and utilizes acoustic 
desorption of a sample deposited on a quartz crystal microbalance electrode prior to RF 
actuation. Ionization occurs via interaction with a continuous ESI stream flowing directly 
above the electrode and oriented towards the mass spectrometer inlet. Using this method, 
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MS signal for several model compounds, such as melittin and ubiquitin, was obtained, 
demonstrating the potential of ultrasonically-assisted desorption as an alternative 
desorption method for the analysis of large molecules.128 
Of the new ambient ionization techniques described above, DART and DESI 
seem to have experienced the most commercial success and have been applied to a 
variety of problems including the direct (i.e. without sample preparation) screening of 
solid pharmaceutical samples176, 183 counterfeit drugs,184-189 writing inks,190 ink 
photoinitiators in food,191 pathogenic bacteria,192, 193 flavors and fragrances,194 analytes 
separated by high performance thin layer chromatography,195 biological fluids,196 food 
contaminants,197, 198 insects,199 and nonpolar compounds not accessible using other 
techniques.173 Several other applications have been posted as on-line application notes 
but without the benefit of the peer-review process.200 The majority of these applications 
have focused on screening samples without requiring any preparation or chromatographic 
separation, which can be followed by a more comprehensive LC-MS examination, if 
necessary.183, 189 In this two-tiered approach, samples are first screened in a high-
throughput fashion to establish an estimate of their complexity, analyte concentration 
range, the presence of unknowns and authenticity. Samples of interest selected during the 
high-throughput screening step are then subjected to more comprehensive, but time- and 
resource-consuming, LC-MS analysis for in-depth chemical characterization. 
Part II of my thesis describes the application of DART for the screening analysis 
of pharmaceutical agents as well as an exploration of the importance of various DART 
parameters on sample throughput. Chapter 5 presents the application of DART to the 
screening of the chemical composition of low quality antimalarial drugs in an effort to 
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identify the contents of these pharmaceuticals, to estimate their effect on the increasing 
prevalence of drug-resistant strains,183  and to determine the realistic sample throughput 
of this technique.189 Chapter 6 presents results for the first application of DART to the 
screening of counterfeit drug samples that mimic the vital antimalarial artesunate,201-203 
the consumption of which has led to the death of many patients.204-206 This technique will 
also be compared to DESI ionization in the same context. 
 
1.5. Conclusion 
Advancements in the development of new ion generation approaches continue to 
revolutionize the field of MS. Progress towards the development of AP ionization 
techniques in μESI and nESI formats as well as miniaturization of these sources has 
alleviated some of the challenges inherent to the electrospray process, but improvements 
are still possible. The introduction of a new approach to ion generation in array format for 
mass spectrometry, AMUSE, attempts to circumvent these limitations by producing ions 
using a method that decouples the processes of droplet formation and droplet charging. 
Recently introduced ambient ionization techniques and a detailed description of the 
DART ion source are also presented to provide a framework for the discussion of the 
applications and the effects of DART parameters included in the following chapters. 
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PART I: ADVANCES IN ATMOSPHERIC PRESSURE IONIZATION 
TECHNIQUES
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Analytical characterization of the AMUSE ion source performed using model 
compounds is presented in this chapter. The basic concept of the technique is described 
followed by a brief explanation of methods for improving ion transmission efficiency. In 
this work, a Venturi device is coupled to the AMUSE to increase desolvation, droplet 
focusing, and signal stability. Three model compounds, a drug, a peptide, and a protein, 
are analyzed under a variety of conditions to determine the effects of the Venturi gas flow 
rate and temperature, DC charging potential, solvent composition, and nozzle diameter, 
which are described in more detail below. 
 
2.2. AMUSE Ionization – Concept and Challenges 
The AMUSE ionization source was invented by Fedorov and Degertekin for high 
throughput, multiplexed MS129 and first demonstrated on a MS system jointly by the 
Fedorov, Degertekin, and Fernández groups.76 AMUSE intends to overcome the 
limitations of conventional microchip ESI based on Taylor cone liquid atomization by 
acoustically driving the ejection of droplets, thus offering the potential for high-
throughput, on-demand, multiplexed and inexpensive mass spectrometric analysis with 
minimum sample consumption. 
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2.2.1. AMUSE Concept 
The AMUSE is a fundamentally different type of ion generation device consisting 
of three major components: 1) a piezoelectric transducer that creates ultrasonic waves at 
one of the resonant frequencies of the sample-filled device, 2) an array of pyramidally-
shaped nozzles micromachined on a silicon wafer, and 3) a spacer which prevents contact 















Figure 2.1. Schematic of the AMUSE ion source. 
 
Droplet ejection is driven by the application of a RF potential to the piezoelectric 
transducer causing resonance within the device and generating a high pressure gradient at 
the apices of the nozzle pyramids. This resonance forces the periodic ejection of multiple 
droplet streams from the device. Droplet charging can be accomplished via a DC 
potential applied to the interior electrode of the piezoelectric transducer. With this device, 
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the processes of droplet formation and droplet charging are separated; hence, the 
limitations of conventional electrospray-type ionization techniques, including the need 
for high charging potentials and the addition of organic solvent to decrease surface 
tension, can be avoided. 
 
2.2.2. AMUSE Nozzle Array Fabrication 
Fabrication of the 20x20 5-μm-nozzle (1st generation) array was first described by 
Meacham and coworkers in 2004.130 Fabrication of these 1st generation devices can be 
broken down into two major steps: 1) the creation of pyramidally-shaped nozzles and 2) 
the opening of orifices at the apices of these pyramidal cavities. Each of these steps can 
be further separated into several individual processing steps, which are shown in Figure 
2.2. As this fabrication protocol has been described in detail elsewhere,130-132 only a brief 
explanation of the method will be provided here. The fabrication process begins with the 
removal of organic contaminants from a 4”-diameter, 500-μm thick wafer of (100) silicon 
via immersion in a Piranha solution (4:1 sulfuric acid:hydrogen peroxide v:v) and is 
followed by the deposition of 1 μm of silicon nitride (Si3N4) using plasma-enhanced 
chemical vapor deposition (PECVD). Photolithography followed by reactive ion etching 
(RIE) is used to create the base pattern of the device. The pyramidally-shaped nozzles are 
wet etched using potassium hydroxide (KOH) until the apex of the pyramid extends 
through the entire wafer thickness. Photolithography followed by RIE is then used to 
open the orifices and the photoresist is removed from the surface. 
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Silicon Silicon Nitride Photoresist Tungsten
 
Figure 2.2. Workflow for fabrication of 1st and 2nd generation AMUSE nozzle arrays. 
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Due to the difficulty of aligning the orifices with the apices of the pyramidal 
cavities, the fabrication process was modified to enable more facile and reproducible 
array fabrication and was used to generate a 20 x 20 array of 3-μm nozzles (2nd 
generation).132 In this workflow, silicon nitride is deposited on both sides of the cleaned 
wafer and the base pattern is generated as described above. KOH is used to etch through 
the silicon forming a large orifice that is capped by the additional silicon nitride layer. 
RIE is used to etch the orifice through the Si3N4 membrane layer and tungsten is sputter-
coated on top to further strengthen this layer. Due to the tungsten deposition, the diameter 
of the orifice diameter decreases from 5 μm to 3 μm as the tungsten coats the walls of the 
orifice opening. 
 
2.2.3. Improving Ion Transmission of AP Ion Sources 
One challenge commonly faced during AP ion generation is the low ion transfer 
efficiency, reported as the ratio of the detected ion current in the analyzer vs. the total ion 
current, from the source to the ion optics via the spectrometer’s AP interface (API) with 
estimated losses of up to 99.9% for ESI,207 99% for nESI,208 and 99.2% for AP-
MALDI.209 To mitigate this difficulty, several solutions have been proposed including air 
amplifiers (also known as Venturi devices),168, 210 flared inlet capillaries,211, 212 flared inlet 
capillaries coupled to Venturi devices,213 and ion funnels.214, 215 
Initial, proof-of-principle experiments performed by Aderogba, et al. using the 
AMUSE on a TOF mass spectrometer (Jeol JMS-100TLC (AccuTOF™), Peabody MA) 
demonstrated the ability of this device to generate ions from small test compounds.76 
However, inconsistent droplet/ion transmission and limited desolvation hindered further 
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practical use of the AMUSE ion source in that particular instrumental configuration (Fig. 
2.3). This is due to the relatively short distance between the AMUSE and the MS inlet 
(~5 mm), which limits the time for adequate desolvation, and to the small inlet aperture 
size (400 μm), which reduces the ion transmission efficiency as the droplet streams are 
not focused (inset of Fig. 2.3). Furthermore, desolvation at this orifice is limited when the 
original ESI ion source is replaced with the AMUSE device, as in this particular 
























Figure 2.3. Schematic of the AMUSE-TOF instrumental configuration. Inset shows 
AMUSE droplet production (AMUSE was assembled using protocol 1, see section 2.3.2). 
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Follow-up experiments involved coupling of AMUSE to a triple quadrupole 
(QqQ) mass spectrometer (PE-Sciex API III+, Perkin Elmer, Waltham, MA) which 
utilized a curtain gas interface. In this interface, a N2 curtain gas flows around the orifice 
to prevent orifice clogging by non-volatile material, to assist in droplet evaporation and to 
aid in declustering of ion-solvent clusters by collisions with gas molecules. AMUSE 
experiments in this instrumental configuration (Fig. 2.4) were unsuccessful primarily due 
to the outflow of N2 from the orifice which tended to blow away the low-linear velocity 


















Figure 2.4. Schematic of the AMUSE QqQ instrumental configuration. 
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These difficulties were circumvented by coupling the AMUSE to an ion trap (IT) 
mass spectrometer which uses a long (17.8 cm) heated capillary as the first element of the 
API as shown in Figure 2.5. Despite the substantial improvement in the performance of 
the device, sensitivity was still lacking leading to speculation that incorporation of a 













35 VDC, 300 ºC  
Figure 2.5. Schematic of the AMUSE-IT instrumental configuration. 
 
Venturi devices are devices that rely on the Venturi and Coanda effects.210 They 
have been applied to the task of focusing a charged droplet cloud towards the mass 
spectrometer inlet by Zhou, et al.,210 Hawkridge, et al.,216 Yang, et al.,168 and Dixon, et 
al.213, 217 The device consists of two threaded metal cylinders which, when attached, 
create an annular gap through which a high pressure gas flows. Compression of the gas at 
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this gap increases the velocity of the gas. This high velocity gas flowing along the walls 
creates a low pressure region in the center of the device, which provides suction as shown 
in Figure 2.6. Incorporation of a Venturi device in the AMUSE assembly and the 









Figure 2.6. Overview of Venturi device operation. (1) Compressed N2 enters the device 
and is (2) forced through a constriction. N2 then (3) flows along the curved inner surface 
at a high velocity creating (4) suction of the droplet cloud. 
 
2.3. Experimental Details 
2.3.1. Materials 
Reserpine (Sigma, St. Louis, MI), horse heart cytochrome C, (Acros Organics, 
Geel, Belgium), and leucine enkephalin (YGGFL, American Peptide, Sunnyvale, CA) 
were purchased and used without additional purification. Methanol (HPLC grade) was 
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purchased from Fisher (Hampton, NH). Working solutions of each compound (1–10 μM) 
were prepared in nanopure water (18 MΩ cm-1, Barnstead International, Dubuque, IA) 
containing 0.1% (v/v) glacial acetic acid (Sigma-Aldrich, St. Louis, MO). Except for 
initial exploratory experiments with reserpine, no organic solvent was added to the 
working solutions. The sample solution was delivered to the analyte reservoir at flow 
rates ranging from 30 to 100 μL min-1, equivalent to 75–250 nL min-1 per nozzle. 
 
2.3.2. Acoustic Micromachined Array Assembly 
The AMUSE assembly has undergone continuous modifications since its 
introduction in 2004.130 In initial experiments, the device was sealed using a combination 
of cyanoacrylate (Loctite SuperGlue®, Rocky Hill, CT), epoxy (2-ton epoxy®, Devcon, 
Danvers, MA), and double-sided polyimide tape (Kapton®, Dupont, Wilmington, DE) 











Figure 2.7. (A) AMUSE assembly components and (B) image of intact device assembled 
using protocol 1. 
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In this protocol, a 2-cm long liquid inlet tube (360 μm OD x 150 μm ID 
polytetrafluoroethylene (PTFE) tubing, Upchurch, Oak Harbor, WA) was glued into a 
375 μm-deep channel etched in a 0.5 mm-thick brass spacer using cyanoacrylate. The 
spacer was then attached to a gold-coated lead zirconate titanate piezoelectric transducer 
(PZT-880, American Piezo Ceramics, Inc., Mackeyville, PA) using double-sided 
Kapton® tape. Double-sided tape was also used to adhere the opposite side of the spacer 
to the micromachined 25-mm x 25-mm x 500-μm silicon wafer containing the array of 
400 pyramidally-shaped cavities each capped with a 5-μm orifice at the apex. A thin 
layer of epoxy was applied to the edges of the device and allowed to cure for 24 hours 
producing a water-tight seal around the entire device. 
This assembly protocol allowed for the execution of preliminary proof-of-
principle experiments but was not amenable to mass spectrometric analysis due to need to 
fully disassemble and decontaminate the prototype device when switching sample 
solutions. Use of this assembly protocol was further hindered by dissolution of the epoxy 
when using samples incorporating some organic solvent and difficulty in preventing 
leaks, which tended to trip the DC power supply due to shorts in the electrical circuit. 
To circumvent these issues, the assembly protocol was modified by Thomas P. 
Forbes, a collaborator working in the research groups of Drs. F. Levent Degertekin and 
Andrei G. Fedorov in the George W. Woodruff School of Mechanical Engineering at the 
Georgia Institute of Technology (personal communication). The current AMUSE 
assembly incorporates the ability to rapidly assemble and disassemble the device and is 
shown in Figure 2.8. 
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Figure 2.8. (A) AMUSE assembly components including (1) piezo, (2) Kapton® spacer, 
(3) silicone insert with PEEK sample inlet tube, (4) silicon array, (5) silicone spacer, and 
(6) brass spacer. (B) Image of intact device assembled using protocol 2. 
 
This assembly consists of six components compressed together using spring-
loaded clips. To assemble the device, a 2-mm thick gold-coated piezoelectric transducer 
(1) is topped by a 730-μm thick spacer made of double-sided Kapton® tape (2) and 
containing a 790-μm thick silicone insert (McMaster-Carr, Atlanta, GA) (3). This spacer 
is used to define the thickness of the 105-μL analyte reservoir. One edge of the silicone 
insert is pierced by a 3-cm long piece of 255-μm i.d. 510-μm o.d. poly-ether-ether-ketone 
(PEEK) tubing (Upchurch Scientific, Oak Harbor, WA) that is connected to the external 
sample flow circuit via a 1-mm slit cut into one side of the Kapton® spacer. The 24x24-
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mm micromachined nozzle array (4) containing 400 pyramidally-shaped 125-nL cavities 
each capped with a 3- or 5-μm diameter nozzle, is then placed on top of the spacer/insert 
assembly sealing the reservoir. A second silicone spacer (5) is placed on top of the nozzle 
array to protect it from accidental damage during the sealing process and is topped with a 
1-mm thick brass seal (McMaster-Carr, Atlanta, GA) (6) that provides a rigid surface for 
compression by a pair of spring-loaded clamps. 
 
2.3.3. AMUSE Setup and Operation 
Operation of the AMUSE required an electrical lead to be soldered to the 
electrode on each side of the piezoelectric transducer. In initial experiments (Fig. 2.9.A). 
The lead wire soldered to the interior electrode was directly connected to the active lead 
of a DC power supply (Stanford Research Systems Inc., Sunnyvale, CA) while the lead 
wire soldered to the exterior electrode was connected to an RF amplifier (ENI 350L, 
Electronic Navigations Industries, Rochester, NY) which amplified a 980 MHz sine wave 
generated by an external function generator (DS345, Stanford Research Systems, Inc., 
Sunnyvale, CA). The ground wires from each of these power sources were connected to a 
common ground. Sample was introduced into the reservoir by connecting the PEEK tube 
protruding from the assembled device to a 10-mL syringe via a Luer tip. In this 
configuration the AMUSE is self-pumping, therefore, no attempt was made to control the 
sample flow rate in these early experiments and gravity was used to ensure that the 
sample reservoir was replenished. 
 








(20 – 100 μL min-1)
DC Power Supply





Function Generator / RF 
Amplifier
910 / 980 kHz
0.22 / 0.30 VppDC Power Supply
0 – 200 VDC
(A) (B)
 
Figure 2.9. Electrical circuit used for (A) initial and (B) current AMUSE experiments 
(connections shown correlate to operation in DC-AMUSE mode). 
 
To determine the detection limits of this system, it became necessary to 
mechanically pump solution into the device which was accomplished by connecting the 
protruding PEEK tube to a piece of 508-μm i.d. PEEK tubing (Upchurch Scientific, Oak 
Harbor, WA), which was attached to a liquid handling pump (Valco Instruments Co., 
VICI M6, Houston, TX.). The optimal flow rate for each array was determined by 
balancing the solution and ejection flow rates. This was accomplished by pumping 
solution into the AMUSE reservoir using a low flow rate (20 μL min-1) until solution 
emerged from the nozzles, indicating that the AMUSE reservoir was full, and then 
turning on the RF amplifier to allow ejection. After 1 minute, the amplifier was turned off 
and the time required to refill the reservoir was recorded. The solution flow rate was 
increased by 10 μL min-1 and the process repeated until the refill time was less than 5 
seconds, the approximate refill time when using the self-pumping setup. 
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During initial experiments, it was observed that droplet ejection using the 
AMUSE was enhanced by directly connecting the RF ground wire to the interior lead 
wire (Fig. 2.9.A). However, this caused cross-talk between the DC power supply and RF 
amplifier resulting in tripping of the DC power supply and damage to the RF amplifier. 
The RF amplifier was replaced by a unit that incorporated a function generator (T&C 
Power Conversion Inc., Rochester, NY) and cross-talk between this unit and the DC 
power supply was overcome by the inclusion of two capacitors into the electrical circuit 
as shown in Figure 2.9.B. An oscilloscope (Tektronix, Beaverton, OR) was also included 
to allow monitoring of the amplified RF signal. 
Two AMUSE operating modes were explored. In DC-AMUSE operating mode, 
the electrical circuit shown in Figure 2.9.B is used and in addition to the RF signal, a DC 
potential ≤ 1000 VDC is applied to the inner electrode. Under the operating conditions 
used in this study, droplets approximately have an average diameter that is 1–2 μm larger 
than the orifice diameter.132 In RF-only AMUSE operating mode (Fig. 2.10), the 
connection between the exterior piezo electrode and the DC power supply was removed. 
Instead, the ground lead of the RF amplifier was directly connected to the interior piezo 
electrode and the only potential applied to the AMUSE is the RF potential which is in the 
frequency range of 900 kHz – 1 MHz with 0.220 – 0.300 VPP amplitude. 
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Liquid Inlet 
(20 – 100 μL min-1)
Oscilloscope
0.01 μF
Function Generator / RF 
Amplifier
910 / 980 kHz
0.22 / 0.30 Vpp  
Figure 2.10. Electrical circuit used for RF-only AMUSE experiments. 
 
Prior to mass spectrometric experiments, the AMUSE was placed approximately 
2 mm from the inlet of a stainless steel Venturi device (HMC Brauer Co., Milton Keynes, 
England) operated with N2 at rates of 0 – 17 L min-1. The N2 flow rate was controlled 
using a differential pressure flowmeter (Bel-Art, Pequannock, NJ). The N2 gas was used 
at room temperature except for experiments with proteins, where the N2 was heated using 
an inline air circulation heater (Omega, Stamford, CT) and a temperature controller 
(Eppendorf, Hamburg, Germany). 
 
2.3.4. MS Experimental Setup 
Initial experiments with 5-μm AMUSE devices were performed with a linear ion 
trap (LiT) mass spectrometer (LTQ, ThermoFinnigan, Waltham, MA). Access and 
training on the use of this instrument was provided by Dr. Charlene Bayer and Dr. Victor 
de Jesus in the Georgia Tech Research Institute. These experiments, which were carried 
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out in 2005, provided the framework for subsequent experiments using 3-μm devices 
performed with a quadrupole ion trap (QiT) mass spectrometer (LCQ Deca XP+, 
ThermoFinnigan, Waltham, MA) acquired by our group in early 2006. In both cases, the 
standard electrospray ion source was removed, and the Venturi device was positioned 
directly in front of the heated capillary inlet of the mass spectrometer as shown in Figure 
2.11. 
For LiT experiments, the following mass spectrometer settings were used: 13 – 34 
VDC inlet capillary voltage, 275 ºC capillary temperature, 100 – 200 ms trapping time. 
For QiT experiments, the following settings were used: 8 – 23 VDC inlet capillary voltage, 
300 ºC capillary temperature, 100 ms trapping time. Settings were optimized for the 
respective protonated molecules using the auto tune function of the mass spectrometer. 
Prior to mass spectrometric analysis, the liquid reservoir of the AMUSE device was 
primed with the sample to be analyzed, and after stable liquid ejection was visually 
verified, gas was supplied to the Venturi device and mass spectral data was acquired in 
positive ion mode. Conventional pESI and nESI experiments were performed on the QiT 
with the standard commercial ion sources provided by the mass spectrometer 
manufacturer (ThermoFinnigan, Waltham, MA), at a flow rate of 10 μL min-1 and 4.5 
kVDC for pESI, and 0.8 µL min-1, and 2.5 kVDC for nESI. Nanospray emitter tips (30-µm 
i.d.) were obtained from New Objective (Woburn, MA). 
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Figure 2.11. Schematic of Venturi-assisted AMUSE-MS setup.
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2.4. Effect of Venturi Device on Signal Intensity and Stability 
Visualization studies performed by Meacham, et al. showed that droplet ejection 
from the AMUSE produces droplets with velocities in the 10 – 20 m s-1 range which 
decelerate rapidly due to Stokes drag.131, 132 In terms of coupling this device to a mass 
spectrometer, this behavior translated into unstable focusing of the AMUSE-generated 
droplets on the mass spectrometer inlet. Zhou, et al. reported that the incorporation of a 
non-biased Venturi device can lead to a 5-fold increase in the [M+H]+ ion intensity of 
electrosprayed reserpine relative to signal obtained without the Venturi device, due to 
improved focusing of the highly-charged diverging nanodroplet cloud formed during 
ESI.210 Therefore, we speculated that the coupling of such a device to the AMUSE would 
provide the necessary droplet stream stabilization, focusing and desolvation to achieve 
more stable ionization of polar biomolecules. 
Figure 2.12 shows the mass spectra obtained for a reserpine solution ionized by 
the application of 100 VDC charging potential to a 5-μm AMUSE device with and without 
Venturi-assisted droplet desolvation. Reserpine was chosen as it is easily ionized and 
because it serves as a sensitive standard compound used by most instrument 
manufacturers. 
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Figure 2.12. Mass spectra for 4 pmols reserpine nozzle-1 ionized by a 1st generation 
AMUSE array (5-μm apertures), with (9.3 L min-1) or without (0 L min-1) Venturi-
assisted droplet desolvation and focusing. The solvent used in both cases was 
10:89.9:0.1 (v:v:v) methanol:water:glacial acetic acid. AMUSE settings: 100 VDC, 
40 μL min-1 liquid flow rate, LiT detection. 
 
As can be seen in the figure, the signal intensity of the protonated molecule (m/z = 
609.2) obtained using the Venturi device was increased 10-fold with respect to that 
obtained without it. A similar gain in signal-to-noise (S/N) ratio was observed. This gain 
is a result of both the improved stabilization and transmission of the ejected droplet 
stream into the heated capillary inlet, and of the aforementioned desolvation effect 
afforded by the Venturi device. 
The greater sensitivity gain obtained here (10x) compared to that reported by 
Zhou, et al. in the absence of a potential applied to the Venturi device (5x), can most 
likely be attributed to the improved sampling of the multiple droplet streams when the 
AMUSE is used in the Venturi mode. Figure 2.13 shows the total ion trace obtained for 
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the reserpine mass spectrum obtained when the gas flow to the Venturi device is shut off 
(Fig. 2.13.A) and when the device is operated at a flow rate of 9.3 L min-1 (Fig. 2.13.B). 
As can be seen in Figure 2.13.A, unstable droplet collection when there is no Venturi 
assistance causes the signal to oscillate precipitously throughout the analysis, leading to a 
large instability in the detected signal (% relative standard deviation (RSD) = 202%). 
Incorporation of a Venturi device increased the overall stability of the source to 47% 
RSD, but sensitivity was still lower than expected, most likely due to the relatively large 
initial droplet diameter produced by the 5-μm nozzle array. 
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Figure 2.13. Total ion trace for 4 pmols reserpine nozzle-1 ionized by a 1st generation 
AMUSE array (5-μm apertures) with no N2 flowing through the Venturi device (A) and 
with 9.3 L min-1 N2 flowing through the Venturi device (B). The solvent used was 
10:89.9:0.1 (v:v:v) methanol:water:acetic acid. Operating conditions: 100 VDC, 
40 μL min-1 liquid flow rate, LiT detection. 
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2.5. Comparison of 1st and 2nd Generation Arrays 
As demonstrated by the higher sensitivity afforded by nESI and μESI relative to 
that of ESI, droplet size has a significant impact on the quality of mass spectra obtained. 
To that end, experiments were performed to compare the absolute signal intensity and 
S/N ratio observed for the analysis of reserpine and YGGFL solutions prepared using 
nanopure water with 0.1% acetic acid using a 1st generation array having 5-μm apertures 
(6-7 μm diameter droplets) and a 2nd generation array having 3-μm apertures (4-5 μm 
diameter droplets).132 The droplet ejection and Venturi focusing conditions were 
optimized for each device type. An applied DC potential of 100 VDC was used in all 
cases, which represents a 20- to 45-fold decrease in charging voltage if compared to 
traditional electrospray operation. The results of these studies are shown in Figure 2.14. 
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Figure 2.14. AMUSE mass spectra produced by averaging 1.2 sec of data obtained using a 1st generation array (5-μm apertures) for 
(A) 5 μM reserpine and (B) 10 μM YGGFL or a 2nd generation array (3-μm apertures) for (C) 5 μM reserpine and (D) 5 μM YGGFL. 
Operating conditions: (A-B): 100 VDC, 100 μL min-1 liquid flow rate, 7.5 L min-1 N2; (C-D): 100 VDC, 30 μL min-1 liquid flow rate, 
9.3 L min-1 N2. The absolute intensity of the base peak is given in the upper right corner of each panel. 
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The ion intensity of the [M+H]+ peak of reserpine (m/z = 609.2) using the 3-μm 
device was more than 30,000 times greater than that of the 5-μm device, while the overall 
S/N ratio was increased from 172 for the 5-μm device to 345 for the 3-μm device. 
Improvements were also observed for the ionization of YGGFL, where the absolute 
signal gain was greater than 3,000, while the S/N ratio showed a 10-fold increase. When 
examining these improvements, it must also be considered that LiT MS detection was 
used to measure ions produced by the 5-μm device while QiT MS detection was used to 
measure ions produced by the 3-μm devices. As LiT detection is more sensitive than QiT 
detection due to a larger ion trapping capacity, these results suggest that had the 
experiments using the 3-μm device been performed on the LiT, the improvement in 
response could have been even greater. 
One interesting observation arising from inspection of the AMUSE mass spectra 
of YGGFL is the relatively abundant peaks of the dimer ([2M+H]+; m/z = 1111.1) and 
trimer ([3M+H]+; m/z = 1666.1) ion species (Fig. 2.14 B and D). These peaks are 
generally not observed in pESI mass spectra (Fig. 2.15), therefore, their presence in mass 
spectra obtained using AMUSE ionization suggests that the ionization processes in 
AMUSE may differ from those of ESI. 
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Figure 2.15. Mass spectra for a 1 μM YGGFL solution prepared in 99.9:0.1 (v:v) 
water:acetic acid obtained using pESI (10 pmol; 10 μL min-1, 4500 VDC, OiT detection.) 
 
In the AMUSE, droplets production does not rely on Taylor cone 
electrohydrodynamic instability and vigorous Coulombic explosions as is typical in ESI. 
The lower DC potential applied to the droplets produced by the AMUSE is still capable 
of inducing droplet charging by electrophoretic charge separation or electrochemical 
reactions. This fundamentally different ionization mechanism possibly favors ion 
formation by evaporation of solvent from the charged droplets rather than ion 
evaporation, thus, favoring the stabilization of non-covalent interactions and possibly 
producing softer ionization than ESI. This suggests that AMUSE ionization may find 
applicability for the ionization of labile species such as non-covalent protein complexes. 
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Because individual liquid ejection from each cavity is not yet implemented in the 
prototype devices evaluated here, it is not possible to estimate the number of droplet 
streams being sampled by the inlet capillary. Thus, detection limits can only be estimated, 
but not accurately calculated, until development of a fully multiplexed AMUSE device, 
which enables ejection from a single nozzle, is accomplished. The amount of reserpine 
giving rise to the mass spectrum in Fig. 2.14.A (5-μm nozzle array) was 10 picomoles. 
Extrapolation of this signal, which gave S/N = 172, to signal having S/N = 3 corresponds 
to a theoretical detection limit of 174 femtomoles reserpine. For the reserpine signal 
detected from a 3-mm nozzle array, the theoretical detection limit was 26.1 attomoles 
reserpine. These theoretical limits of detection are on the same order as those for other 
common spray-based ionization techniques such as ESI,31 pESI,51 UA-ESI,70 and nESI,218 
which are typically in the low femtomole – attomole range for common protein and drug 
standards. Calculation of the amount of analyte ejected per nozzle required that the 
number of ejecting nozzles be visually estimated. It was observed that the average 
number of nozzles ejecting at a given time was typically 10% for the 5-μm arrays and 
25% for 3-μm arrays. This corresponds to a theoretical detection limit of 4.4 femtomoles 
reserpine/nozzle for the 5-μm devices and 0.26 attomoles reserpine/nozzle for 3-μm 
devices. 
The Venturi device N2 flow rate was found to have a marked effect on the 
intensity of the [M+H]+ (m/z = 556.1) YGGFL ion. The results shown in Figure 2.16 
suggest that the optimum flow rate of N2 to the inlet of the Venturi device is between 7 – 
10 L min-1 which is amplified 10-fold at the outlet, according to the manufacturer’s 
specifications.219 
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Figure 2.16. Intensity of [M+H]+ ion of YGGFL vs. Venturi device N2 flow rate for a 
1 μM solution in 99.9:0.1 (v:v) water:acetic acid using an array with 3-μm nozzles. 
Operating conditions: 100 VDC, 35 μL min-1 liquid flow rate, QiT detection. 
 
The use of 3-μm arrays in combination with the Venturi device not only increased 
sensitivity, but also increased the stability of the ion signal, as seen in Figure 2.17, which 
shows the total and extracted ion traces for the ionization of a 5 μM solution of YGGFL. 
The 3-μm devices were shown to be stable (8.5% RSD) for up to 30 minutes at the liquid 
flow rates assayed here. Using these optimized conditions, the effect of changing the bias 
voltage used for droplet charging during ionization was explored. 
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Figure 2.17. Total ion trace (black) and extracted ion trace for [M+H]+ = 556.1 (red) for 
the continuous ejection of 5 μM YGGFL using a 3 μM AMUSE array. Operating 
conditions: 100 VDC, 30 μL min-1 liquid flow rate, 4.0 L min-1 N2, QiT detection. 
 
2.6. Effect of Varying the Applied DC Potential 
Despite the use of the word “electrospray” in the AMUSE acronym to provide 
familiarity, ionization by the AMUSE is accomplished in a different manner than in 
conventional electrospray due to decoupling of droplet formation and charging. The 
decoupling of these two processes enables the stable ionization of peptides and small 
molecules dissolved in acidified aqueous solutions at potentials of a few hundred volts. 
This results in safer operation of the ion source and enables placement of the AMUSE 
assembly in close proximity to the Venturi device inlet without generating electrical 
discharges, which provides improved droplet suction into the device and better focusing. 
To further explore the dependence of AMUSE ion generation on the applied DC 
charging potential, a series of spectra were collected for the analysis of a 1 μM YGGFL 
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solution at different DC bias voltages. Figure 2.18 shows the intensity of the protonated 
molecule of YGGFL (A) as well as the corresponding S/N ratio (B) as a function of the 
applied DC potential. 
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Figure 2.18. (A) Absolute intensity and (B) S/N for the YGGFL [M+H]+ ion vs. DC 
charging potential for a 1 μM solution using an AMUSE array with 3-μm nozzles. 
Operating conditions: 40 μL min-1 liquid flow rate, 7.2 L min-1, QiT detection. 
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As can be seen in this figure, it is possible to obtain ionization using a range of 
potentials, or even without any DC potential at all (RF-only AMUSE mode). The 
absolute intensity appears to be at a maximum at approximately 350 VDC while the 
corresponding S/N ratio appears to increase throughout the entire range of applied DC 
potentials, with a local maximum at 280 VDC. Although Fig. 2.18.A shows that signal 
intensity for RF-only AMUSE is low compared to that obtained using a DC charging 
potential, RF-only AMUSE provides higher S/N due to a simultaneous reduction in 
baseline noise as discussed in detail in section 3.9. For charging voltages of 350 VDC and 
higher, significant liquid buildup on the device surface was observed, which hindered 
droplet ejection from some nozzles or nozzle clusters. This phenomenon was 
accompanied by a concomitant reduction in signal intensity. One possible explanation to 
this phenomenon is that the negatively-charged hydroxyl group on the tungsten oxide 
array surface may attract the positively-charged liquid meniscus produced at the onset of 
the droplet ejection event.220 Higher potentials cause higher surface droplet charging, and 
thus could favor wetting of the tungsten surface. Covalent chemical modification of the 
array surface via silane chemistry to minimize this effect is currently being investigated 
and is described in Chapter 4. 
Devices with smaller nozzle orifice diameter appeared to produce the most stable 
signal with no DC potential applied at all. Figure 2.19 shows the mass spectrum and total 
ion trace obtained for a 1 μM YGGFL solution when the AMUSE was operated in RF-
only mode. The S/N ratio of the [M+H]+ peak obtained using this mode was 41, while the 
total ion trace showed a 2.6% RSD over the course of one minute. In this ionization 
mode, the RF voltage signal induces periodic charging on the electrode facing the analyte 
Hampton, C. Y.  60 
solution. With amplification, the amplitude of the RF signal needed for ejection 
approaches 50 – 150 VPP, so the period-averaged positive potential seen by the sample is 
+ (50 – 150) VPP / (2π) = (8 – 24) V, sufficient for droplet charging, as observed from 
experiments with time-invariant DC potentials. In other words, we speculate that droplet 
charging still occurs even though the DC bias is not applied to the electrode. It must be 
noted, however, that this mode is less efficient, as the analyte “sees” the positive potential 
only half of the time, thus leading to the lower S/N ratio observed. 
 
m/z








































Figure 2.19. Mass spectrum (A) and total ion trace (B) obtained for 1 μM YGGFL in 
RF-only AMUSE mode using an array with 3-μm nozzles. Operating conditions: 0 VDC, 
40 μL min-1 liquid flow rate, 7.2 L min-1 N2, QiT detection. 
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2.7. AMUSE Ionization of Proteins 
To further explore the usefulness of AMUSE as a viable ionization technique for 
biological MS, the feasibility of ionizing a model protein from aqueous media was 
investigated. Initial experiments with 4 μM cytochrome C in 0.1% acetic acid (pH 3.2) 
yielded spectra with low S/N ratio, as shown in Figure 2.20.A. This can most likely be 
attributed to incomplete protein ion desolvation, as proteins are more difficult to 
desolvate due to their larger number of hydrogen-bonding sites. 
To improve desolvation, a heater was used to increase the temperature of the N2 
flowing through the Venturi device. Figure 2.20.B shows the spectrum obtained for the 
same solution and identical conditions to the spectrum in Figure 2.20A but with the 
addition of N2 heated to 40 ˚C, as measured at the outlet of the Venturi device. The use of 
heated N2 caused a slight narrowing of the charge state distribution generating a spectrum 
with an average charge state of 8.8, and a S/N ratio of 55 for the +8 charge state as 
compared to an average charge state of 10 and S/N ratio of 7 for the +11 charge state in 
the spectrum obtained using ambient temperature N2. 
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Figure 2.20. Mass spectra of cytochrome C (2.4 pmol nozzle-1) obtained using an array 
with 3-μm apertures and flowing (A) room temperature N2 or (B) 8 L min-1 N2 heated to 
40 ºC through the Venturi device. Operating conditions: 60 μL min-1 liquid flow rate, 
100 VDC, QiT detection 
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Additional experiments demonstrated that it was also possible to ionize 
cytochrome C in RF-only AMUSE mode, as shown in Figure 2.21. In this spectrum, the 
+8 charge state peak had an S/N ratio of 21 and the average charge state of the entire 
distribution was 8.9, which almost identical to the value obtained for the spectrum shown 
in Figure 2.20.B. 
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Figure 2.21. RF-only AMUSE mass spectrum of cytochrome C using an array with 
3-μm apertures (240 pmol total). Operating conditions: 0 VDC, 60 μL min-1 
liquid flow rate, 8 L min-1 N2 heated to 40 ºC, QiT detection. 
 
Figure 2.22 shows the nESI mass spectrum obtained for the exact same solution 
previously ionized with the AMUSE. As can be seen in the figure, the charge state 
distribution in this case was quite narrow, yielding an average charge state of 9.24, which 
is higher than what was obtained using the AMUSE. 
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Figure 2.22. Mass spectrum of cytochrome C in 99.9:0.1 (v:v) water: acetic acid 
obtained with nESI (0.8 pmol, 0.8 μL min-1, 2500 VDC, QiT detection). 
 
This charge state distribution is consistent with previous reports for cytochrome C 
solutions containing no organic solvent and at a pH higher than 3.221 The slight decrease 
in the average charge state observed using the AMUSE relative to that using nESI could 
be attributed to the gentler ionization provided by the Venturi device as reported by 
Yang, et al.168 This could also possibly be attributed to the AMUSE ionization process 
itself. By comparison, pESI (Fig. 2.23.A) and nESI (Fig. 2.23.B) using the more standard 
1:1 methanol:water with 0.1% acetic acid solvent mixture (pH 4.0) and under the exact 
same instrumental conditions produced spectra having wide charge state distributions and 
an average charge state of 16. 
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Figure 2.23. Mass spectra of cytochrome C in 50:49.9:0.1 (v:v:v) methanol:water:acetic 
acid obtained with (A) pESI (10 μL min-1, 4500 VDC, OiT detection) and 
(B) nESI (0.8 pmol, 0.8 μL min-1, 2500 VDC, QiT detection). 
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2.8. Conclusion 
The results presented here are the first demonstration of the sensitive and stable 
ionization of proteins and peptides at femtomole levels per nozzle by using the Venturi-
AMUSE ion source. This was possible without the addition of organic solvent into the 
analyte mixture and using very low, or no, applied charging potential, thus opening new 
avenues for the production of gas-phase ions for biological MS. The incorporation of the 
Venturi device provided a 10-fold gain in both the signal and S/N ratio for a reserpine 
spectrum obtained using a 5-μm array as well as a 4-fold reduction in the relative 
standard deviation of the corresponding total ion trace indicating an overall increase in 
sensitivity and stability as a result of the improved droplet desolvation and focusing 
efficiency of this setup. 
Modifications to the fabrication protocol to generate 3-μm arrays led to an 
increase in sensitivity by at least 3 orders of magnitude and a 2- to 10-fold increase in the 
S/N ratio. The stability of the signal produced by the AMUSE was also much improved 
using the new arrays yielding a relative standard deviation of 11.3% in the intensity as 
measured over 30 minutes while that measured over 1 minute was generally 2-3%. The 
effectiveness of this device for the soft ionization of cytochrome C in aqueous media was 
also examined, yielding spectra with an average charge state of 8.8 when analyzed with a 
100 VDC charging potential. Ionization of model proteins was also possible in RF-only 
AMUSE mode. The reduced average charge state for cytochrome C when interrogated by 
AMUSE provided further support for the need for experiments to investigate AMUSE 
ionization mechanisms which is described in the next chapter. 
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CHAPTER 3. INTERNAL ENERGY DEPOSITION OF 
VENTURI-ASSISTED ESI AND AMUSE 
 
3.1. Abstract 
A detailed comparison of the internal energy (IE) deposition of Venturi-assisted 
AMUSE, with and without the application of a DC charging potential, and Venturi-
assisted ESI using the “survival yield” (SY) method on a series of para-substituted 
benzylpyridinium salts is presented in this chapter. An explanation of the importance of 
ion energetics in MS is provided followed by a tutorial explanation of the SY method for 
measuring the mean internal energy (<E>) of a given ion population. Under conditions 
previously shown to provide maximum ion yields for standard compounds when 
analyzed by either Venturi-assisted AMUSE or Venturi-assisted ESI, the observed <E> 
between these two techniques were nearly identical (1.93 – 2.01 eV). AMUSE operation 
without N2 flow to sustain the Venturi focusing effect generated energetically-colder ions 
with <E> that were up to 39% lower than those for ESI. This suggested that a balance 
between improved ion transfer, adequate desolvation and favorable ion energetics could 
be achieved by selection of optimum operational ranges for the parameters that most 
strongly influence the ion population, namely the Venturi device gas flow rate and API 
capillary temperature. An investigation of the effect of these parameters on ion energetics 
is presented and the chapter concludes with a discussion of the effect of varying these 
parameters on the quality of MS signal obtained. 
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3.2. Importance of Ion Energetics in MS 
Internal energy (IE) is defined as the “total energy of a species above its 
electronic, vibrational and rotational ground state.”222 In MS, IE has a profound effect on 
the reactivity of gas-phase ions and a significant influence on the ion species observed in 
the mass spectrum of a given compound as the amount of IE deposited on a molecule 
during ionization is one of the biggest predictors of whether the analyte will survive 
intact or fragment prior to reaching the mass analyzer. 
 
3.2.1.  IE Deposition by Various Ionization Techniques 
As MS measurements are performed under vacuum, ions are effectively isolated 
from their environment once in the mass spectrometer. Thus unwanted IE deposition 
most generally occurs prior to the ions entering the mass analyzer, i.e. during ionization 
or, for instruments utilizing differential pumping, during transmission of ions from AP to 
the vacuum region of the mass spectrometer via an API. Although energy can also be 
intentionally deposited on the ions once they are in the mass analyzer to induce 
dissociation via either collisions with a gas, surface, or electrons, these processes are 
controlled and do not affect the initial IE of the ions and thus will not be included in this 
discussion. 
Three factors determine the initial IE of an ion (1) the IE of the analyte prior to 
ionization, (2) the number of degrees of freedom (DOF) in the analyte, and (3) the 
amount of energy deposited during ionization and subsequent transmission through the 
API. Most ionization techniques can be loosely classified as being either hard or soft 
depending on the amount of IE they deposit on the ions, as briefly mentioned in section 
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1.2 during the discussion of the proto-typical examples of hard and soft ionization 
techniques, EI and CI. However, strictly speaking, EI and CI can be placed into either 
category depending on the energy of the primary electron beam used to ionize the analyte 
(EI) or the choice of reagent gas (CI), and on our particular definitions for “hard” and 
“soft”, with regards to IE deposition. In general terms, a hard ionization technique is 
defined as a technique that produces spectra containing abundant fragment ions while a 
soft ionization technique is defined as a technique that produces spectra dominated by the 
presence of an intact analyte ion. Clearly, this is also a function of the chemical structure 
of the ions being considered, and the nature of the chemical bonds present (covalent and 
non-covalent). As an example of the extreme difference between spectra obtained using 
hard and soft ionization techniques, consider Figure 3.1. 
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Figure 3.1. (A) EI mass spectrum of reserpine showing M+. and significant fragmentation 
(reproduced from the NIST database223). (B) ESI-QiT mass spectrum of 1 μM reserpine 
in 50:49.9:0.1 (v:v:v) methanol:water:acetic acid showing [M+H]+ and fragments at m/z 
196 and 396 (10 μL min-1, 5000 VDC). 
Hampton, C. Y.  70 
Figure 3.1 shows mass spectra of reserpine obtained using EI-MS (Fig. 3.1.A) and 
pESI-QiT (Fig. 3.1.B). The EI-MS spectrum clearly demonstrates the extensive 
fragmentation that is typical for hard ionization techniques while the relatively clean 
pESI-QiT mass spectrum shown in Fig. 3.1.B is dominated by the presence of [M+H]+ 
and shows very few fragment peaks. 
Hard ionization techniques, such as EI, typically produce, high-IE ions (“hot” 
ions, 10’s of electronvolts222) which tend to fragment in the timeframe prior to reaching 
the detector of the mass spectrometer as a result of electronic and vibrational excitation of 
the ions induced by collision with energetic electrons (70 eV). As a result, mass spectra 
produced via EI may show some signal due to the intact radical ion (M+., formed by the 
loss of an electron from the valence shell of the gas-phase molecule, M), but also show 
extensive fragment ion species. This type of spectral data is particularly useful for the 
identification of organic compounds as the fragments observed can be matched against 
databases and correlated to the cleavage of specific bonds in the molecule as it undergoes 
gas-phase unimolecular dissociation. Since the energy deposited by these sources is 
typically fixed and ionization occurs under vacuum, spectra are highly reproducible; thus, 
mass spectral databases can be transferred among different types of instruments. 
However, as explained in section 1.2, these methods are not amenable to the analysis of 
labile species, and may be impractical for the identification of molecules not in the 
database, as molecular weight information may be missing. 
The generation of low-IE ions is particularly important for the study of fragile 
organic and biological compounds and non-covalent biological species, such as protein 
complexes. The development of soft ionization techniques now considered routine was 
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motivated by the need to ionize large species without fragmentation. Examples include 
MALDI (mean IE = 3-5 eV224, 225) and ESI (mean IE = 1-3 eV226, pESI,226 μESI,227 and 
nESI227 also show IE deposition in the same range). These techniques produce low-IE 
ions (“cold” ions, < 10eV222) which typically reach the mass spectrometer detector intact. 
These “survivors” generally appear as intact ions formed by adduction of an ion to the 
molecule, such as the protonated molecule ([M+H]+), in the mass spectrum. However, 
fragment ions or cluster ions may also be observed if the appearance energy of the 
molecule (Eapp, the minimum IE required to observe a given fragment ion) is low or if the 
ion source parameters are modified to allow for high IE deposition as described in section 
3.2.2. 
Despite the widespread appeal of MALDI and ESI, there has been considerable 
activity towards the development of even “softer” methods. For example, AP-MALDI,34 
sonic spray ionization (SSI),228 electrosonic spray ionization (ESSI),229 and cold spray 
ionization (CSI)230 were developed with the intent of exploring improved ways for 
detecting biological species such as peptides,231 proteins,232, 233 non-covalent 
complexes,234 and nucleic acids.235 
AP-MALDI has been shown to produce ions with mean IE similar to ESI (1-3 
eV236). This is colder than conventional vacuum MALDI as the IE of the AP-MALDI ion 
population is reduced through low-energy collisional cooling with ambient gas prior to 
entering the mass spectrometer and within the API. In SSI, droplets are produced by the 
flow of solution through a fused silica capillary with a high velocity gas flow coaxial to 
the capillary. The technique is similar to pESI but differs in that no potential is applied 
between the capillary and the counter-electrode and the gas flow rates are 100 times 
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higher than those of pESI. Although ion generation in SSI is not completely understood, 
one possible mechanism is that charging occurs via the statistical charging model 
proposed by Dodd237 which states that, although the bulk liquid is electrically neutral, 
microscopic fluctuations in the ion concentration in the bulk liquid lead to the formation 
of some droplets having a positive or negative charge. Although SSI has been shown to 
form more clusters than ESI,231 suggesting that it is softer than ESI, recent experiments 
by Zenobi and coworkers demonstrated that the actual IE deposited on the ion population 
in SSI is the same as that of ESI (1 – 3 eV).227 Like SSI, ESSI, which is essentially SSI 
but with a potential applied to a union through which the analyte flows before it enters 
the SSI probe, has been shown to have an IE deposition similar to that of ESI.227 
In CSI, the temperature of both the sample probe (similar to the design used in 
ESI, pESI, or SSI) and desolvation chamber is reduced to temperatures ranging from -80 
to 10 ºC, causing a concomitant reduction in the IE of the system prior to ionization.226, 
230, 235 No measurements of the IE deposited on ions by CSI have been reported, thus it is 
unclear if the reduction in system IE translates into a reduction in the final energy of the 
fully desolvated ions. However, Albiz and coworkers recently compared the performance 
of CSI and ESI for the characterization of protein conformation and ionization of 
noncovalent complexes and found a shift to lower charge states in the CSI protein mass 
spectra suggesting that these ions may indeed be colder than those of ESI.238 Like CSI, 
AMUSE ionization of proteins has also demonstrated a shift to lower charge states as 
shown in Section 2.7 suggesting that AMUSE ions could also be colder than those of ESI 
and providing motivation for an investigation of IE deposition by this technique. 
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3.2.2. Parameters Affecting IE Deposition in AP Spray-Based Ion Sources 
In AP spray-based ion sources, the parameters which most strongly affect IE 
deposition can be loosely categorized as parameters which affect droplet desolvation226 
and parameters affecting ion transmission.239 Efficient droplet desolvation in spray-based 
sources is critical to obtaining high ion yields from most analytes as evidenced by the 
increased sensitivity for peptides using nESI (subattomole68) in comparison to ESI 
(femtomole240). This is a direct result of the smaller nESI average droplet radius (<200 
nm50) compared to that by ESI (1 μm53). Consequently nESI droplets experience 
enhanced desolvation,68 tolerate higher salt concentrations (and consequently have lower 
background noise) due to the decreased amount of solvent in these smaller droplets,68, 241 
and show higher ion surface activity due to the higher surface-to-volume ratio, which 
enhances ion evaporation mechanisms.68 However, in spray-based ion sources the excess 
energy not used to aid in droplet desolvation can be imparted into IE modes; thus, by 
modulating the parameters that affect droplet desolvation, it is possible to reduce IE 
deposition although reduced signal intensities may also result. The parameters which 
most strongly effect desolvation are the ion source pressure,242 acceleration potential in 
the skimmer region of the API,239, 243 and incorporation of heat in the ionization probe via 
use of a heating block encasing the probe,46 prior to entry into the API via heated gas,133, 
244, 245 or in the API via a heated capillary.246 
Karas and coworkers used nESI to monitor the signal intensity of maltopentaose, 
a carbohydrate that requires harsh desolvation conditions, and its corresponding fragment 
species. This data was used to determine the relative IE deposition upon changing the 
source pressure by calculating the fragmentation ratio (fragment ion intensities / 
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precursor ion intensity) and comparing this ratio for each set of conditions tested.242 
Increasing the source pressure from 0.84 to 2.0 mBar (0.6 to 1.5 mTorr) was found to 
improve desolvation and to cause a decrease in IE deposition as indicated by an 80% 
decrease in the fragmentation ratio. This effect can be explained by considering the 
interdependence of the droplet evaporation and ion activation processes. Gomez and 
Tang demonstrated that ESI droplet sizes are represented by a bimodal distribution in 
which the larger diameter distribution represents residual parent droplets while the 
smaller diameter distribution is due to progeny droplets, which usually become fully 
desolvated and are detected.50 By raising the source pressure, this lower abundant 
desolvated fraction of the ion population may undergo ion activation after colliding with 
gas in the source. However, the more abundant large diameter droplets will be desolvated 
due to an increase in the number of low-energy inelastic collisions resulting in energy 
transfer to the gas molecule. These droplets will also experience a concomitant reduction 
in kinetic energy prior to entering the mass analyzer and being detected. This collisional 
cooling of the droplets translates into a mass spectrum having a lower fragmentation ratio 
indicating lower IE deposition. This effect was verified by Gabelica et al. who studied the 
shape of the IE distributions obtained using the SY method (section 3.3) and observed a 
reduction in IE deposition and narrower distributions when the source pressure was 
increased from 1.65 Torr to 2.93 Torr, also indicating more efficient desolvation.247 
Increasing the potential gradient in the first skimmer region has been shown to 
cause an increase in IE deposition,248, 249 and this is the basis of in-source collision 
induced dissociation (CID) experiments. This can be attributed to an increase in kinetic 
energy in a medium pressure region caused by the acceleration voltage. Hoxha et al. 
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performed ion trajectory calculations to gain an understanding of this phenomenon and 
observed that 90% of the IE uptake occurs at the first stage of the API suggesting that 
activation occurs primarily as a result of high energy collisions in this region.250 
Frictional heat as a result of these collisions also contributes to the increased IE.251 
De Pauw and coworkers demonstrated that the addition of thermal energy 
generated mass spectra showing a higher fragmentation extent.247 This thermal energy, 
which was supplied to the analyte by increasing the temperature of the mass 
spectrometer’s capillary inlet, resulted in improved desolvation leading to an excess of IE 
that was no longer needed to aid in desolvation. 
As mentioned in section 2.2.3, AP ionization techniques suffer from ion transfer 
losses of up to 99% of ions.207-209 In our previous work, we observed that coupling a 
Venturi device to the AMUSE resulted in a 10-fold gain in S/N ratio of 10 μM reserpine 
accompanied by a 77% reduction in %RSD of the signal.133 We attributed these 
improvements to the increased droplet velocity and droplet desolvation; thus, it is likely 
that use of Venturi devices will contribute to the overall IE deposition due to increased 
kinetic energy of the entrained droplets as they pass through the low pressure region of 
the device and due to improved desolvation. However, no measurements of the IE 
deposition by these devices had ever been reported. Therefore, we performed an 
investigation of the effect of these devices when coupled to AMUSE and ESI focusing on 
the effect of varying the flow rate of N2 through the Venturi device and the API capillary 
inlet temperature as those parameters most strongly affect desolvation. The survival yield 
(SY) method developed by Kenttämaa and Cooks was used to measure the IE 
deposition.252 
Hampton, C. Y.  76 
3.3. Measuring IE Deposition – The Survival Yield Method 
The SY method correlates the fragmentation extent of a thermometer molecule 
with the IE deposited on it during the ionization process.252 Thermometer molecules are 
generally small, well-characterized compounds that undergo a specific dissociation(s) at a 
known critical energy (E0, the minimum energy of the precursor ion needed to overcome 
the dissociation energy barrier). Several compounds such as benzylpyridinium salts,247, 
249, 251, 253-255 peptides such as YGGFL,236, 254 and protonated esters254 have been used as 
probe ions. Collette and De Pauw introduced the use of substituted benzylpyridinium 
salts as probe ions because they undergo a simple cleavage reaction at known 





benzyl cation  
Scheme 3.1. Scheme showing the dissociation reaction of p-substituted benzylpyridinium 
ions to produce neutral pyridine and a p-substituted benzyl cation. 
 
By using a series of p-substituted benzylpyridinium salts which have a similar 
number of DOF but differing dissociation energies,247 the simultaneous measurement of 
SY for each molecule under controlled experimental conditions is obtained. The critical 
energy can be empirically calculated as the heat of the fragmentation reaction (ΔHr), 
which is the difference in ground state energy between the precursor ion (ΔHf(Py+R), heat 
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of formation of benzylpyridinium cation) and its fragment ions (heat of formation of 
pyridine (ΔHf(Py) and the benzyl cation (ΔHf(R+))) as shown in Equation 3.1.253 
 
 R)(PyΔH)](RΔH(Py)H[ΔHE ffff0
++ −+Δ=Δ=  (Eq. 3.1) 
 
The critical energies for the p-substituted benzylpyridinium salts used in these studies 
having tert-butyl- (tBu), methyl- (CH3), fluoro- (F), chloro- (Cl), cyano- (CN) and nitro- 
(NO2) substituents are given in Table 3.1. 
 
Table 3.1. Nominal m/z for precursor and product ions, critical energies, and DOF for the 
p-substituted benzylpyridinium compounds used. *Critical energies taken from 







(eV) * DOF 
OCH3 200 121 1.508 81 
tBu 226 147 1.738 105 
CH3 184 105 1.767 78 
F 188 109 1.867 69 
Cl 205 125 1.899 69 
CN 195 116 2.097 72 
NO2 215 136 2.352 75 
 
The SY method is predicated by two assumptions: (1) all ions having the same 
DOF have identical P(E) and (2) ions do not dissociate until their IE surpasses their 
intrinsic dissociation threshold. SY for a thermometer ion (Equation 3.2) can be 
determined experimentally by measuring the fraction of ions below (IntProduct, the 
intensity of the product ion peak in the mass spectrum) and above (IntPrecursor, the intensity 
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of the precursor ion peak(s) in the mass spectrum) the dissociation threshold (critical 








=  (Eq. 3.2) 
 
This is theoretically equivalent to the value of the integral below the P(E) curve 
evaluated from E=0 to E0, the dissociation energy of the molecule. The SYs of these 
compounds plotted against their respective dissociation energies can then be fitted to a 
sigmoidal function with the general form described in Equation 3.3 and differentiated to 



















 (Eq. 3.3) 
 
The parameters a, b and x0 in Equation 3.3 are variables fitted to the experimental 
data. Finally, the mean internal energy (<E>) of the ions (which give the average IE of 













E  (Eq. 3.4) 
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The observed <E> deposition not only depends on the intrinsic dissociation rate 
constant and activation energy, but is also strongly influenced by the time scale of the 
mass spectrometric experiment, manifested as the excess energy (“kinetic shift”) required 
to observe dissociation products. For absolute measurements or for comparative 
measurements utilizing different types of mass analyzers, correction for this kinetic shift 
is necessary but can be a challenging task as it requires knowledge of the ions’ residence 
times as they are transported and analyzed within the different stages of the mass 
spectrometer. However, a comparison of the relative changes in P(E) as a result of using 
different ionization techniques with the same mass analyzer can be accurately obtained if 
the residence time remains consistent throughout all experiments or/and if the SYs of the 
ions used in calculating P(E) do not vary significantly within the experimental time scale. 
 
3.4. Experimental Details 
3.4.1. Synthesis and Preparation of Thermometer Compounds 
Pyridine, nitromethane, anhydrous diethyl ether, anhydrous ethanol and the para-
substituted benzyl halide starting reagents were purchased from Sigma-Aldrich (St. 
Louis, MO) and used without further purification. All compounds except the methoxy-
substituted salt (OCH3; Arkat USA, Inc., Gainesville, FL) were synthesized by Catherine 
Silvestri, an undergraduate student who spent a semester working in our group. Para-
substituted benzylpyridinium salts with tBu, CH3, F, Cl, CN and NO2 substituents were 
synthesized using a method based on that reported by Katritzky, et al.256 The basic 
protocol involves condensation of the p-substituted benzyl halide with pyridine followed 
by recrystallization from diethyl ether. In general, synthesis was accomplished by 
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combining 0.01 mol of the starting reagent with 0.015 mol pyridine and stirring the 
mixture at room temperature for 7 – 24 hours. (Synthesis of the F, Cl, CN, and NO2 salts 
also required the addition of 3 mL nitromethane to the reaction vessel prior to the 
addition of pyridine.) The mixture was then diluted with 30 mL diethyl ether and chilled 
before the product was filtered from the solution. Specific synthesis details are given in 
Table 3.2. 
 











OCH3 --- --- --- White salt 
tBu p-Tertbutylbenzyl chloride No 16 White salt 
CH3 
p-Methylbenzyl 
chloride No 24 Clear oil 
F p-Fluorobenzyl chloride Yes 24 Yellow oil 
Cl p-Chlorobenzyl chloride Yes 12 
Yellow, prism-like 
crystals 









Mass spectral analysis was performed to assess the purity of the synthesized 
compounds that were stored in a -80 ºC freezer until needed. Unless otherwise specified, 
an equimolar mixture (5 μM each) was freshly prepared prior to analysis in either a 50% 
methanol solution (HPLC grade, Sigma-Aldrich, St. Louis, MO) or nanopure water 
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(Barnstead International, Dubuque, IA) and delivered to the ion source under 
investigation at a flow rate of 20 μL min-1, the minimum flow rate possible for this 
particular AMUSE device. No organic acid was added as the analytes are pre-charged. 
 
3.4.2. AMUSE Fabrication, Assembly, Setup and Operation 
Fabrication of the 2nd generation 20x20 array of 5-μm nozzles in silicon was 
accomplished as described in section 2.2.2132 and assembled using protocol 2 (see section 
2.3.2). Experiments were performed using the RF-only AMUSE and DC-AMUSE 
operational modes as described in section 2.3.3 with the electrical circuit shown in Figure 
2.9.B. The AMUSE was positioned as close as possible to the Venturi device inlet (4 
mm) and the Venturi device outlet was flush with the QiT capillary inlet resulting in a 
total distance of 77 mm between the point of droplet emission and the inlet orifice (255 










Figure 3.2. Setup of the Venturi-assisted experiment and relevant compounds of the mass 
spectrometer's API. 
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3.4.3. Venturi-Assisted ESI Setup 
The needle assembly of a commercial pESI source (ThermoFinnigan, Waltham, 
MA) fitted with an 83 μm i.d. spray capillary (Small Parts, Miramar, FL) was removed 
from the source housing and mounted to a post using a clamp. The needle was centered 
with respect to a Venturi device and positioned so that the needle tip-Venturi device 
distance was equal to that used for the AMUSE. A 4 kVDC electric potential was applied 
to the needle using the built-in power supply of the QiT mass spectrometer to produce 
stable electrospray. No N2 was used to aid in nebulization. The source was positioned 4 
mm in front of the inlet of the Venturi device, the minimum distance possible using the 
current AMUSE assembly, while the outlet of the Venturi device was positioned flush 










Figure 3.3. Setup of the Venturi-assisted ESI experiment and relevant components of the 
mass spectrometer's API. 
 
3.4.4. Venturi Operation 
A differential pressure flow controller (Bel-Art, Pequannock, NJ) controlled the 
flow rate (0 – 10.6 L min-1) of industrial grade N2 gas (130 psi, Airgas, Radnor, PA) used 
to provide suction of the droplet streams through the low pressure region in the center of 
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the Venturi device. Table 3.3 provides the gas pressures that correspond to the 
experimental flow rates that would be observed if gas flow was controlled solely by a 
pressure regulator. These values were obtained by fully opening the flow controller valve 
and adjusting the gas pressure at the regulator until the desired reading (flow rate) was 
achieved on the controller. 
 
Table 3.3. List of experimental flow rates used with the Venturi device and 
corresponding gas pressures. Flow rates requiring gas pressures lower than the 
measurable range on the pressure regulator used are indicated by dashes. 













3.4.5. Measurement of Droplet Size Distributions 
Droplet size distributions (Sauter mean diameter (D[3,2]) vs. frequency) were 
measured in triplicate with a laser diffraction particle size analyzer equipped with a 63 
mm focal length optical collection system (Model 2600C, Malvern, Worcestershire, UK). 
The correct performance of this instrument was verified by interrogating a calibrated 
graticule (46.5 μm nominal particle size), and particle size measurements were found to 
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be accurate within 4%. All particle size measurements were performed perpendicular to 
the ejection axis, with the laser measurement area placed immediately at the exit of the 
Venturi device. The area over which time-averaged particle-size measurements were 
obtained is approximately cylindrical in shape, and 22 mm long by 7 mm diameter. 
 
3.4.6. Mass Spectrometry 
A commercial pESI source was interfaced to the QiT and used to optimize the ion 
optics and mass analyzer settings to obtain maximum signal intensity for the base peak 
(m/z 226; precursor ion of the tBu compound) using the auto tune function. These settings 
were used for all subsequent experiments. For all experiments performed, the inlet 
capillary voltage was set to -30 V while the capillary temperature was varied between 
230 – 300 ºC and the tube lens offset voltage (TL), which is equivalent to a capillary-
skimmer voltage in this instrument, was varied from 0 – 100V to modify the 
desolvation/declustering conditions. The automatic gain control (AGC) was kept on and 
set to a maximum of 5x 107 ions, with a maximum trap time of 100 ms (3 microscans) for 
all experiments. Mass spectra were acquired in profile mode for 1 minute using the built-
in mass spectrometer software (Xcalibur 2.0, ThermoFinnigan, Waltham, MA) and 
exported into Excel (Microsoft, Auburn, WA). 
 
3.5. Data Analysis 
Data analysis of preliminary mass spectral results required several steps to be 
performed after the acquired mass spectra were exported into Excel. The first step was to 
determine the precursor and product ion intensities for each of the thermometer 
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compounds present in the mass spectrum (seven compounds, fourteen peaks of interest). 
Figure 3.4 shows a typical AMUSE mass spectrum for a solution containing a mixture of 
p-substituted benzylpyridinium compounds with the peaks of interest labeled. 
 
m/z


























































Figure 3.4. Mass spectrum for an aqueous 5 μM mixture ionized by RF-only AMUSE at 
TL = 40V. Operating conditions: 300 ºC capillary, 8.76 L min-1 N2.) 
 
Examination of the mass spectrum shows two clear peak distributions with a set 
of seven peaks on the left (m/z 105, 109, 116, 121, 125, 136, and 157) corresponding to 
fragment ions of the precursor ion peaks located in the set of seven peaks in the upper 
mass range of the spectrum (m/z 184, 188, 195, 200, 204, 215, 226). An assessment of the 
IE deposition can be determined visually by inspection of the relative heights of the sets 
of peaks. In this spectrum, matching precursor-fragment ion peaks across both sets of 
peaks have the same intensity which indicates SY = 0.5. If no precursor ions are detected, 
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then SY = 0, which corresponds to maximum IE deposition conditions. Conversely, for 
spectra showing no fragment ion peaks, SY = 1.0, which corresponds to minimum IE 
deposition conditions. 
Although the analyte mixture is equimolar, the spectrum shows significant 
variations in intensity due to the wide variability in ionization efficiency as a result of the 
difference in hydrophobicity of the substituent which increases as follows: CN < OCH3 < 
NO2 ≈ F < CH3 < Cl << tBu. This trend in hydrophobicity matches the relative intensities 
of the corresponding peaks in the mass spectrum and correlates well with the relative 
intensities observed by ESI. This can be explained by the higher abundance of the more 
hydrophobic components on the aqueous droplet surface; thus, these analytes are 
desorbed more readily from the droplet leading to high mass spectral intensities.257 
Gabelica et al. suggested the use of dilution factors to normalize the mass spectrometer 
response, however, preliminary experiments using equiresponse mixtures showed the 
same <E> as those for the equimolar mixture, therefore the equimolar mixture was used 
to preserve sample.247 
Next, the SY for each compound in the mass spectrum was calculated using 
Equation 3.2. In step 3 of the data analysis protocol, the breakdown curve (SY vs. 
parameter of interest) was plotted to ensure that the experimental SYs were distributed 
over the entire SY range (0 – 1) increasing the probability that the subsequent data 
processing steps will yield good results. Figure 3.5 shows the breakdown curves as a 
function of TL obtained for a series of RF-only AMUSE mass spectra (the legend lists 
the compounds in order of highest to lowest E0). 
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Figure 3.5. Breakdown curves as a function of TL for all compounds analyzed during 
collection of eleven mass spectra for an aqueous 5 μM mixture ionized by RF-only 
AMUSE. Operating conditions: 300 ºC capillary, 8.76 L min-1 N2. The black box 
indicates the TL that provides the optimal spread of SYs. 
 
As can be seen in Figure 3.5, the tBu compound (pink circle) does not fall 
between the OCH3 (blue circle) and CH3 (dark blue triangle) compounds as expected 
from their relative E0’s. This can be attributed to the higher DOF of the tBu compound 
(DOF = 105) relative to that of the other compounds. The actual energy required to 
observe dissociation of tBu is greater than expected due to the dispersion of IE to each 
oscillator, i.e. due to the presence of a kinetic shift; thus, tBu was not included in 
subsequent steps of the data analysis workflow. A detailed investigation of the effect of 
ion residence time on the SYs obtained is described in detail in section 3.5. Another 
interesting observation from Figure 3.5 is the increased SY with higher TL voltages. This 
can be attributed to further fragmentation of the product ion species, which was not 
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accounted for in our SY calculations but was verified experimentally. Figure 3.6 shows 
the intensity of the precursor and product ion peaks of the OCH3 compound at various 
TL. 
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Figure 3.6. Ion intensities for the precursor and product ions of the CH3 compound 
analyzed during collection of eleven mass spectra for an aqueous 5 μM mixture ionized 
by RF-only AMUSE for TL = 0 – 100 V. Operating conditions: 300 ºC, 8.76 L min-1 N2. 
 
As can be seen in Figure 3.6, the intensity of the precursor ion decreases rapidly 
with increasing TL up to 40 V and is negligible at higher potentials. The product ion 
intensity increases rapidly with increasing TL up to 30 V and then decreases until it 
reaches 80 V, at which point it too becomes indistinguishable from the baseline noise. In 
other words, the product ion begins to fragment at 30 V causing a corresponding inflation 
of the SY as these new fragments are not incorporated into the denominator of the SY 
equation. Other thermometer compounds showed similar trends; thus, any spectra that 
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fall into regions where the SY begins to increase (at high TL) must be carefully 
interpreted and possibly discarded. 
In step 4, the experimental SYs were plotted as a function of E0 and fitted using 
either 1 sigmoid as shown in Equation 3.3 or 2 sigmoids (in the 2-sigmoid fit, the first 
sigmoid is used to fit OCH3 and CH3 while the second is used for CH3, F, Cl, CN, and 
NO2) which are linked at their crossing point and smoothed to avoid steps in the 
derivative. These two alternate methods of fitting the experimental SY curves were 
implemented by Gabelica et al.247 to account for deviation of the breakdown curve at low 
critical energies caused by a slight increase in SY for OCH3 and CH3 due to further 
fragmentation of the product ion species as demonstrated in Figure 3.6. Figure 3.7 shows 
a plot of SY vs. E0 fitted using both methods. 
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Figure 3.7. Breakdown curve showing 1 sigmoid and 2 sigmoid fits to data from an 
aqueous 5 μM mixture ionized by RF-only AMUSE at TL = 40 V. 
Operating conditions: 300 ºC, 8.76 L min-1 N2. 
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Visual inspection of Figure 3.7 clearly indicates that the 2 sigmoid curve function 
provides a better fit of the data. However, determination of the method providing a better 
fit may be ambiguous in some datasets. Thus, the residual error associated with each fit 
type was also calculated, and the fit providing the highest correlation coefficient was 
chosen for subsequent analysis. In step 5 of the data analysis workflow, P(E) was 
determined by calculating the derivative of the sigmoidal curve chosen during step 4. The 
last step of the data analysis protocol was to calculate <E> using Equation 3.4. Figure 3.8 
shows the P(E) curves of the sigmoidal curves in Figure 3.7 and lists <E> for each fit. 
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Figure 3.8. P(E) curves and <E> for sigmoidal fit data from an aqueous 5 μM mixture 
ionized by RF-only AMUSE at TL = 40V. Operating conditions: 300 ºC, 8.76 L min-1 N2. 
 
Initially, the data analysis workflow was performed manually and required several 
hours for a single spectrum. A set of macros generated in Excel and in SigmaPlot (Systat 
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Software Inc., San Jose, CA) was used to expedite the data analysis process. The Excel 
macro was used to identify the peak maxima for each of the ions of interest and to 
calculate SY for each species. The SY values were then exported into SigmaPlot and 
plotted against their respective critical energies. A series of SigmaPlot macros and 
transforms were used to fit the experimental SYs to a sigmoidal curve (using both fitting 
methods) and to calculate the residual error of each fit, P(E), <E>, and full width half 
maximum (FWHM) of the distribution. Use of these macros provided a significant 
reduction in analysis time (2 min / spectrum) and enabled us to perform studies that were 
previously considered unfeasible due to the lengthy data analysis times that would have 
been required. 
 
3.6. Effect of Trapping Time on IE Deposition 
In commercial QiT mass spectrometers, AGC is used to control MS signal 
sensitivity and peak resolution by automatically varying the trapping time. Generally, this 
is accomplished by either increasing the trapping time, which improves the signal 
intensity, or by decreasing the trapping time, which improves peak resolution by 
minimizing space-charge effects and detector saturation. With the AGC on, a pre-scan is 
first performed during which the QiT determines the flux of incoming ions so that it can 
adjust the trapping time of the following analytical scan to provide maximum sensitivity 
and resolution. However, it is sometimes beneficial to turn the AGC off, particularly for 
experiments that require a fixed time scale (as when monitoring kinetic reactions) or 
when performing comparative experiments with ionization sources exhibiting different 
ionization efficiencies. 
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Previous experiments to determine the sensitivity and stability of the Venturi-
assisted AMUSE demonstrated that a trapping time of 100 ms, with 3 microscans and the 
AGC set to 5 x 107 provided the best sensitivity and resolution for the analysis of 
reserpine, YGGFL and cytochrome C. To verify that these conditions were optimal for 
the analysis of the thermometer compounds and to verify that the kinetic shift was 
constant within the range of assayed trapping times, experiments were performed with 
the AGC turned off while all other parameters were held constant (Fig. 3.9). 
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Figure 3.9. Plot of <E> measured for a 5 μM aqueous mixture at trapping times ranging 
from 2 – 100 ms. Operating conditions: TL = 40 V, 300 ºC, 8.76 L min-1 N2. 
 
<E> for these three ionization methods at all trapping times increased by 2% with 
increasing trapping time, which is within experimental error, suggesting that there is no 
appreciable difference in the kinetic shift at any of the trap times tested. It was observed 
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during subsequent experiments that when the AGC was on, the typical trapping time per 
scan automatically selected was 3-5 ms regardless of the ionization method used, and that 
the SYs of each compound varied by <1%. This indicated that the P(E) curves would not 
be significantly affected, even if fluctuations in ion source intensity caused the trapping 
time to be automatically adjusted by the instrument’s software. 
 
3.7. IE Deposition Under Optimized Desolvation Conditions 
In our prior studies of Venturi-assisted AMUSE ionization, it was found that 
maximum ion yields for a variety of test compounds were obtained using an API 
capillary temperature of 300 ºC and 8.76 L min-1 flowing through the Venturi device. The 
mass spectra obtained for ESI, RF-only AMUSE, and DC-AMUSE ionization of a 5 μM 
mixture of thermometer molecules prepared in 50% methanol, with and without the use 
of ambient N2 flowing through the Venturi device, are shown in Figure 3.10 while the 
corresponding IE distributions are shown in Figure 3.11. 
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Figure 3.10. Mass spectra for ESI (A and B), RF-only AMUSE (C and D), and 
DC-AMUSE (E and F) ionization of a 5 μM mixture of thermometer compounds 
prepared in 50% methanol without Venturi focusing (A, C, and E) or with 
8.76 L min-1 N2 (B, D, F). Operating conditions: TL = 40 V, 300 ºC. 
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Figure 3.11. P(E) curves for ESI, RF-only AMUSE, and DC-AMUSE ionization of a 
5 μM mixture prepared in 50% methanol without Venturi focusing (A) or with 
8.76 L min-1 N2 (B). Operating conditions: TL = 40 V, 300 ºC. 
 
Examination of the ESI spectra (Fig. 3.10 A and B) showed a clear improvement 
in signal intensity with a relatively small difference in the relative intensities of the 
precursor and product ion mass spectral distributions. This corresponded to a small 
difference in <E> for operation with and without N2 flowing through the Venturi device 
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(Fig. 3.11 A vs. B). This effect was not as obvious for the AMUSE spectra (Fig. 3.10 C-
F) as there was also a marked decrease in signal intensity of the precursor ions which 
translates into an increase in <E> (Fig. 3.11 A vs. B). However, an improvement in signal 
intensity upon using the Venturi device with AMUSE was previously observed for the 
analysis of less labile compounds.133 In the absence of N2 flowing through the Venturi 
device (Fig. 3.11.A), RF-only AMUSE ionization was the softest of all techniques, with 
<E> = 1.38 eV, which is 39% lower than the corresponding value observed for ESI (1.92 
eV). For DC-AMUSE ionization, <E> was also lower than that for ESI but was slightly 
higher than for RF-only AMUSE (1.60 eV), possibly due to decreased mass transfer as a 
result of liquid buildup on the array surface as discussed in more detail below. 
Flowing N2 through the Venturi device at 8.76 L min-1 resulted in a marked 
increase in <E> for AMUSE ionization in both modes but only resulted in a 4% increase 
for ESI. With Venturi focusing, <E> for RF-only AMUSE was only marginally lower 
than that of DC-AMUSE and ESI resulting in <E> of, 1.93, 1.96 and 2.01 eV, 
respectively. The moderate increase in <E> observed for ESI when utilizing Venturi 
focusing indicates that, under optimum focusing conditions, the use of a Venturi device 
does not have a detrimental effect on the IE deposited on ions. The variation in observed 
<E> between the different ionization methods can be attributed to changes in the droplet 
size distribution upon use of the Venturi device which has been shown to be an important 
factor in P(E) when using spray-based ionization techniques.255 
The decreased droplet size due to use of the Venturi device can be attributed to 
the increase in droplet velocity which causes a reduction of droplet/ion residence time 
before entering the heated inlet of the mass spectrometer and results in an effective 
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decrease in ion sub-cooling associated with solvent evaporation. Increased frictional 
droplet heating due to hydrodynamic friction within the flowing N2 is not expected to be 
of any significance because N2 viscosity is very small and there are no significant 
velocity gradients along the center axis (parallel to the walls) of the Venturi device. Even 
if there is any small gas heating, the heat capacity of the liquid is much larger than that of 
the gas, so no appreciable increase in droplet temperature due to this effect could be 
expected. Since droplets are carried by the flowing air because of their low inertia due to 
small size, the relative tangential droplet-to-N2 velocity is zero. In other words, no slip is 
expected, as droplet and flowing N2 gas are moving at the same velocity, resulting in 
minimal frictional heating. The ESI droplet size distributions produced in this 
configuration with and without Venturi focusing are shown in Figure 3.12. 
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Figure 3.12. Droplet size distributions (top) and images of light scattered by spray 
(bottom) observed for a 50% methanol solution sprayed using ESI without 
Venturi focusing (A) or with 8.76 L min-1 N2 (B). (The white box in the 
image outlines the edge of the Venturi device.) 
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Without the use of Venturi focusing, the mean droplet diameter was 46.0 μm with 
a FWHM of 16.3 μm for ESI (Fig. 3.12.A), which is indicative of considerable droplet 
coalescence during the transit from the ESI capillary to the MS inlet. Close examination 
of the droplet size distribution obtained by ESI shows the additional presence of a low-
abundance droplet population with a wide diameter distribution ranging from 5 to 20 μm. 
The presence of multiple droplet size populations when no N2 flows through the Venturi 
device is not unexpected and can be attributed to the long residence time of droplets, 
which allows some droplets to emerge individually while others coalesce and exit as 
larger droplets. The distribution obtained with 8.76 L min-1 N2 flowing through the 
Venturi device (Fig 3.12.B) shows a more uniform droplet population with a significantly 
lower mean diameter and FWHM, 16.1 μm and 3.5 μm, respectively, compared to that 
obtained without Venturi-assisted droplet entrainment. As the probability of generating 
ions via desolvation of the more abundant large-diameter population is low, it is likely 
that the mass spectrometric signal observed during the non-Venturi focusing experiment 
is due mostly to the low abundant small-diameter droplet population mentioned above. 
This would explain the similarities observed for ESI IE distributions between Figs. 
3.11.A and 3.11.B as the spectrometer is sampling from droplet populations having 
similar diameters. 
Comparative measurements of the droplet size distribution were also performed 
for RF-only AMUSE droplets. Figure 3.13 shows these distributions (top) and also shows 
images of light scattered by spray (bottom) observed for a 50% methanol solution 
sprayed using RF-only AMUSE with and without Venturi focusing. 
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Figure 3.13. Droplet size distributions (top) and images of light scattered by spray 
(bottom) observed for a 50% methanol solution sprayed using RF-only AMUSE 
without Venturi focusing (A) or with 8.76 L min-1 N2 (B). 
 
The mean diameter and FWHM of droplets produced by RF-only AMUSE (Fig. 
3.13.A) without Venturi-assisted transmission were 13.4 μm and 2.8 μm, respectively, 
with a tail reaching values as high as 20 μm. Since upon ejection AMUSE-generated 
droplets have uniform size of 5-7 μm (defined by the nozzle aperture),132 this increase in 
the mean diameter suggests droplet coalescence during transport to the MS inlet 
capillary. These larger droplets could be responsible for the lower <E> observed in 
Figure 3.11.A. The mean droplet diameter and FWHM decreased to 12.7 μm and 1.8 μm 
when 8.76 L min-1 N2 was flowed through the Venturi device (Fig. 3.13.B) with a 
concomitant increase in <E> (Fig. 3.11.B). The intensity of scattered light increased for 
ESI upon use of the Venturi device (Fig. 3.12 A and B, lower panels), following the 
creation of a spatially-concentrated population of smaller droplets. The scattering 
intensity correlates with the total number of scatterers/droplets per unit volume and 
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relative size of the droplets as compared to the wavelength of light. For RF-only 
AMUSE, the intensity of light scattered by the spray (Fig. 3.13 C and D, lower panels) 
was reduced when N2 was flowed through the Venturi device, suggesting that desolvation 
is enhanced by the Venturi device. 
To investigate the behavior of Venturi-assisted AMUSE and ESI with solvent 
systems that are more compatible with biological species, the previous experiments were 
repeated using pure water solutions. The mass spectra obtained for ESI, RF-only 
AMUSE, and DC-AMUSE ionization of an aqueous 5 μM mixture of thermometer 
molecules, with and without the use of ambient N2 flowing through the Venturi device, 
are shown in Figure 3.14 while the corresponding IE distributions are shown in Figure 
3.15. 
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Figure 3.14. Mass spectra for ESI (A and B), RF-only AMUSE (C and D), and 
DC-AMUSE (E and F) ionization of an aqueous 5 μM mixture without 
Venturi focusing (A, C, and E) or with 8.76 L min-1 N2 (B, D, and F). 
Operating conditions: TL = 40 V, 300 ºC capillary. 
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Figure 3.15. P(E) curves for ESI, RF-only AMUSE, and DC-AMUSE ionization of an 
aqueous 5 μM mixture without Venturi focusing (A) or with 8.76 L min-1 N2 (B). 
Operating conditions: TL = 40 V, 300 ºC capillary. 
 
Comparison of the P(E) curves shown in panels 3.11.A vs. 3.15.C and 3.11.B vs. 
3.15.D shows that <E> for aqueous ESI, RF-only AMUSE and DC-AMUSE were within 
5% of the values obtained using a 50% methanol solution. The slightly higher <E> 
observed for DC-AMUSE, relative to that for RF-only AMUSE, when operating in non-
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Venturi mode (3.11.A and 3.15.C) can be attributed to decreased mass transfer caused by 
the buildup of liquid on the external surface of the ejector nozzle array, possibly due to 
electrowetting.258 This led to significant variations in the ejection flow rate due to 
sporadic blockage of ejector orifices and thus experiments using this approach were not 
further pursued. An investigation of the effect of functionalizing the ejector nozzle array 
to increase the hydrophobicity of the surface is discussed in section 4.4. 
The most salient difference upon changing the solvent system was the 0.5 eV 
increase in FWHM of the P(E) curve for Venturi-assisted ESI (3.11.B vs. 3.15.D). The 
explanation of this observation is not straightforward. This is possibly caused by a 
decreased evaporative droplet cooling rate,259 or variations in the droplet size distribution 
upon changing the solvent composition. There has been only one report on the influence 
of solvent composition on P(E) curves for electrosprayed droplets. These studies showed 
a shift to higher <E> and wider P(E) curves when less volatile solvents with lower vapor 
pressures are used.249 However, this is not an obvious result of general value, as although 
less volatile solvents do indeed evaporate at the lower rates, their latent heat of 
vaporization is generally much higher and thus they are capable of inducing more 
significant sub-cooling. Figure 3.16 shows droplet size distributions measured for 
droplets produced from an aqueous solution using ESI with and without Venturi 
focusing. 
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Figure 3.16. Droplet size distributions (top) and images of light scattered by spray 
(bottom) observed for an aqueous 5 μM mixture sprayed using ESI without Venturi 
focusing (A) or with 8.76 L min-1 N2 (B). (The white box in the images outlines the edge 
of the Venturi device.) 
 
Without Venturi focusing, a wide droplet size distribution having a mean droplet 
diameter of 44.7 μm and FWHM of 16.3 μm was observed (Fig. 3.16.A). However, when 
Venturi focusing was utilized, bi-modal behavior leading to two distinct droplet size 
distributions was observed (Fig. 3.16.B) The smaller-size population showed a mean 
droplet diameter and FWHM of 12.9 μm and 1.8 μm, respectively, while the more 
abundant population overlaps with the distribution measured without Venturi assistance. 
The presence of these multiple droplet size populations may also explain the broader P(E) 
observed for ESI (Fig. 3.15.D) as Gabelica et al. showed that there is a direct correlation 
between desolvation efficiency, as inefficient desolvation leads to multiple droplet 
populations in varying stages of desolvation, and the shape of P(E).247 The lower 
desolvation efficiency observed for aqueous ESI is also reflected by the increase in 
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scattered light intensity (Fig. 3.12.B vs. 3.16.B, lower panels), indicative of the presence 
of a higher volume concentration of droplets. The droplet size distributions and scattered 
light intensities obtained for RF-only AMUSE ionization of an aqueous solution (Fig. 
3.17) were found to be similar to those obtained for the methanolic solution. The focus of 
all further experiments was on measuring the effect of the API capillary temperature and 
N2 flow rate on the IE landscapes of ESI and RF-only AMUSE. 
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Figure 3.17. Droplet size distributions (top) and images of light scattered by spray 
(bottom) for an aqueous 5 μM mixture sprayed using RF-only AMUSE without Venturi 
focusing (A) or with 8.76 L min-1 N2 (B). (The white box in the images outlines the edge 
of the Venturi device.) 
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3.8. Influence of Capillary Temperature and Venturi Device Flow Rate 
on IE Deposition 
Recent experiments by Dixon et al.217 indicated that the use of a Venturi device in 
combination with ESI provides both a focusing effect and improved droplet desolvation. 
Varying the Venturi gas flow rate provides control over both the desolvation efficiency 
and the aerodynamic focusing of the droplets, which results in improved ion transport. 
These two effects are strongly coupled and are expected to influence both P(E) and S/N 
as demonstrated by the work of Drahos and co-workers, who showed that for quadrupole 
and Fourier Transform mass spectrometers operated at various ion source temperatures 
(25-150 °C), P(E) of ESI ions can be approximated by a Boltzmann distribution with 
different characteristic temperatures.251 For capillary temperatures of 50 – 75 °C, 
Gabelica et al. have shown that P(E) curves exhibit a low energy tail, indicating the 
presence of partially-solvated ions reaching the capillary-skimmer region of the mass 
spectrometer.247 
These previous reports prompted us to perform additional experiments to 
determine the combined effect of the API capillary temperature and N2 flow rates on the 
IE deposited by Venturi-assisted ESI and AMUSE and to explore the IE landscapes of 
these techniques. Figure 3.18 shows a 3D surface plot of <E> for ions produced by 
Venturi-assisted ESI (3.18.A) or RF-only AMUSE (3.18.B) vs. capillary temperature and 
N2 flow rate. 



































































































Figure 3.18. <E> deposited on ions produced from an aqueous 5 μM mixture using (A) 
ESI or (B) RF-only AMUSE at capillary temperatures ranging from 230 – 300 ºC and N2 
flow rates from 0 – 10.6 L min-1. Operating conditions: TL = 30V. 
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The overall shape of these surfaces differs in several aspects. Venturi-assisted ESI 
is characterized by the presence of a low-IE (<E> < 1.5 eV) valley in the regime map, 
occurring at conditions with capillary temperatures of 230 – 275 °C and N2 flow rates 
between 0 – 7 L min-1. A region with <E> ≤ 1.0 eV was present at capillary temperatures 
up to 250 ºC and N2 flow rates between 2 – 4 L min-1. The RF-only AMUSE landscape 
was characterized by a low IE (<E> < 1.5eV) region present at all capillary temperatures 
tested with N2 flow rates up to 5 L min-1. A region with <E> ≤ 1.0 eV was present at 
capillary temperatures up to 280 ºC and N2 flow rates up to 2.5 L min-1. Ions with 
<E> < 1.5 eV were obtained in 42% of the conditions tested by ESI and in 46% of 
conditions tested by RF-only AMUSE. Ions with <E> ≤ 1.0 eV were obtained in 9 and 
13% of conditions tested by ESI and RF-only AMUSE, respectively. The average <E> 
obtained by RF-only AMUSE was 7% lower than that obtained by ESI under all 
conditions examined. 
The shape of the ESI landscape implies that ions of high IE can be produced at 
either high capillary temperatures or high N2 flow rates. The fact that flow rates between 
7 – 10 L min-1 also result in ions with higher mean IE, even for capillary temperatures as 
low as 250 °C, is inherently related to the decrease in residence time as the flow rate of 
N2 is increased. Shortening the droplet/ion residence time causes a reduction in 
evaporative cooling, and thus leads to a higher IE. The characteristic droplet 
temperature251 increases with increasing droplet velocity resulting in ions being ejected 
with higher internal energies. Interestingly, at low N2 flow rates and high capillary 
temperatures, a region of high IE ESI ions is also observed. In this case, the sensible heat 
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convectively transferred to the droplets during their transit in the heated capillary seems 
to be sufficient to significantly elevate the ion’s IE. 
The generation of AMUSE ions with high <E> requires conditions combining 
both high temperatures and high flow rates. Because of the different principle used for 
liquid atomization in AMUSE, the droplets produced are uniform in size,132 even at the 
extremes of Venturi device flow rates (Fig. 3.13 and 3.17). These droplets are also 
expected to have lower charge density due to the lower charging potential effectively 
applied to the liquid reservoir during each RF half-period, resulting in lower Coulombic 
explosion rates. This translates into larger AMUSE droplets surviving longer within the 
heated capillary. The increase in <E> measured for AMUSE ionization can be attributed 
to: (1) the increase in capillary temperature resulting in an equivalent increase in the rate 
of convective heat transfer to the droplet in combination with (2) the increase in flow rate 
resulting in an increase in the convective heat transfer coefficient, which in turns results 
in increased sensible heat transfer to the droplets. At high flow rates but lower capillary 
temperatures, the energy transferred at the API inlet results in ions with intermediate 
<E>. 
 
3.9. Comparison of Spectral Quality Under High– and Low-IE 
Deposition Conditions 
An investigation of the S/N of ions produced by Venturi-assisted ESI and RF-only 
AMUSE at the upper and lower limits of the sampled capillary temperatures was also 
performed. The p-CH3-substituted thermometer compound was selected for this 
experiment as it has the second lowest critical energy of the compounds tested and can be 
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easily fragmented while still providing a measurable signal for the intact ion (m/z 184). 
The S/N for this ion at increasing N2 flow rates and capillary temperatures of 230 °C 
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Figure 3.19. S/N of m/z 184 peak (precursor of p-CH3 compound) for Venturi-assisted 
ESI and RF-only AMUSE ionization of a 5 μM aqueous mixture at flow rates ranging 
from 0 – 10.6 L min-1 N2 and capillary temperatures of (A) 230 ºC or (B) 300 ºC. 
TL = 30 V for all experiments. 
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Examination of the ESI energy landscape (Fig. 3.18.A) at 230 °C suggests that the 
S/N of the intact ion should be relatively constant at most of the flow rates tested and 
should have a maximum value that corresponds to the flow rates which provide the 
minimum <E> (2 – 5 L min-1). The observed S/N values appear to follow this trend 
reasonably well, with a maximum S/N observed between 4 – 6 L min-1. The S/N obtained 
by AMUSE ionization at 230 °C increases with flow rates up to 2.5 L min-1 where it 
levels off. This correlates well with the AMUSE energy landscape (Fig. 3.18.B). 
The differences in S/N observed for ESI and RF-only AMUSE cannot be solely 
explained by examination of their respective IE landscapes, but also requires 
consideration of the differences in spray divergence and electrochemical processes 
between these two methods. ESI droplets have a significantly higher charge density than 
AMUSE droplets and thus experience a greater degree of spray divergence. Therefore, 
Venturi focusing of this highly-divergent ESI plume produces a significant increase in the 
analyte signal intensity, as observed in the mass spectrum in Figure 3.14 A vs. B. This 
was not observed in the matching AMUSE mass spectra (Figure 3.14 C vs. D) due to the 
concomitant increase in IE deposition, which resulted in a reduction of the absolute 
intensity of the CH3 precursor ion peak. Although the analyte signal intensity was higher 
in the ESI mass spectra, the background noise was also higher as a result of the high 
potential applied to the ESI sprayer which causes an increase in the rate of solvent 
oxidation processes54 and also leads to ionization of volatile contaminants present in the 
laboratory air.55 This is apparent upon inspection of the baseline noise in the mass spectra 
shown in Figures 3.10 and 3.14. In other words, although the analyte signal intensity in 
the AMUSE mass spectra was not as high as those for ESI, the reduction in background 
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signal in the AMUSE spectra resulted in a lower S/N for ESI at all assayed Venturi gas 
flow rates. 
An examination of the S/N when the capillary is kept at 300 °C (Fig. 3.19.B) 
shows that the S/N for both ionization methods also correlates well with the trends 
suggested by their respective IE landscapes (Fig. 3.18). The ESI S/N has a local 
maximum between 1 and 3.5 L min-1 which levels off at higher flow rates while the 
AMUSE S/N decreases sharply as the flow rate is increased up to 3.5 L min-1 and 
exhibits a slower decrease at higher flow rates. The average S/N obtained using AMUSE 
ionization was five times higher using a capillary temperature of 230 ºC and eight times 
higher than that of ESI at 300 ºC. 
 
3.10. Conclusion 
We have shown that AMUSE ionization without Venturi assistance is inherently 
softer than ESI with a <E> that is 39% lower. AMUSE IE deposition was significantly 
modified by increasing the Venturi device gas flow rate, but a less marked effect was 
observed for ESI. Modulation of P(E) was accomplished by tuning the Venturi device N2 
gas flow rate and the API capillary temperature, as these parameters most strongly 
influence desolvation and droplet residence times. Examination of the energy landscapes 
obtained demonstrated that ions with <E> < 1.5 eV could be obtained using 46% of the 
conditions tested during RF-only AMUSE ionization compared to 42% of those tested 
during ESI. A low IE region (<E> ≤ 1 eV) was observed at capillary temperatures up to 
250 ºC and N2 flow rates between 2 – 4 L min-1 for ESI and at capillary temperatures up 
to 280 ºC and N2 flow rates up to 2.5 L min-1 for AMUSE. Finally, it was shown that at 
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all N2 gas flow rates tested, the average S/N of the intact p-CH3-substituted thermometer 
ion by AMUSE was five times higher than ESI at 230 ºC and eight times higher at 300 ºC 
due to the difference in background noise observed between AMUSE and ESI spectra. 
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CHAPTER 4. TOWARDS AN EFFICIENT LC-MS COUPLING 
USING THE AMUSE ION SOURCE 
 
4.1. Abstract 
In this chapter, proof-of-principle results on the coupling of LC to MS via an 
AMUSE ion source are presented for the analysis of calpain inhibitors. A brief 
introduction to LC-MS, with an emphasis on the criteria required for optimum 
interfacing, is provided. Efforts to improve MS signal stability of the AMUSE by 
silanizing the ejector array are discussed in detail, concluding with results that 
demonstrate the first coupling of LC with AMUSE. 
 
4.2. The Ideal LC-MS Interface 
This chapter discusses the challenges for coupling LC to AMUSE with regards to 
long term stability of ejection and fidelity in reproducing the analytical pulse. As such, it 
would be beneficial to define a list of features that would be desired in the ideal LC-MS 
interface.260, 261 (1) The interface must be tolerant to different solvent systems (including 
programmed solvent gradients and additives) and (2) varying flow conditions. (3) The ion 
yield must be high to provide good detection limits and (4) should be constant and 
independent of the nature and concentration of the solute while providing (5) high 
molecular weight detection capabilities. (6) There should be no loss of separation in the 
interface (i.e. there should be minimal dead volume). In essence, the ideal interface 
should allow decoupling of mobile phase selection from MS analysis while retaining 
chromatographic fidelity. 
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Despite the widespread appeal of pESI, nESI, and APCI for coupling LC with 
MS, none of these ionization techniques meet all of the criteria for an ideal LC-MS 
interface. AMUSE ionization has the potential to meet several of the aforementioned 
criteria. Since droplet ejection is primarily dependent on the resonant frequency of the 
reservoir,130 AMUSE ionization is amenable to a wide variety of solvent systems 
including those with variable solvent composition (gradient elution) and containing 
additives such as acids, bases, or buffers. AMUSE ion yields using 2nd generation arrays 
are high with detection limits per nozzle that are on par with those of other spray-based 
techniques (section 3.2.2). Furthermore, the analysis of cytochrome C (section 2.7) 
demonstrated the wide mass range of compounds accessible to AMUSE ionization. 
Although it is likely that the AMUSE technique does show some dependence on the 
nature of the solute (as evident in the differing MS signal intensities observed for mass 
spectra of the thermometer compounds due to their varying hydrophobicities), ionization 
suppression effects as a result of charge or space competition have not yet been observed. 
Long-term stability of AMUSE signal is highly affected by electrowetting of the 
surface. Karger and coworkers coated the outlet edge of their multichannel microchip for 
ESI-MS with a hydrophobic reagent to minimize electrowetting of their device.93, 94 This 
strategy was implemented with AMUSE to improve signal stability, particularly when 
operating in DC-AMUSE mode. A detailed investigation of the effect of silanizing the 
array is presented here. To assess the analytical performance of LC-AMUSE-MS for 
potential “real-life” quantitation applications, experiments were performed using a 
candidate drug synthesized by Dr. Zhaozhao Li in the research group of Dr. James C. 
Powers at the Georgia Institute of Technology.262 This drug, benzyloxycarbonyl-leucine-
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4-aminobutyric acid-CONH-(CH2)3-4-morpholinyl (AK-295) has been shown to inhibit 
the activation of calpains, calcium dependent enzymes that play a role in initiating 
neuronal degeneration.263 Quantitation of AK-295 was performed using an internal 
standard (ISTD), benzyloxycarbonyl-leucine-norvaline-CONH-(CH2)3-4-morpholinyl 
(ZLAK-74). ZLAK-74, an analog having a similar molecular weight and structure as AK-
295 but which does not exhibit significant calpain inhibition, was added early in the 
sample preparation process to account for variation in LC-MS performance. Figure 4.l 




























Figure 4.1. Structures of AK-295 and ZLAK-74. The main structural difference is 
indicated by a red circle. 
 
4.3. Experimental Details 
4.3.1. Materials 
ACS-grade acetone and HPLC-grade acetonitrile, methanol, and ethanol were 
purchased from EMD Chemicals, Inc. (Gibbstown, NJ). ACS-grade sulfuric acid and 
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hydrogen peroxide (30% by weight) were purchased from Mallinckrodt (Phillipsburg, 
NJ). Anhydrous dichloromethane, HPLC-grade chloroform (Burdick and Jackson 
Morristown, NJ), n-hexadecane, n-octadecyltrichlorosilane (OTS) containing 5% 
branched isomers (Alfa Aesar, Ward Hill, MA), formic acid (88% by weight, Fisher 
Scientific, Hampton, NH), 99.9% glacial acetic acid (Sigma Aldrich, St. Louis, MO), and 
YGGFL (American Peptide, Sunnyvale, CA) were purchased and used without additional 
purification. 
Stock solutions of AK-295 and ZLAK-74 prepared by dissolving 1 mg of each 
compound in methanol (1mg/mL) were pipetted into centrifuge vials in 50 μL aliquots 
and stored at -80ºC until needed. 
 
4.3.2. AMUSE Array Silanization 
Fabrication of the 2nd generation 20x20 array of 5-μm nozzles in silicon was 
accomplished as described in section 2.2.2. To improve AMUSE signal stability, the 
nozzle-side of the ejector array was functionalized with silane groups using a procedure 
based on that reported by Graham and coworkers.220 Optimization of the silanization 
protocol for use with a newly-fabricated ejector array is depicted in Figure 4.2. 
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Figure 4.2. Workflow describing optimization of the silanization protocol via iterative 
characterization and reaction steps. Original protocol used was described by Graham and 
coworkers220 and included a cleaning step in piranha solution at 100 ºC for 60 minutes 
and silanization for 18 hours. After optimization, room temperature piranha was used for 
1 minute to clean the array and silanization was completed in 1 hour. 
 
Upon arrival, the ejector array was rinsed with acetone to remove residual organic 
contaminants from the surface and dried using a low flow of industrial grade N2. The 
array was then characterized to determine its average contact angle (see section 4.3.3) 
and to assess the stability of MS signal produced in each operational mode (RF-only 
AMUSE and DC-AMUSE as described in section 2.3.3). After characterization the array 
was cleaned and functionalized using the original protocol reported by Graham et al.220 
First, the array was immersed in 100 ºC piranha solution (3:1 sulfuric acid:hydrogen 
peroxide) for 60 minutes to remove organic contaminants and to promote hydroxylation 
of the surface. The array was removed from the piranha solution using Teflon tweezers 
rinsed twice with water, dried under N2, and placed in a Teflon vessel with the nozzle-
side facing upwards. To initiate silanization, 25 mL n-hexadecane and 10 mL chloroform 
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were added to the vessel followed by 175 μL OTS which was added under a stream of 
N2. The vessel was immediately capped and placed into an enclosure with desiccant to 
reduce the probability of silane polymerization occurring as a result of the presence of 
excess moisture.264 After 18 hours, the array was removed from the mixture and 
examined. Visual inspection of the array after completion of the protocol revealed that 
the tungsten oxide layer had been stripped from the surface. It was speculated that this 
was due to the relatively harsh cleaning conditions used during the piranha clean; thus, 
room temperature piranha was used instead but led to the same result. The optimal time 
for cleaning 2nd generation arrays (1 minute) was determined by immersing fragments of 
unusable 2nd generation arrays in piranha solution for successively shorter times. These 
fragments were also used to optimize the time required for the silanization reaction, 
which was ultimately reduced from 18 hours to 1 hour as shown in Figure 4.2. 
 
4.3.3. Contact Angle Measurement 
The change in hydrophobicity of the ejector array upon silanization was 
quantified by measuring the water contact angle (θ, Fig. 4.3.A) at nine different positions 
along the nozzle-side of the array (Fig. 4.3.B). Text indicating the orifice diameter etched 
onto a corner of each array during fabrication was used to ensure that the orientation of 
the array was consistent. All measurements were made using a goniometer assembled by 
Jenny Raynor from the research group of Dr. David Collard (Fig. 4.3.C). 
 
Hampton, C. Y.  120 
θ
(A)
Designed by Jenny Raynor
(C)







Figure 4.3. The water contact angle (A) was measured at nine positions on the nozzle 
side of the ejector array (B) using a goniometer assembled by Jenny Raynor (C). 
 
For contact angle measurements, a 2-μL drop of nanopure water was suspended 
from a 10-μL syringe. The ejector array was placed on a jack that was raised until the 
suspended droplet was transferred to the chosen position on the array and the jack was 
lowered until the droplet was visible through the goniometer eyepiece. The cross-hairs in 
the eyepiece were aligned with the vertex of the contact angle and the eyepiece was 
rotated until the vertical cross-hair fell on the tangent with the droplet edge. The angular 
displacement of the vertical cross-hair, which was designated as 0º, was read from the 
scale on the eyepiece and the contact angle was calculated by adding this angular 
displacement to 90 (for θ > 90ºC) or subtracting from 90 (for θ < 90º). Triplicate 
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measurements were made at both sides of the droplet for all nine positions on the array. 
These measurements were performed in duplicate with a fresh drop deposited at each 
position and the average contact angle calculated. 
 
4.3.4. AMUSE MS Signal Stability Studies 
Stability studies were performed by continuously pumping a 5 μM solution of 
YGGFL prepared in nanopure water (18 MΩ cm-1, Barnstead International, Dubuque, IA) 
containing 0.1% (v/v) glacial acetic acid into the AMUSE using a liquid handling pump. 
The optimal liquid flow rate for the array used in these studies, as determined using the 
method described in section 2.3.3, was 80 μL min-1. Optimal settings for the ion optics 
and mass analyzer settings of the QiT were determined by tuning with the commercial 
pESI source installed on the front end. The capillary was set to 30 V and held at 300 ºC 
with TL = 10 V for all experiments. Experiments were performed in the RF-only 
AMUSE and DC-AMUSE operational modes using a 910 kHz sine wave amplified to 33 
VRMS for ejection in both modes and an applied potential of 100 VDC in DC-AMUSE 
mode. The AMUSE was positioned 4 mm from the Venturi device inlet. The Venturi 
device outlet was flush with the QiT capillary inlet and 8.76 L min-1 N2 was used to 
sustain the Venturi focusing effect. 
 
4.3.5. LC-MS Operation 
For LC-MS experiments, a series of calibration standards containing AK-295 
(0 - 5 μM) and ZLAK-74 (1 μM, internal standard) were prepared in 30:69.9:0.1 (v/v) 
acetonitrile:nanopure water:formic acid. A commercial pESI source was interfaced to the 
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QiT mass spectrometer and used to optimize the ion optics and mass analyzer settings to 
obtain maximum signal intensity for both AK-295 (m/z 505.2) and the ISTD (ZLAK-74, 
m/z 519.2). The capillary inlet was set to 34 V and held at 275 ºC with TL = 25 V for all 
subsequent experiments. 
An Agilent 1100 LC system (Agilent, Santa Clara, CA) equipped with a solvent 
degasser, a binary pump, an autosampler, and a thermostatic column compartment held at 
25º was coupled to the QiT using either the commercial pESI ion source or the AMUSE 
ion source. A 15 μL aliquot of analyte was injected into a Symmetry Shield® reverse 
phase C18 column (3.5 μm, 1.0 x 150 mm, pore size 100Å; Waters, Milford, MA). The 
analytical column was preceded by a Zorbax® RX-C18 guard column (5.0 μm, 4.6 mm x 
12.5 mm, pore size 2 μm; Agilent). The gradient LC method was optimized to provide 
high sensitivity for AK-295 and used A = nanopure water + 0.1% formic acid and B = 
acetonitrile + 0.1% formic acid as the mobile phases. The mobile phase flow rate was set 
to 80 mL min-1 and the following gradient program was used: 0.0 min – 30% B, 0.5 min 
– 30% B, 0.7 min – 100% B, 9 min – 100% B, 10 min – 30% B. Settings for the Venturi-
assisted AMUSE setup were identical to those described in section 4.4.4. 
 
4.4. Effect of Increasing Ejector Array Hydrophobicity on MS Signal 
Stability 
Early experiments demonstrated that ejection stability, particularly when 
operating in DC-AMUSE mode, was affected by electrowetting of the array surface that 
sometimes tended to block nozzles and make ejection of droplet streams more difficult 
(section 3.7). It was speculated that electrowetting might be minimized by increasing the 
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hydrophobicity of the array surface. Measurement of the water contact angles suggested 
the existence of zones of varying hydrophobicities along the surface as indicated in 
Figure 4.4. This figure shows the profile image of the unsilanized array after deposition 




























Figure 4.4. Profile image of the unsilanized array after deposition of water droplets (A) 
and contact angles measured prior to functionalization (B). Inset shows position of array 
corresponding to each measurement. 
 
The average contact angle across the entire surface of the array prior to 
silanization was 47º ± 9º (mean ± standard deviation) with values ranging from 26º – 62º. 
Although arrays were cleaned by immersion in acetone and drying under N2 and were 
only handled with gloves, it is likely that a large part of the variability in hydrophobicity 
along the array surface is due to residual contaminants transferred during fabrication and 
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handling. Microscopic surface defects may also contribute to this variability. Visual 
inspection of the array immediately after initiating ejection also showed variability in the 
location of the electrowetted area on the surface for DC-AMUSE which progressively 
grew over the entire array surface within the first minute. Wetting of the surface in RF-
only AMUSE operating mode was also visually observed but to a much lesser extent. An 
examination of MS signal stability for YGGFL demonstrated that DC-AMUSE was less 
stable than RF-only AMUSE, probably because of the aforementioned difference in 
surface electrowetting tendency. Figure 4.5 shows the extracted ion traces for m/z = 556.1 
([M+H]+ for YGGFL) corresponding to these two modes. 
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50000 RF-only AMUSE (6.8 %RSD)
DC-AMUSE (79.1%RSD)
 
Figure 4.5. Extracted ion trace for [YGGFL+H]+ (m/z = 556.1) from YGGFL using an 
unsilanized array with 5-μm nozzles operated in RF-only AMUSE (solid red line) or 
DC-AMUSE (dotted black line) modes. 
 
Figure 4.6 shows mass spectra corresponding to the ion traces shown in Figure 
4.5 also indicating a significant difference in the [M+H]+ peak intensity of YGGFL. 
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Examination of these spectra provide further evidence of the deleterious effect of 
electrowetting on the AMUSE analytical performance, particularly when operating in 
DC-AMUSE operating mode. 
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Figure 4.6. Mass spectra corresponding to averaged extracted ion traces shown in Figure 
4.5 for an unsilanized array with 5-μm nozzles operated in RF-only AMUSE (solid red 
line) and DC-AMUSE (dotted black line) modes. 
 
A dramatic improvement in long-term signal stability was observed following 
surface derivatization. After silanization, the average contact angle was observed to 
increase to 104.2º ± 0.6 º with values ranging from 103.0 – 106.5 º. A profile image of the 
functionalized array after droplet deposition and the contact angles measured at different 
positions on the array are shown in Figure 4.7. 
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Figure 4.7. Profile image of the functionalized array after deposition of water 
droplets (A) and contact angles measured from a functionalize array (B). 
Positions match those shown in Figure 4.2. 
 
The most striking difference in the relative hydrophobicity of this array before 
and after silanization is the improvement in hydrophobicity homogeneity across the 
surface. This can be attributed to the more rigorous cleaning provided by immersion in 
piranha solution immediately prior to silanization, which removes surface contaminants. 
Deposition of OTS on the array surface may have also mitigated the effect of microscopic 
surface defects, as these are probably covered by the silane layer(s). The MS signal 
stability observed for silanized arrays is presented in Figure 4.8. 
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RF-only AMUSE (3.3 %RSD)
DC-AMUSE (8.6 %RSD)
 
Figure 4.8. Extracted ion trace for [YGGFL+H]+ using a functionalized array with 
5-μm nozzles operated in RF-only AMUSE (solid red line) and DC-AMUSE (dotted 
black line) modes. 
 
Functionalizing the array surface had a positive effect on the MS signal stability 
for both RF-only AMUSE and DC-AMUSE as indicated by the low %RSDs in the 
signals, 3.3% and 8.6%, respectively, obtained for ejection over the course of 1 minute. 
Clearly, reducing the wettability of the array surface by increasing the surface 
hydrophobicity minimized the effect of electrowetting and provided a significant 
improvement in DC-AMUSE signal stability with an 89% improvement in %RSD. The 
51% improvement in %RSD for RF-only AMUSE signal can also be attributed to a 
reduction in electrowetting also occurring in RF-only AMUSE, but to a much lower 
extent due to the lower potential applied. Silanization resulted in a 2-fold increase in 
signal intensity for RF-only AMUSE and a 10-fold increase for DC-AMUSE, as shown 
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in Figure 4.9. Silanization of the array surface also enabled the collection of nearly 
identical RF-only AMUSE and DC-AMUSE mass spectra. 
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Figure 4.9. Mass spectra corresponding to extracted ion traces presented in Figure 4.8 
for a functionalized array with 5-μm nozzles operated in RF-only AMUSE (red) and 
DC-AMUSE (black) modes. 
 
4.5. LC-AMUSE-MS of AK-295 
As a first step in using AMUSE in “real-life” applications, quantitation of 
candidate drugs for the treatment of peripheral neuropathy and chemotherapy-induced 
axonal damage by LC-MS was investigated using AMUSE as the chosen ion generation 
technique. These studies involved AK-295 (analyte) and ZLAK-74 (ISTD), as described 
in section 4.2. Figure 4.10 shows a mass spectrum for an equimolar solution of these two 
drug candidates obtained using RF-only AMUSE mode. 
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Figure 4.10. Mass spectrum of a solution containing 1 μM each AK-295 and ZLAK-74 
analyzed by continuous-infusion RF-only AMUSE using a functionalized 2nd generation 
array with 5-μm nozzles. 
 
The mass spectrum clearly shows [M+H]+ peaks, as well as [M+H2O+H]+ peaks, 
for both AK-295 and ZLAK-74. The intensity of the [ZLAK-74+H]+ peak at m/z 519.2 is 
roughly twice as high as that of AK-295 at equimolar concentrations. This difference in 
intensity is most likely due to differences in the purity of each compound in the samples 
provided, as there is not a significant difference in the polarity of these compounds, 
which would give rise to different ionization efficiencies. 
One common method of enhancing the selectivity of LC-MS experiments is by 
performing selected reaction monitoring (SRM) experiments. In this type of MS scan, a 
precursor ion is selected and then fragmented in the collision cell giving rise to multiple 
product ions that are filtered so that the intensity of only the most specific and abundant 
product ion is monitored. In other words, in SRM mode the signal intensity corresponds 
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to one particular precursor-to-product ion transition. In our QiT mass spectrometer, up to 
10 different scan functions can be run during a single acquisition; however, increasing the 
number of scan types also reduces the duty cycle for a given transition causing a 
concomitant reduction in sensitivity for each targeted compound. For LC-AMUSE-MS 
experiments, three scan types were alternated during each acquisition. The first scan was 
set to monitor the intensity of signal over m/z 150 – 2000, the second was an SRM scan 
for AK-295, while the third scan was an SRM scan for ZLAK-74. The transitions that 
would provide the highest sensitivity for these experiments were determined from 
product ion (MS/MS) spectra obtained for AK-295 and ZLAK-74 (Fig. 4.11). 
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Figure 4.11. MS/MS mass spectra obtained by fragmenting the [AK-295+H]+ ion 
(m/z = 505.2) (A) and [ZLAK-74+H]+ (m/z = 519.2) (B) from a solution containing 
1 μM each AK-295 and ZLAK-74 analyzed by continuous-infusion RF-only AMUSE 
using a functionalized array with 5-μm nozzles. Mass selection window width = 1.2 u, 
C.E. = normalized collision energy. 
 
The fragment ion having the highest intensity in each spectrum was m/z 443.2 for 
AK-295 and m/z 457.2 for ZLAK-74. Thus, the SRM transitions chosen were m/z 505.2 
→ 443.2 for AK-295 and m/z 519.2 → 457.2 for ZLAK-74. Figure 4.12 shows 
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chromatograms for each scan type run during acquisition of a 1 μM AK-295 standard and 
ZLAK-74 by LC-RF-only AMUSE-MS while Figure 4.13 shows chromatograms for the 
SRM transition of AK-295 for two injections of a 2.5 μM AK-295 standard showing 
unwanted mixing effects. 
 


























ZLAK-74 SRM (m/z 519.2 → 457.2)
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Figure 4.12. Chromatograms showing signal for all acquired scans (A), signal over entire 
mass range (B), signal for AK-295 SRM transition (C) and signal for ZLAK-74 SRM 
transition (D) for solution containing 1 μM each AK-295 and ZLAK-74 analyzed by 
LC-RF-only AMUSE using a functionalized array with 5-μm nozzles. 

































Figure 4.13. Chromatograms showing AK-295 SRM transition signal for two sequential 
injections of a 2.5 μM AK-295 standard analyzed by RF-only AMUSE using a 
functionalized 5-μm nozzle array. 
 
As can be seen in these chromatograms, the peak shape of the AK-295 and 
ZLAK-74 signals can sometimes suffer severe distortions between runs. One limitation of 
the AMUSE assembly in its current configuration is the relatively large size of the 
analyte reservoir, 105 μL, which is seven times larger than the volume of sample injected 
into the column. Diffusional and convective broadening of the sample plug can occur 
within this compartment. It is well known by LC-MS practitioners that chromatographic 
band broadening, such as that occurring in the tubing connecting LC to the ion source 
mounted on a mass spectrometer, has to be carefully minimized to optimize peak shape 
and reduce memory effects. In LC-AMUSE-MS, the analyte reservoir is filled via a tube 
that is inserted approximately 3 mm into the reservoir from the center of the top-most 
edge of the AMUSE assembly. If ejection is actively occurring from the nozzles near the 
sample inlet tube, then it is likely that diffusion will be minimal and the chromatographic 
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peak will be relatively narrow as shown in 4.12.C. However, if no ejection hot spots are 
near the inlet, the sample will instead unevenly mix throughout the reservoir and will be 
sporadically ejected causing signal spikes and significant broadening of the 
chromatographic peak as shown in Figure 4.13. Attempts to minimize broadening due to 
the large reservoir volume by preparing silicone inserts (which define the reservoir 
volume as explained in section 2.3.2) having internal volumes as low as 20 μL were 
unsuccessful because of the poor ejection efficiency of this particular device (~10%) 
which made alignment of the reservoir with ejection hot spots extremely difficult. 
Quantitation of drugs in biological samples with possible matrix effects is usually 
performed by calculating the area under the curve of the SRM chromatograms, and 
creating a calibration curve correlating the ratio of the area of the drug of interest (AK-
295) / area of the ISTD (ZLAK-74) with the drug concentration ([AK-295]) in the 
sample. Calibration curves obtained following this approach by pESI, RF-only AMUSE 
and DC-AMUSE for the AK-295 standards are shown in Figure 4.14. Interestingly, 
despite the poor peak shape, the overall integrated peak intensity observed in SRM 
chromatograms still follows a linear relationship with analyte concentration, indicating 
quantitative elution and ionization of AK-295. These observations support our hypothesis 
of uneven mixing followed by ejection within the AMUSE ion source sample reservoir. 
The correlation coefficient for each calibration curve is > 0.98 indicating good fit 
between the experimental data and the regression line. 
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pESI   (R2 = 0.99)
RF-only AMUSE (R2 = 0.98)
DC-AMUSE (R2 = 0.98)
 
Figure 4.14. LC-MS calibration curves using pESI, RF-only AMUSE, and DC-AMUSE 
ion sources. The correlation coefficient for each curve is indicated in the legend. Peak 
areas for AK-295 and Zlak-74 were calculated using the QiT manufacturer's software 
(Xcalibur 2.0, ThermoFinnigan, Waltham, MA) by integrating over the entire SRM 
chromatograms. 
 
One common pitfall with LC-ESI-MS quantitation using area ratios is deviation 
induced in the ratio due to ionization suppression when the analyte concentration 
becomes significantly larger than the concentration of the internal standard. In the pESI 
experiments, the ZLAK-74 peak area increased until [AK-295] > [ZLAK-74] at which 
point it steadily decreased with increasing AK-295 area as shown in Figure 4.15. 
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Figure 4.15. Peak areas for AK-295 (black circle) and Zlak-74 (red triangle) for 
LC-pESI-MS. The dashed line indicates the concentration of ZLAK-74 in the standards. 
 
The decreased ZLAK-74 peak area with increasing [AK-295] causes the 
calibration curve to deviate to higher ratios for AK-295 concentrations that are higher 
than the concentration of ZLAK-74. Due to the inherently different ionization 
mechanisms, this distortion is not present in the calibration curves obtained with AMUSE 
suggesting that this technique is not significantly affected by ionization suppression. One 
minor experimental difficulty sometimes observed during these experiments was the 
presence of contaminant peaks in the LC-AMUSE mass spectra as shown in Figure 4.16. 
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Figure 4.16. Mass spectra obtained for scans at (A) and after (B) the expected tR of 
the chromatographic peak of AK-295 for a 5 μM standard analyzed using 
LC-RF-only AMUSE-MS. The corresponding SRM chromatogram is shown 
in Figure 4.13.C. 
 
As can be seen in the spectrum at time = 3.0 min, the [M+H]+ peaks for AK-295 
and ZLAK-75 are apparent. However at 3.8 min, these peaks are completely obscured by 
the presence of a polymeric contaminant that has been identified as 
polydimethylcyclosiloxane (PDMS), an ubiquitous contaminant that has been shown to 
produce significant background signals in mass spectra.265 The specific origin of this 
contaminant has not yet been identified; however, it was not observed in LC-pESI-MS 
studies performed prior to the LC-AMUSE experiments suggesting that it originates from 
the AMUSE assembly. PDMS is commonly found in silicone rubber so these signals may 
be due to leaching from the silicone insert used in the AMUSE assembly when the 
mobile phase was ramped to 100% acetonitrile. As these contaminants were not observed 
in the continuous-infusion experiments, which used 30% organic solvent, leaching 
because of the high organic content in LC-AMUSE is a strong possibility. Potential 
solutions to this problem include switching the insert material to polyethylene, latex, or 
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polyurethane, which are readily available in the same thickness as the silicone film used 
for the insert. 
 
4.6. Conclusion 
These critical proof-of-principle experiments demonstrated that increasing the 
hydrophobicity of the ejector array significantly improved MS signal stability for DC-
AMUSE and RF-only AMUSE as indicated by decreases of up to 89% in %RSD of the 
MS signal. Furthermore, mass spectral peak intensities for DC-AMUSE and RF-only 
AMUSE were increased by 10-fold and 2-fold, respectively, upon silanizing the array. 
The first report of coupling of LC with AMUSE was also presented for the analysis of 
AK-295. However, several challenges need to be overcome before LC-AMUSE-MS can 
be used for routine separation and ionization of complex samples. Multiplexed AMUSE 
devices having smaller analyte reservoirs have recently been reported134  and may aid in 
reducing diffusional/convective broadening of the chromatographic peak; however, the 
availability of these devices is still limited. Despite these remaining challenges, it is clear 
that the AMUSE ion source has clear potential for LC-MS experiments. 
Hampton, C. Y.  138 
PART II: ADVANCES AND APPLICATIONS OF AMBIENT 
PLASMA-BASED IONIZATION TECHNIQUES 
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In this chapter, results from screening experiments using DART-MS and LC-MS 
performed on a large collection of low quality drugs sold along the border between 
Thailand and Myanmar (Burma) are presented. The chapter begins with an explanation of 
the effect that distribution of low-quality drugs has on public health, with regards to the 
potential curative effect of these pharmaceuticals for patients and to the increasing 
prevalence of drug resistance, especially in areas most affected by Plasmodium 
falciparum (P. falciparum) malaria. This is followed by a description of the DART 
ionization technique. An examination of the effect of different DART experimental 
variables on the observed sensitivity for common drug molecules and a detailed study of 
the mass accuracy obtained during elemental composition determination of the ions 
generated is also presented. The chapter concludes with results of an investigation to 
identify the composition of these low-quality drugs via LC-MS and DART-MS. 
 
5.2. Yaa Chud Medicine on the Thai-Myanmar Border 
Multi-drug resistant P. falciparum malaria is a severe public health problem in 
Southeast (SE) Asia, particularly along the Thai-Myanmar border.266-268 Traditional 
antimalarial medicines such as chloroquine, pyrimethamine+sulphadoxine, quinine, and 
mefloquine are no longer effective when used alone.267 Instead, artemisinin derivative 
combination therapy (ACT), such as artesunate+mefloquine or artemether+mefloquine, 
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can be used to successfully treat P. falciparum malaria.266, 267, 269, 270 Although these drugs 
are available from government clinics, many Thai villagers and Burmese migrant workers 
buy small packets of drugs over-the-counter from grocery shops and pharmacies as their 
first line of treatment for fever. 
These small plastic bags, which contain 4-5 tablets or capsules are called “yaa 
chud” in Thai, or literally “combination medicine”, and are sold to patients or their 
families without prescription or medical assessment.271-273 Yaa chud are prepared by 
putting tablets and capsules, obtained from pharmaceutical wholesalers, in small plastic 
bags that are sold individually to patients according to the symptoms they present. They 
are often the first line of care for patients with malaria and “fever” and it has been 
estimated that 20 – 50% of total worldwide antimalarial distribution was through these 
informal outlets and sellers.274 
There are many potential problems with the unregulated distribution of drugs in 
this way. Their use may reduce the effectiveness of antimalarial therapy.275, 276 The 
medicines are unlabelled and in varied combinations, and are generally sold without 
instructions on how to take the drugs or what dosing regimens to follow. Furthermore, 
they are typically prepared by untrained staff who are probably unaware of drug 
interactions and contraindications and there is evidence that many yaa chud medicines are 
composed of inappropriate and/or unnecessary drugs.271-273 Although the tablets and 
capsules within the bags may be genuine, yaa chud may also include counterfeit, 
substandard or degraded pharmaceuticals. However, without evidence of the chemical 
identity of these tablets and capsules, this is extremely difficult to determine. The use of 
yaa chud may also have important wider implications for public health as sub-therapeutic 
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doses may increase the prevalence of parasites, such as P. falciparum, that are resistant to 
the few remaining effective antimalarial drugs.270, 277 Thus, the identification of AIs in 
these unlabelled drugs, which were purchased along the Thai/Myanmar border by a local 
volunteer, is of critical importance. These samples were provisionally identified by their 
appearance and the entire set was screened using DART-MS. A subset of these samples 
was further assayed using LC-MS and atomic absorption spectroscopy (AAS). 
 
5.3. DART Ionization 
DART has quickly gained popularity among MS practitioners due to the relative 
simplicity of obtaining useful data from chemical systems with sample throughputs of up 
to 3 samples per min.189 At the core of the DART ion source (Fig. 5.1) is a point-to-plane 




























Figure 5.1. Schematic of the DART ion source depicting use for the analysis of a 
pharmaceutical tablet. 
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5.3.1. DART Desorption / Ionization Mechanism 
A series of complex processes within this discharge region (electron-impact, ion-
electron recombination) produces metastable He atoms (He*, 23S1, 19.8 eV) which are 
carried downstream by the He gas flow. N2 can be used instead of He, in which case, the 
excited species correspond to energetic N2 vibronic states. Ions and electrons also 
produced in the discharge region are filtered out by a perforated electrode positioned 
downstream. The He*-containing gas stream can then be heated to temperatures varying 
from 200 to 450 °C prior to exiting the ion source. A second grid electrode at the exit of 
the ion source prevents ion-ion recombination.38 
Cody et al have proposed several reasonable DART ionization mechanisms. Most 
of these mechanisms begin with reaction 5.1, where, upon exiting the ion source, the 
heated He* stream induces Penning ionization278 of atmospheric water, generating 
protonated water clusters.38 
 
 (g)(g)1n2(g)(g)2(g)
* OHHO)(HHeOnHHe −+− ++⎯→⎯+  (Rxn. 5.1) 
 
This mechanism for the formation of reactive protonated water clusters is 
supported by examination of the typical background mass spectrum obtained by DART-
MS which shows clusters with n = 1 – 14.38 Vaporized analyte(s) (AB) are generated via 
thermal desorption or chemical sputtering from the solid analyte surface by the heated 




(s) ABAB ⎯→⎯  (Rxn. 5.2) 
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Proton transfer from the protonated water clusters to the analyte will occur for 
analytes having a higher proton affinity than water. Proton transfer from these water 
clusters to the gas-phase analyte can lead to the generation of protonated gas-phase 
molecules ([AB+H]+) as shown in reaction 5.3. 
 
 (g)2(g)(g)(g)1n2 O1)H(nH][ABABHO)(H −++⎯→⎯+
•++
−  (Rxn. 5.3) 
 
The predominance of this cluster-mediated mechanism seems to be consistent with most 
observations that [AB+H]+ ions are the major species generated by DART-MS. However, 
fragmentation of the protonated molecule has also been observed for analytes having a 
much higher proton affinity than water and can be induced by increasing the DART gas 
temperature.173 
Molecular ions have also been observed for analytes such as atmospheric gases 
and small organic molecules which have an ionization energy that is lower than the IE of 
the excited metastable (19.8 eV for He*). The mechanism for the formation of M+· ions 
from nonpolar species has been proposed to follow reaction 5.4.173 
 
 −•+ +⎯→⎯+ e[AB]ABHe (g)(g)(g)
*  (Rxn. 5.4) 
 
Ionization in negative ion mode has also been reported.38, 174, 184 In negative ion 
mode, ionization occurs via one of four mechanisms: electron capture, dissociative 
electron capture, proton transfer, and anion attachment as shown in reactions 5.5 – 5.8.174 
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 (g)(g) ABeAB
•+− ⎯→⎯+  (Rxn. 5.5) 
 (g)(g)(g) BAeAB
•−− +⎯→⎯+  (Rxn. 5.6) 
 (g)(g)-(g)(g) [HX]H][ABXAB
++−⎯→⎯+  (Rxn. 5.7) 
 (g)(g)(g) Cl][ABClAB
−− +⎯→⎯+  (Rxn. 5.8) 
 
Following ionization, the combined forces exerted by the He flow towards the 
spectrometer inlet, the suction from the API orifice, and the weak electrical field applied 
to the ion source exit electrode contribute to transmit ions into the first differentially 
pumped region of a mass spectrometer utilizing orthogonal acceleration TOF38, 173, 176, 183, 
184, 186, 188, 190-192, 195 or triple quadrupole194 mass analyzers. 
 
5.3.2. Effect of DART Experimental Parameters on Ion Transport and Signal Intensity 
Although qualitative analysis via DART-MS has been applied to a wide variety of 
problems, there have been few systematic studies on the factors influencing mass 
accuracy, ion yield, and thermal ion activation in DART-MS. Recent work by Harris and 
Fernández focused on investigating the parameters which most strongly affect ion 
transport.279 Simulations of the effect of thermal gradients induced by the heated gas, 
convective gas currents, sample position, and electrical fields on the intensity of DART-
MS signal showed that optimal signal could be obtained by aligning the DART ion 
source with the mass spectrometer inlet and placing the target analyte near the ion source 
at a position that is slightly below the center axis formed by the source and inlet. This 
phenomenon was verified experimentally and it was proposed that signal was enhanced 
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due to enhanced thermal desorption as a result of the higher temperature in this region 
and due to more efficient particle transport via gas currents. 
Cody has recently investigated the effect of several parameters, including the 
distance between the ion source and mass spectrometer inlet, temperature, voltage on the 
discharge needle, and grid voltage on the relative abundances of molecular ions vs. 
protonated molecules of the same analyte.173 It was found that by increasing the distance 
between the source and inlet, the abundance of the protonated molecule increased (due to 
the higher availability of water molecules) while the abundance of the molecular ion 
decreased. Increasing the voltage on the discharge needle caused a corresponding 
increase in the ion current but also increased analyte oxidation which tends to promote 
hydride extraction rather than protonation or electron transfer, resulting in a decrease in 
the abundance of both the molecular ion and the protonated molecule. Increasing the grid 
voltage was found to increase fragmentation in the mass spectra, an observation that was 
supported by the simulations performed by Harris.279 
To extend these fundamental investigations of the effect of varying the DART 
source parameters on MS signal intensity, analyses using common drug molecules were 
performed. Specifically, the effect of changing the He*-stream temperature, gas flow rate, 
and grid voltage on signal sensitivity was monitored. A study of the effect of the He 
stream temperature on the time-resolved appearance of fragment ions during the 
ionization of labile drugs was also performed. These results allowed us to optimize 
instrumental settings for the screening of a collection of yaa chud with the intent of 
identifying, by accurate mass measurements, the AIs present in these low quality 
pharmaceuticals. 
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5.4. Experimental Details 
5.4.1. Sample Collection 
Sample collection was organized by Dr. Paul N. Newton (Wellcome Trust-
Mahosot Hospital-Oxford Tropical Medicine Research Collaboration and Centre for 
Clinical Vaccinology and Tropical Medicine, University of Oxford). 
Between July 2000 and January 2001 a Thai, Burmese and Karen speaking 
researcher, dressed as a Burmese migrant worker from Myanmar, visited “kong cham” 
shops in 16 villages astride the Thai-Myanmar border in Mae Sot District, Tak Province, 
Thailand and adjacent Myawaddy District, Myanmar. The area is endemic for multidrug 
resistant P. falciparum malaria, and the first diagnosis to consider this area would be 
malaria. A total of 50 yaa-chud containing 254 tablets and capsules with a median (range) 
of 5 (1-8) tablets or capsules per plastic bag was purchased from 44 shops – 31 (70%) 
shops were in Thailand and 13 were in Myanmar. A further 20 shops visited did not have 
yaa chud. The median (range) retail price per bag and per tablet/capsule were 5 (4-12) 
and 1 (0.7-5.0) baht, respectively (5 baht was worth ~0.12 and 0.14 US$ in 2000 and 
2009, respectively). Figure 5.2 shows an image of the entire yaa chud collection. 
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Figure 5.2. Yaa chud collection. 
 
The mystery shopper said that his “wife was pregnant, has bad fever and is 
drowsy, could I have some medicine please”. A fictional pregnant patient was chosen as 
they are especially vulnerable to malaria and treatment is not straightforward. If the 
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shopper was offered a packet of yaa chud, he asked where the drugs came from, how 
many should be taken and when, will it work for malaria, and might it harm her or the 
baby. 
Fifteen (34%) of the sellers indicated that the yaa chud were prepared on-site 
while the remaining sellers indicated that the yaa chud were purchased from shops in 
Mae Sot town. Shopkeepers usually recommended taking a single yaa chud (96%) once 
every 24 hours (35%), 8 hours (33%), 12 hours (30%), or 4 hours(2%). None said that 
one yaa chud packet was insufficient to cure the illness or gave any advice regarding the 
length of time to continue taking yaa chud. Shopkeepers said that 45 (90%) of yaa chud 
samples would work for malaria, while 4 (8%) said that they would not work and 1 (2%) 
did not know. 
All samples were inspected, described and reviewed by local pharmacists (Mae 
Sot Hospital and Faculty of Pharmacy, Mahidol University, Bangkok) prior to chemical 
analysis. All samples were refrigerated (4 ºC) prior to analysis. 
 
5.4.2. LC-MS Sample Preparation and Analysis 
All LC-MS sample preparation and analyses were performed by Krystyn Alter-
Hall, a master’s student in the Fernández group, and Colleen McShane and Horace 
Leung, two undergraduate students who conducted research in our group. 
Drug standards (Sigma-Aldrich, St. Louis, MO) and yaa chud samples were first 
crushed with a mortar and pestle. Approximately 30 mg of sample was suspended in 1 
mL of methanol (Sigma-Aldrich, St. Louis, MO) and extracted on a rotary shaker for 2 
hours. Following extraction, suspensions were filtered through a 0.45 µm PTFE 
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membrane filter (Pall Corporation, Ann Arbor, MI) and were diluted with methanol or 
50:50 acetonitrile:water (v/v) as needed. Tablets and tablet extracts were kept refrigerated 
(4°C) until analysis. 
LC separations were performed on an Agilent 1100 system equipped with a 
solvent degasser, a binary pump, a thermostatted column compartment (held at 25°C), an 
autosampler, and a diode array detector. An analytical Zorbax® Extend-C18 column (2.1 
x 150 mm, 5 μm particles, 80 Å pore size Agilent) equipped with a Zorbax® RX-C18 
guard column (4.6 mm x 12.5 mm, 5 μm particles, 2 μm pore size; Agilent) was used. 
The gradient LC method was optimized to provide good separation of a wide range of 
drugs and used A = nanopure water + 0.01% acetonitrile and B = acetonitrile. The mobile 
phase flow rate was set to 200 μL min-1 with an injection volume of 20 μL. The 
following gradient program was used: 0 min – 5% B, 7 min – 45% B, 8 min – 100% B, 
12 min – 100% B. The system was set with a four minute post run time to re-equilibrate 
the column to the original mobile phase composition. 
The LC system was coupled to a TOF mass spectrometer (AccuTOF, JEOL, 
Peabody, MA) via an orthogonal pESI interface operating at 2 kV. The mass 
spectrometer ion optics settings were as follows: inlet orifice = 80 ºC, 30 V; ring 
electrode = 8 V; orifice 2 = 5 V; ion guide bias voltage = 26 V; ion guide RF amplitude = 
2 kV; nebulizing gas flow rate = 1.0 L min-1; desolvation gas flow rate = 2.5 L min-1; 
desolvation chamber = 250 ºC; detector = 2500 V. Spectra were collected with a data 
sampling interval of 0.5 nanoseconds and a spectrum recording interval of 0.4 seconds. 
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5.4.3. DART-MS Analysis 
Sensitivity and fragmentation studies were performed by Arti Navare, a graduate 
student in the Fernández research group, and used paracetamol (acetaminophen, 500 mg, 
Tylenol®; McNeil-PPC Inc., bought in the USA) and erythromycin. Yaa chud 
experiments were performed by Christina Y. Hampton, Dr. Facundo M. Fernández, and 
Dr. Robert B. Cody of JEOL USA, Inc. 
This technique did not require sample preparation and thus samples were 
analyzed as provided. A commercial DART ion source (IonSense, Saugus, MA) was 
coupled to the AccuTOF and both were operated in positive-ion mode. He gas was 
introduced into the DART discharge chamber at flow rates ranging from 4 – 7 L min-1. 
The glow discharge was initiated by application of 3.5 kV to the DART needle electrode 
and the first DART ion source electrode was held at 150 V. The grid voltage ranged from 
25 – 375 V while the DART gas temperature ranged from 150 – 450 ºC. For yaa chud 
experiments, the He gas flow was set to 4 L min-1 and heated to 275 ºC while the grid 
voltage was set to 250 V. The mass spectrometer ion optics settings were as follows: inlet 
orifice = 150 ºC, 54 V; ring electrode = 59 V; orifice 2 = 34 V; ion guide bias voltage = 
29 V; ion guide RF amplitude = 1000 V; detector = 2800 V. Spectra in the 50 to 1000 m/z 
range were collected with a data sampling interval of 0.5 nanoseconds and a spectrum 
recording interval of 0.4 seconds. The distance between the DART ion source exit and 
the spectrometer inlet was fixed at 2 cm. 
Uncoated tablets were held with a pair of metal tweezers in front of the DART ion 
source for an average time of 20 s for yaa chud experiments. Exposure times were 20 s 
for sensitivity studies, and 80 s for fragmentation studies. The distance between the tablet 
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and the TOF inlet was 1 cm. In the case of coated tablets, these were first broken in half, 
and the interior was analyzed by DART. Capsules were opened, and the contents were 
sampled with the open end of a melting point capillary (for powders, 1.5 mm o.d. x 90 
mm long glass capillary), or with tweezers (for granules). For sensitivity and ion 
fragmentation studies, which required a careful measurement of ion intensities and thus a 
higher degree of sample positioning reproducibility, a sliding arm terminated with an 
alligator clip was used to position the samples. No memory effects were observed as long 
as care was taken not to contact the inlet orifice of the mass spectrometer with the tablet. 
The total acquisition time to screen the complete sample set was 142 minutes, which 
corresponded to a sample throughput of 3 samples min-1. 
Due to the poor yaa chud packaging, cross contamination between tablets was 
common and problematic for DART-MS analysis as contaminant particles embedded on 
the sample surface produced signals corresponding to AIs from other tablets in the 
package. This is evident in Figure 5.3, which shows the DART-MS mass spectra obtained 
for samples in a single yaa chud packet that is shown in the top left panel. Contaminants 
embedded on the sample surface produced signals corresponding to AIs from other 
tablets in the package (Fig 5.3, panels A – E). If cross contamination between samples in 
a given package was suspected, tablets were broken in half, and the internal surface of the 
tablets was also subjected to DART-MS. The AIs were thus assigned based on the 
common peaks observed for both the external tablet surface, and the internal surface of 
the broken tablet. 
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Figure 5.3. Accurate mass DART-MS mass spectra obtained from tablets and capsules 
found in a representative yaa-chud bag (shown in top left panel). Peaks were assigned if a 
match was found within a 5 mmu tolerance. 
 
5.4.4. Mass Spectral Data Analysis 
Spectra were continuously acquired over 10-20 minute runs, during which time 
drug samples and a melting point capillary dipped in neat poly(ethylene glycol) (PEG, 
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average molecular weight 600) were alternately placed within the DART ionization 
region. During data post-processing and analysis, a mass spectrum of each unknown was 
obtained by averaging the mass spectral data over the time interval corresponding to the 
exposure of the corresponding sample to the DART gas. Mass spectral background 
subtraction, data centroiding, and drift correction were performed using the built-in mass 
spectrometer software (MassCenter, version 1.3). Mass drift correction was performed by 
obtaining a reference mass spectrum using the PEG mass spectra acquired at the 
beginning of each sample run and immediately after each sample analysis during the run. 
AI identification was performed by importing the spectral peak list into Excel (Microsoft, 
Auburn, WA) and using a system of macros to search for matches against an in-house 
library of protonated molecules derived from the Model List of Essential Drugs published 
by the World Health Organization (WHO).280 A match was considered positive if the 
difference between the experimental and theoretical m/z values was less than 5 mmu. 
Data on drug collection and identity was analyzed using Stata 10 (College Station, Texas, 
USA). 
 
5.4.5. Elemental Analysis Using AAS 
All AAS experiments were performed by Dr. Mabel B. Tudino and Natalia 
Mancuso of the Department of Inorganic, Analytical, and Physical Chemistry / 
INQUIMAE, at the University of Buenos Aires in Argentina. 
Samples that were provisionally identified as containing either mineral 
supplements or antacids (3/132 or 2%) were analyzed using AAS using the method 
detailed by Newton, et al.188 Briefly, 100 mg sample was digested in closed PTFE vessels 
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with 5 mL of 70 % w/w nitric acid using a microwave digestion system (MDS 2000, 
CEM Co, Matthews, NC, USA). After digestion, the PTFE vessels were cooled to room 
temperature and the final clear solution was diluted to a final volume of 10 mL with 
distilled water. Metal concentrations were determined by AAS (Shimadzu 6700 AAS, 
Kyoto, Japan) employing a flame air/acetylene atomic source (Hamamatzu single hollow 
cathode lamps, Cu, Fe, Mn, Zn, Ca and Mg, Shimadzu). The metal concentrations in the 
samples were obtained by the working curve methodology. 
 
5.5. Factors Affecting DART-MS Sensitivity 
As paracetamol was one of the most common AIs provisionally-identified in the 
yaa chud collection, it was selected as a probe molecule to better understand the effect of 
DART helium flow rate and exit (grid) electrode voltage on the observed DART-MS 
sensitivity. Figure 5.4 shows the results obtained by repetitively exposing identical 
paracetamol tablets to the DART stream under varying gas flow and voltage conditions. 
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He 4 L min-1
 
Figure 5.4. Effect of He gas flow and grid electrode voltage on the observed DART-MS 
ion yield for a paracetamol tablet. DART gas temperature: 200 °C, ion guide peaks 
voltage: 600V. Other conditions were as described under experimental. 
 
It was observed that for the protonated paracetamol ion ([M+H]+; m/z = 152), 
sensitivity increased with increasing He flow rate. One possible explanation for this 
effect is that, as He flow rate is increased, more heat is transferred to the sample per unit 
time, thus resulting in an increase in the paracetamol desorption rate (Rxn. 5.2), with a 
concomitant increase in ion yield (Rxn 5.3). This was also observed in simulations 
performed by Harris and Fernández.279 Despite the increase in sensitivity at increased He 
flow rates, the S/N was still sufficient for detecting the major sample components even at 
the lowest flow rates assayed, and thus, from a practical standpoint, lower flow rates may 
be preferable if reducing He consumption is an important factor. 
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In DART, efficient transmission of ions into the vacuum of the mass spectrometer 
is crucial, because once formed, ions are rapidly dispersed. Ions formed externally by 
DART, must enter the TOF mass spectrometer through a small orifice (400 μm i.d.). 
Thus, a significant fraction of the ions formed are lost. In this sense, an additional factor 
to explain the increase in sensitivity observed with increased He flow, is improved ion 
transmission into the first differentially-pumped region of the mass spectrometer due to 
enhanced convective ion transport. Higher He flow rates effectively transport more ions 
to the inlet orifice before ion diffusion into the atmosphere takes place. 
Prior to entering the mass spectrometer, ions are also subjected to a constant 
electrical field exerted by the grid electrode. Originally, this field was put in place to 
prevent ion/ion recombination.38 In our experiments, it was observed that at the lowest 
He flow rate assayed (4 L min-1), increasing the grid electrode voltage had only a small 
effect on the abundance of the [M+H]+ paracetamol ion. However, as He flow rates were 
increased from 4 to 5 and 7 L min-1, sensitivity became more dependent on the exit 
electrode voltage. Higher sensitivities were observed at lower exit electrode voltages, 
which was also observed in the simulations performed by Harris,279 and in this case, an 
optimum value between 75 and 125 V was determined. Voltages higher than 175 V 
resulted in a systematic decrease of the ion abundance, as can be seen in Figure 5.3. At 
higher values, the grid voltage also affects ion transmission. Following ionization, ions 
are transported towards the mass spectrometer inlet under the influence of various forces, 
including the force created by the He flow, the spectrometer’s intake airflow, and the 
static electrical field from the exit electrode. At low electrical fields, the air inflow is 
sufficient to attract ions near the inlet orifice, but at higher voltages, the ion’s kinetic 
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energy is such that the intake airflow is not sufficient for effectively sampling ions that 
are not closely on-axis with the inlet. Thus, more ions are forced to collide with the mass 
spectrometer’s front plate resulting in a decrease in the overall ion transmission. 
 
5.6. Effect of Temperature on the Fragmentation of Labile Molecules 
During DART-MS analyses, fragment ions are sometimes observed.38, 173, 184 One 
potential origin of these fragment ions is thermal activation, either in the gas phase within 
the open air ionization region in front of the DART, or in the solid phase, prior to 
desorption. It was observed that, in most cases, fragment appearance was significantly 
reduced at lower temperatures (e.g. 200 °C), but a short lag time of 5-20 seconds 
(depending on the size of the tablet) between the introduction of the sample into the 
DART stream and the appearance of ions was noticed. This effect could be attributed to 
the finite time required to heat a solid sample in order to produce a detectable amount of 
volatile AB species following reactions 3.2 and 3.3. It was also noticed that at 
temperatures lower than 275 °C, the m/z range of the signals observed was significantly 
reduced to ~600 and accompanied by a decrease in the overall signal intensity. It was 
concluded that for the majority of samples being screened, a He gas temperature of 275 
°C was a good compromise to minimize thermal ion activation and maintain the ability of 
desorbing unknowns with higher m/z. 
To further study the effect of He gas temperature on the appearance of fragment 
ions, temperature-resolved DART-MS experiments were performed on a large (250 mg) 
erythromycin tablet. The reasons for choosing this sample were three-fold. First, for 
larger tablets such as these, the heating and desorption rates are probably significant with 
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respect to the time scale of the DART measurement. Thus, higher temperatures may be 
required for effective desorption, which may bring a concomitant increase in thermal ion 
activation. Secondly, erythromycin (Fig. 5.5) is known to readily dehydrate at 55 °C and 












































m/z = 588  
Figure 5.5. Fragmentation scheme for erythromycin. 
 
Hampton, C. Y.  159 
The appearance of these ions can thus be monitored as an indicator of increased 
IE deposition during the ionization process. Thirdly, the erythromycin protonated 
molecule (m/z 734) is at the upper range, in terms of molecular weight, of the drugs 
contained in our database, and thus, its efficient desorption at a given temperature 
indicates that efficient desorption of other molecules in a mass range equal to this would 
also be feasible. Figure 5.6 shows DART-MS spectra of four identical erythromycin 
tablets obtained using variable He gas temperatures. 
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Figure 5.6. DART-MS mass spectra obtained for an erythromycin tablet exposed for 30s 
to a He stream at varying temperatures. Ion guide peaks voltage:1400 V. Other conditions 
as described under experimental. a = [M+H]+ (m/z = 734), b = [M-H2O+H]+ (m/z = 716), 
c = [M-C8H16O2N+H]+ (m/z = 558). 
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It was observed that the S/N for the erythromycin [M+H]+ ion was maximized at 
temperatures between 300 ºC and 350 ºC. At 200 ºC, the observed S/N was less than 
desirable, whereas at temperatures of 150 ºC, no ions were observed. From Figure 5.6, it 
can also be observed that the [M-H2O+H]+ (m/z = 716) ion was detected at temperatures 
of 200 ºC and above. As the ratio between the m/z 716 and 734 ions increased as a 
function of temperature, it was concluded that the m/z 716 ion, corresponding to 
dehydroerythromycin, was produced, at least partially, by thermal activation of the 
[M+H]+ ion or thermal degradation of erythromycin in the solid sample. 
The [M-C8H16O2N+H]+ fragment ion (m/z 558) was also observed with 
significant intensity. The abundances of this ion, the dehydroerythromycin ion and the 
erythromycin [M+H]+ ion were not only a function of He gas temperature, but also a 
function of the exposure time to the DART ionizing gas. Figure 5.7 shows the temporal 
evolution observed for the [M+H]+, [M-H2O+H]+, and [M-C8H16O2N+H]+ ions as a 
function of time. 
 


























































































Figure 5.7. Time-resolved DART-MS selected ion traces for (A) the erythromycin 
protonated molecule ([M+H]+, (B) [M-H2O+H]+, and (C) [M-C8H16O2N+H]+. Spectra 
were acquired every 0.5 s. A fresh sample was introduced into the DART stream at 
t = 0.2 min for each measurement. 
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At temperatures of 350 ºC and higher, the mass spectra obtained by averaging the 
first few seconds of data were significantly different than the ones obtained by averaging 
the data collected after having exposed the sample to the heated DART gas stream for 
more than a minute. For temperatures higher than 350 ºC, an initial spike signaling the 
abrupt desorption of erythromycin from the tablet was observed and quickly followed by 
an increase in the relative abundance of the [M-H2O+H]+ ion, and at longer times, of the 
m/z = 558 fragment ion. These experiments highlight the importance of selecting the 
appropriate DART gas temperature to avoid artifacts in the spectra arising from thermal 
sample degradation, or thermal ion activation. 
 
5.7. Accurate Mass DART-MS Analysis 
The identification, by accurate mass measurements, of the AIs and impurities 
present in yaa-chud pharmaceuticals is of critical importance, as these may contain drugs 
contraindicated in pregnancy or childhood, give rise to clinically confusing adverse 
events, and, if used in subtherapeutic courses, engender antimicrobial drug resistance. 
The identification process involves obtaining accurate m/z values for the constituents 
ionized by DART in each sample. Although a single mass calibration check per day or 
per week is generally sufficient to ensure the accuracy of m/z measurements for most 
mass analyzers, it is a good practice to incorporate a mass drift correction when 
performing long analyses, such as for long LC runs, or if temporal shifts in the local 
environment are expected, as in the case of DART-MS analyses. 
As mentioned in section 5.4.4, each sample was preceded and followed by a PEG 
standard to facilitate correction of the polynomial coefficients used in the mass 
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calibration file and to compensate for drifts in the m/z scale. When screening sample 
collections containing in excess of 254 samples, such as in this survey, this approach can 
be time consuming, as it involves repeating the mass drift correction procedure 254 
times. Any drift in mass calibration during a DART run is usually due to a temperature 
change, since both the power supply output and the length of the flight tube are a function 
of temperature.283 Evaluating the extent to which these changes affect the observed mass 
accuracy is thus important in deciding the limits for matching candidates in our database, 
and for the calculation of elemental compositions using software tools. If the mass 
accuracy threshold is set too low, then it is possible to miss the actual compound. If the 
mass accuracy threshold is set too high, then too many matches can be obtained. To 
estimate the mass accuracies obtainable by alternative DART-MS data processing 
strategies, two approaches were evaluated – a single mass drift correction and a time-
dependent mass drift correction. 
In the single mass drift correction approach, multiple peaks (> 5) within the PEG 
spectrum collected at the beginning of the DART run are compared to a reference file and 
are used to create a single calibration file. This calibration file is then applied to all 
sample spectra collected within the run. The primary benefit of this approach is the 
reduction in time required to collect and analyze the data. However, the advantage of 
increased throughput using this method may be offset by lowered mass accuracies. To 
explore this further, a second mass drift correction approach was performed. For the 
time-dependent mass drift correction, an individual calibration file is created for each 
PEG spectrum collected during the run, which contains alternating PEG and analyte mass 
spectra. The calibration file for the PEG spectrum collected immediately after a given 
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sample spectrum is then applied as a correction for that sample, thus, each sample 
spectrum is corrected using the PEG reference spectrum most closely associated to the 
sample spectrum in time. Figure 5.8 shows mass accuracies observed for drugs identified 








































Figure 5.8. Observed mass accuracies for drugs analyzed during three independent 
DART-MS runs. Full circles show mass accuracies observed when a single initial mass 
drift correction was employed for the whole run. Green triangles show mass accuracies 
obtained for each individually-corrected sample (time-dependent calibration). 
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The average mass accuracy for each DART run was 3.3 ± 1.7 ppm, 5.7 ± 5.1 ppm 
and 5.3 ± 2.7 ppm (average ± standard deviation) using the single initial calibration 
method, and 2.2 ± 2.1 ppm, 2.4 ± 1.7 ppm and 3.0 ± 2.5 ppm using the time-dependent 
calibration. Significant statistical differences in the observed mass accuracies were 
observed for individual runs between the two mass calibration approaches tested. The 
differences in observed mass accuracy were greatest for samples analyzed at the end of 
the runs emphasizing the importance of using the more rigorous time-dependent 
calibration approach for analyses with long run times. The average mass accuracy of each 
run was better using the time-dependent calibration for each sample; however, the 
throughput of this approach is lower. For example, using the average time it took us to 
collect a spectrum (22.1 seconds), 4.1 minutes would be required to collect data for 10 
samples (and 1 PEG spectrum) analyzed in a single run using the single mass drift 
correction approach. Using the time-dependent approach requires the analysis of an 
additional nine reference spectra, which adds 3.4 minutes to the collection time. The data 
analysis time would also be increased using this method. 
The decision as to whether throughput or accuracy is the determining factor for 
which of these approaches to apply is dictated by the requirements of the experiment and 
the use of shorter run times would appear to negate this conflict entirely. The mean mass 
accuracy observed for all PEG standards was 3.8 ± 3.2 ppm, which is comparable with 
the manufacturer’s specification of 5 ppm for ESI-TOF accurate mass measurements, 
indicating that the DART ion source did not introduce additional variables that negatively 
influenced mass accuracy. As the time-dependent calibration produced better mass 
accuracies, it was used for subsequent correction of yaa chud spectra. 
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5.8. Identification of Yaa Chud Contents 
An attempt was made to visually identify the tablets and capsules in yaa chud 
using knowledge as to what was locally available along the Thai-Myanmar border, but 
this proved to be extremely difficult; thus, chemical identification was necessary. Of the 
254 samples analyzed via DART-MS and/or AAS, 96% could be correlated to a 
particular AI and the percentage (number) of samples identified as having a particular AI 
is given in column 2 in Table 5.1. A subset of 100 physically-distinct pills (39%), 
representing all the “taxa” of medicine with different shape, printed codes and color that 
were present in the collection was also analyzed using LC-MS and/or AAS. An AI was 
identified in 89% of this subset and the percentage (number) of samples corresponding to 
a given AI within this subset is given in column 3. The frequency with which a given AI 
was identified in a single yaa chud packet is given in column 4 of Table 5.1 while adverse 
effects for these pharmaceuticals, as specified by the U. S. Food and Drug Administration 
(FDA), are given in column 5.284 
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Table 5.1. Composition of 50 yaa chud (N = 254 pills). G1 = gastrointestinal; Antacid 1 
contains Cu, Zn, Mg, Fe, Ca, and Mn; G6PD = glucose-6-phosphate dehydrogenase; 
Antacid 2 contains Mg, Fe, and Ca. †FDA pregnancy categories are shown in brackets 
([C] = animal studies show toxicity but there is insufficient human data, [D] = evidence 
of human risk, but clinical benefits outweigh risks).284 
 
Drug 
No. (%) of 
pills 
(N=254) 








FDA pregnancy category† & 
potential negative consequences 
(adverse effect) 
Paracetamol 56 (22.0) 18 (18) 39 (78)  
Chlorpheniramine 34 (13.4) 12 (12) 30 (60) Drowsiness, anti-muscarinic 
Chloroquine 32 (12.6) 7 (7) 29 (58) Not efficacious against P. falciparum malaria 
Tetracycline / 
Doxycycline 29 (11.4) 12 (12) 26 (52) 
[D] Efficacious against P. 
falciparum malaria in 
combination with quinine or 
artemisinin derivative. Upper 
GI irritation 
Quinine 13 (5.1) 2 (2) 11 (22) 
Remains effective if given for 7 days 
in combination with 
tetracycline. Tinnitus, 
hypoglycaemia 
Vitamin B6 12 (4.7) 3 (3) 12 (24) ------ 
Chlorpheniramine 
+ Paracetamol 12 (4.7) 2 (2) 8 (16) Drowsiness, anti-muscarinic 
No AI detected 11 (4.3) 11 (11) 0 ----- 
Acetylsalicylic 
acid 11 (4.3) 5 (5) 8 (16) [D] Acidosis 
Metamizole 10 (3.9) 5 (5) 10 (20) [D] Agranulocystosis 
Vitamins B3 & C 5 (2.0) 2 (2) 4 (8)  
Ampicillin 5 (2.0) 2 (2) 4 (8) Rash 
Antacid 1 3 (1.2) 1 (1) 3 (6) Negative interaction with doxycycline absorption 
Paracetamol + 
Sulphamethoxazole 3 (1.2) 1 (1) 3 (6) 
[C] Neonatal haemolysis, 
methaemoglobinaemia 
Dexamethasone 2 (0.8) 2 (2) 2 (4) Immunosuppression 
Indomethacin 2 (0.8) 2 (2) 2 (4) [D] Gastric irritation 
Primaquine 2 (0.8) 1 (1) 2 (4) [C] Haemolysis in G6PD deficiency
Thiamin 2 (0.8) 2 (2) 2 (4)  
Pyrimethamine 1 (0.4) 1 (1) 1 (2)  
Chloroquine + 
Paracetamol 1 (0.4) 1 (1) 1 (2) 
Not efficacious against P. 
falciparum malaria 
Alprenolol 1 (0.4) 1 (1) 1 (2) [C] Bradycardia 
Tolperisone 1 (0.4) 1 (1) 1 (2) Contraindicated in pregnancy 
Amitriptyline 1 (0.4) 1 (1) 1 (2) Anti-muscarinic 
Prednisolone 1 (0.4) 1 (1) 1 (2) Immunosuppression 
Prazepam 1 (0.4) 1 (1) 1 (2) Habit forming 
Vitamin B3, B6 B7 1 (0.4) 1 (1) 1 (2)  
Diclofenac 1 (0.4) 1 (1) 1 (2) [D] Gastric irritation 
Antacid 2 1 (0.4) 1 (1) 1 (2) Negative interaction with doxycycline absorption 
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Throughout the survey, there was good agreement between the DART-MS and 
LC-MS results providing an additional level of confidence about the identity of the AI(s) 
in any given sample. As an example, consider Figure 5.9 that shows mass spectra for 





















































Figure 5.9. (A) DART-MS spectrum of a sample visually identified as paracetamol (code 
22-2; inset shows an image of this tablet), (B) LC-MS spectrum of sample 22-2, and (C) 
LC-MS spectrum of a paracetamol tablet (Tylenol®). The peaks observed correspond to 
the monomer ion ( ; [M+Na]+ for LC, [M+H]+ for DART), dimer ion ( ; [2M+Na]+ for 
LC, [2M+H]+ for DART), [3M+Na]+ ( ), and excipient ( ).The structure of paracetamol 
is shown in the upper, right corner. 
 
The DART-MS mass spectrum for this sample (Fig. 5.9.A), which only shows 
peaks corresponding to the protonated paracetamol monomer and dimer species, is 
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relatively clean when compared to the LC-MS mass spectra of sample 22-2 (Fig. 5.9.B). 
The identification of this tablet as paracetamol was verified experimentally by 
comparison to the LC-MS mass spectrum of a paracetamol reference standard (Tylenol®, 
Fig. 5.9.C), which shows sodiated paracetamol monomer, dimer, and trimer peaks, 
formed by the adduction of sodium to the neutral paracetamol molecules, as well as the 
presence of lactose/sucrose as an excipient. 
Sporadic, low intensity signals due to impurities and partially extracted excipients 
were frequently observed during collection of mass spectral data, but their assignment to 
known chemical substances was outside the scope of this study. In eleven (4.3%) of the 
samples, no AI could be identified in either the mass or atomic spectra collected 
suggesting that these drugs may be composed of degraded or counterfeit drugs, or may 
not contain any AI. A database of color photographs of the tablets, mass spectral peak 
lists, and compounds identified is available for viewing on the Fernández group 
website.285 
Of 132 yaa chud capsules and/or tablets that had both a provisional identity, based 
on physical appearance, and also a confirmed identity from chemical analysis, 85 (64%) 
were identified correctly by visual inspection. Of the samples that could not be 
provisionally identified, 82% were subsequently identified via MS, further emphasizing 
the need for rapid chemical analysis as visual inspection of tablets and capsules cannot be 
used to definitively assign AIs to pharmaceuticals of unknown composition. Moreover, 
visual inspection by pharmacists also yielded a number of incorrect AI’s including 
diazepam, phenylbutazone, chloramphenicol, co-trimoxazole, ergotamine tartrate, 
ambroxol, vitamin A & E compound and phenylpropapanolamine & belladonna 
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alkaloids. Figure 5.10 shows mass spectra obtained from a sample that had been visually 
identified as diazepam. The MS analysis of this sample revealed that this sample 
contained chlorpheniramine and not diazepam, as can be concluded by comparison of the 
sample mass spectra obtained by both DART-MS (Fig. 5.10.A) and LC-MS (Fig. 5.10.B) 
with the mass spectrum of a chlorpheniramine standard (Fig. 5.10.C). 
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Figure 5.10. (A) DART-MS spectrum of a sample that had been visually identified as 
diazepam (code 10-1; inset shows an image of this tablet), (B) LC-MS spectrum of 
sample 10-1, and (C) LC-MS spectrum of a chlorpheniramine standard. The peaks 
observed correspond to [M+H]+ ( ), a major fragmentation product [M-NHC2H6+H]+ ( ) 
and excipient ( ).The structure of chlorpheniramine is shown in the upper, right corner. 
 
5.9. Implications of These Results for Public Health 
Only 7 yaa chud (14%) contained medicine that could have potentially cured P. 
falciparum malaria if taken as part of an appropriate dosing regimen. The remainder of 
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yaa chud had no potential curative effect for malaria. All but one of the yaa chud 
contained medicines that may have alleviated some symptoms (fever, headache) but 
would have caused harm by delaying access to curative antimalarials, which are freely 
available through local Thai hospitals and governmental agencies. Using the FDA 
pregnancy categories284 and the British National Formulary286 guidelines, 41 (82%) of the 
yaa chud were contraindicated for pregnancy. This indicated that in addition to not being 
efficacious, the use of these medicines may be harmful to pregnant patients and their 
fetuses. Even if the yaa chud contained effective antimalarials, they were unlikely to be 
efficacious if taken as recommended by the sellers. 
These yaa chud were collected in 2000 and 2001 and malaria treatment has 
changed locally since then as considerable effort has been expended to improve the use of 
ACT therapy.266 Mainland SE Asia has had great importance in the spread of 
drug-resistant malaria and preliminary reports that artemisinin resistance has arisen on 
the Thai/Cambodia border are of considerable concern.287, 288 If the consumption of yaa 
chud containing inadequate antimalarial therapy or with inadequate dosing leads to 
treatment failure, the spread of drug-resistant parasites to other communities may 
occur.268, 289 Therefore, further work to determine if artemisinin derivatives and 
mefloquine are now used in yaa chud and also to determine how often yaa chud is taken 
by malaria patients is needed to assess the current threat of yaa chud consumption on 
public health. 
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5.10. Conclusion 
The benefits of rapid screening via accurate DART-MS were presented for studies 
to identify AIs of drugs present in mixed therapeutics. A detailed study of combination 
drug packets screened by DART-MS demonstrated the ability of this latest generation of 
ionization methods to achieve high throughput accurate mass identifications of 96% of 
samples analyzed during this survey. An investigation of the effect of temperature and 
flow rate of the helium gas stream, as well as the potential applied to the grid electrode, 
demonstrated that improved sensitivity for the protonated paracetamol peak was 
generally accessible by increasing the temperature and flow rate and decreasing the grid 
electrode. However, some experimental conditions can also induce fragmentation and/or 
oxidation of the protonated molecule resulting in decreased sensitivity. Two approaches 
to performing mass calibrations were explored to identify the factors that most influence 
the quality of mass spectral data obtained during accurate mass experiments. The results 
emphasize the importance of using a mass correction methodology that addresses the 
needs of the experiment being executed. The following were the most common 
compounds identified in the yaa-chud collection: paracetamol (33.5%), chlorpheniramine 
(18.1%), and chloroquine (16.5%). 
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Since 1998, the serious public health problem in SE Asia of counterfeit 
artesunate, containing no or subtherapeutic amounts of the active antimalarial ingredient 
has led to deaths from untreated malaria, reduced confidence in this vital drug, caused 
large economic losses for legitimate manufacturers, and led to concerns that artemisinin 
resistance might be engendered.186 This chapter presents work aimed at developing rapid 
screening methods to identify counterfeit drugs, and discusses an international 
collaborative effort (named operation Jupiter) led by Dr. Paul N. Newton that is geared 
towards determining the source of these counterfeits. 
 
6.2. Background on Operation Jupiter 
Counterfeit drugs are defined as those which are “deliberately and fraudulently 
mislabeled with respect to identity and/or source” and may include products with the 
“wrong” ingredient(s), without AI(s), or with an insufficient amount of AI(s).290 In recent 
years, a particularly alarming case of drug counterfeiting has been reported by field 
researchers202, 203, 291 who have detected counterfeit products that mimic vital antimalarial 
medicines containing artesunate (Figure 6.1), an antimalarial artemisinin derivative that 
was first developed in the People’s Republic of China292 and is widely used throughout 
SE Asia and Africa for the treatment of P. falciparum malaria.201, 292, 293 
 






R1, R2 = O
R1 = H, R2 = OH
R1 = H, R2 = OCH3
R1 = H, R2 = OCH2CH3
R1 = H, R2 = OCH2CH6H5CO2H








Figure 6.1. Structure of artemisinin derivatives including artesunic acid (artesunate). 
 
It is believed that the consumption of fake antimalarials has resulted in many 
deaths, some of them fully documented,204-206 and evidence suggests that production of 
counterfeit artesunate tablets is on an industrial scale. For example, one health care 
organization in SE Asia purchased 100,000 artesunate tablets, all of which were later 
shown to be counterfeit.291 Classic hyphenated analytical techniques, such as LC-MS, are 
capable of discriminating between genuine and counterfeit pharmaceuticals but lack the 
required sample throughput to survey such large numbers of samples in a reasonable 
amount of time.294 
Although most patients with malaria would survive if provided with timely access 
to affordable, effective medicines, over one million people die each year as a result of the 
disease.290, 295 Unfortunately, due to the global spread of drug resistance and the practical 
difficulty of delivering health care to rural communities, most people who are at risk of 
contracting malaria have not had such access until very recently. The current resurgence 
in activity to eradicate malaria can be attributed to the development of ACT treatment 
and to the accumulation of international financial support allowing for inexpensive, or 
Hampton, C. Y.  175 
free, distribution of antimalarials to at-risk populations.293 However, the poor quality of 
antimalarial medicines available in the tropics has been a major obstacle in the struggle to 
reduce the prevalence of malaria. Furthermore, recent data has indicated that 
antimalarials have been particularly targeted by counterfeiters, which has had a 
detrimental effect on the situation.186 
Since 1998 an epidemic of multiple types of counterfeit artesunate tablets have 
been identified in mainland SE Asia. Ad hoc surveys conducted from the year 2000 until 
present times in Myanmar, Lao People’s Democratic Republic (Lao PDR, Laos), 
Cambodia, Vietnam, and along the Thai-Myanmar border suggested that 33-53% of 
bought artesunate was counterfeit, containing either no or subtherapeutic quantities of 
artesunate.185, 202, 203, 291, 296-298 In SE and East Asia there are at least 16 manufacturers of 
artemisinin and its derivatives299 and millions of tablets are produced each year both for 
consumption in Asia and export to Africa. Of these manufacturers, one major producer of 
artesunate, Guilin Pharmaceutical Co. Ltd. (Guilin, Guangxi autonomous region, China), 
has been exclusively targeted by counterfeiters. Counterfeit artesunate pharmaceuticals 
containing no or subtherapeutic quantities of artesunate have recently been described in 
Asia.185 Such counterfeits, which may foil simple screening tests, will engender the 
selection and spread of artemisinin-resistant P. falciparum parasites, which would be 
disastrous for malaria control in Asia and thereafter in Africa. 
Since the first description of fake artesunate in 2000, there has been little action in 
comparison to its public health consequences. With little progress and worsening 
contamination of the supply of antimalarials in the Greater Mekong sub-Region, a 
confidential meeting was held in Manila in May 2005 at the Western Pacific Regional 
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Office (WPRO) of the WHO. The meeting brought together WHO officials, physicians, 
pharmacists and scientists working in the region with the International Criminal Police 
Organization (INTERPOL) to discuss what could be done. It was decided that a joint 
effort be made to investigate where the counterfeits were being manufactured and to 
develop an intelligence document that could be presented to concerned governments with 
a request that measures be taken to stop the lethal manufacture and trade in counterfeit 
artesunate. This chapter presents the analytical screening methodology developed during 
this investigation and summarizes the findings relevant to public health. 
 
6.3. Experimental Details 
6.3.1. Sample Collection and Details 
Sample collection was organized by Dr. Paul N. Newton. From 1999 – 2006, 391 
counterfeit and genuine artesunate tablets were collected in a wide area of SE Asia 
encompassing Laos (115), Myanmar (137), Vietnam (75), Cambodia (48), and along the 
Thai-Myanmar border (16) and were kept refrigerated (4° C) until analysis. These 
samples underwent Fast Red Trypaflavine (TR) Dye testing300, 301 and/or HPLC and 
ambient MS. A subset of 27 fakes and 5 genuines sent, along with four fake (collected in 
Cambodia) and two genuine samples from the United States Pharmacopeia (USP) Drug 
Quality and Information program, also underwent detailed forensic chemical and 
botanical examination as part of the Jupiter operation. In addition, five samples seized by 
the subsequent Ministry of Public Security (MPS) investigation in China were analyzed. 
All laboratories performed the analyses blinded to the results from other laboratories. 
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6.3.2. Analysis of Physical Appearance 
The physical appearance and text on packets, leaflet inserts and blisterpacks were 
examined by Paul Laurin of the Royal Canadian Mounted Police Forensic Laboratory 
Services National Anti-Counterfeiting Bureau in Ottawa, Ontario, Canada. 
The tablets were compared with known genuine Guilin Pharmaceutical Co. Ltd 
artesunate obtained directly from the company. Packets, leaflets and blisterpacks were 
examined with a 6x hand lens, 100x stereo microscope and a handheld UV (375nm) light 
source and then electronically scanned. Batch numbers, expiration and manufacture 
dates, the color, clarity and text of printing on the blisterpack, packet and leaflet (when 
present) were documented. Guilin provided information about the validity of batch 
numbers. 
 
6.3.3. Botanical Analysis 
Botanical analyses were performed by Dallas C. Mildenhall from GNS Science, 
Lower Hutt, New Zealand as described in Newton, et al.188 Briefly, tablets were dissolved 
in hot distilled water or 10% hydrochloric acid yielding two fractions of material in 
which the top fraction, which contains spores and pollen, was dissolved in 9:1 (v:v) acetic 
anyhydride:sulfuric acid. Mineral material remaining was removed by 50% hydrofluoric 
acid and was filtered through a 6 μm mesh. All residues were mounted on glass 
microscope slides and examined at a magnification of 125-250x. Suspected pollen grains 
were identified by comparison with reference spore and pollen material 
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6.3.4. X-Ray Diffraction and Stable Isotope MS Analyses 
X-ray diffraction (XRD) analyses were performed by S. W. Ray Soong from GNS 
Science, Lower Hutt, New Zealand while stable isotope ratio MS was performed by 
Kevin Faure, also from GNS Science. The basic protocol was as follows: each sample 
was crushed and mounted as a slurry on a silicon plate and was analyzed by XRD (X'Pert 
Pro X-ray Diffractometer, Philips, Almelo) and isotope ratio analysis to determine the 






































































































notation.302 Samples were analyzed in duplicate and the values were averaged. 
 
6.3.5. LC Diode Array Analysis 
Tablets were processed and analyzed for artesunate using HPLC by Dr. Michael 
D. Green from the Division of Parasitic Diseases at the National Center for Infectious 
Diseases of the Centers for Disease Control and Prevention in Atlanta, GA.300, 301 
A 150 x 4.6 mm octadecylsilica column with a mobile phase consisting of 45% 
acetonitrile and 55% 0.05 M perchlorate buffer (pH 2.5) effectively separated 
artemisinin, paracetamol, and artesunate. For quantitative paracetamol analysis, the 
mobile phase was changed to 10% acetonitrile and 90% perchlorate buffer. Components 
were detected using a diode array detector with wavelengths set at 220 and 254 nm. UV 
spectra of samples were compared with artesunate, artemisinin and paracetamol reference 
standards for validation. 
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6.3.6. DART-MS Analysis 
DART-MS analyses were performed using a home-built DART ion source 
coupled to the AccuTOF mass analyzer and using a slightly modified version of the 
method described in section 5.4.3. The DART ion source and the AccuTOF were 
operated in positive-ion mode. He gas (350 ºC) was introduced into the DART discharge 
chamber at 2.8 L min-1. The glow discharge was initiated by application of 3 kV to the 
DART needle electrode while the grid voltage was held at 300 V. The mass spectrometer 
ion optics settings were the same as those described previously with the following 
exceptions: inlet orifice = 80 ºC, 30 V; ring electrode = 5 V; orifice 2 = 34 V; ion guide 
bias voltage = 29 V; ion guide RF amplitude = 300 V; detector = 2950 V. Tablets were 
sampled as previously described. Data processing was also performed using the method 
described in section 5.4.3 and results were searched against an expanded library which 
included the drugs listed in WHO’s List of Essential Medicines280 and a list of 238 
common drugs identified in human blood via LC-MS that was compiled by Gergov et 
al.303 Reactive DART-MS was also performed to improve the specificity of artesunate 
analysis. For these experiments, the sampling region was exposed to ammonia vapors 
emitted from a beaker containing ammonium hydroxide (28% in water, Sigma Aldrich, 
St. Louis MO). 
 
6.3.7. DESI-MS Analysis 
DESI-MS experiments were performed by Leonard Nyadong, a graduate student 
in the Fernández Research Group. 
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As described briefly in section 1.4.1, in DESI-MS analysis, a high-speed 
electrically-charged liquid spray is directed at the surface of a solid for direct analysis of 
the surface composition. For pharmaceuticals, the charged spray is directed at the tablet 














Figure 6.2. Schematic of the DESI-QiT setup. 
 
The DESI spray progressively dissolves material from the tablet, giving a 
qualitative depth profile. The charged droplets containing tablet material are sampled 
downstream by a mass spectrometer, providing a spectrum of the sample components. As 
no tablet dissolution is required, this technique is well-suited for screening large number 
of samples. Several points on the tablet surface and interior were sampled during DESI 
analysis to obtain an accurate representation of the components present. A homebuilt 
DESI ion source was used in all experiments with QiT detection.171 Two operational 
modes were explored – reagentless DESI and reactive DESI. In reagentless DESI, a 
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charged (3 kVDC) solution of 75:25 (v:v) acetonitrile:nanopure water was sprayed onto 
the tablet at a flow rate of 5 μL min-1. This mode allowed for non-specific detection of 
analytes having a larger molecular weight than those typically accessible via DART-MS. 
DESI MS was also performed in “reactive” mode, which allowed for the specific and 
sensitive detection of artemisinin derivatives. Reactive DESI experiments were 
performed by adding 100 μM dodecylamine (DDA) (Sigma-Aldrich) to the spray 
solution, and repeating the procedure described above. 
 
6.4. Analysis of Tablet Packaging 
A total of sixteen different hologram types that mimic the genuine packaging used 
by Guilin (Fig. 6.3.A) have been identified since 1999 and range in sophistication from 
crude stickers (Fig. 6.3.B) to highly sophisticated fake holograms such as the ones shown 
in Figure 6.3 C and D. Like the genuine Guilin packaging, the hologram in Figure 6.3.C 
includes the legend ‘Guilin Pharma’ in microscopic font below the illustrated river and 
the Chinese registration code ‘X-52’ visible under UV light. Upon close visual 
inspection, it is apparent that this packaging has some defects such as misalignment in the 
color, size, and arrangement of the blocks in the circular border at the edge of the 
hologram and also variation in the wavy lines at the bottom of the label. The wavy lines 
at the bottom of the fake hologram shown in Figure 6.3.D are more similar to those of the 
genuine packaging but this fake also shows distortion of the circular border and does not 
contain the UV stamp. 
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Figure 6.3. Examples of genuine and counterfeit holograms. (A) Genuine Guilin 
pharmaceutical artesunate blister pack hologram. (B) A type 2 sticker copy. (C) A type 
10 hologram copy with the fake "X-52" stamp as seen under UV light. (D) Type 15 
hologram copy from a counterfeit artesunate tablet seized from the China/Myanmar 
border. 
 
As of May 2009, sixteen different types of fake packaging have been identified 
and are described in detail in Figure S-1 from Newton, et al.188 One feature common to 
all of these counterfeit holograms is misalignment of the blocks forming the circular 
border of the Guilin logo. Other discrepancies noted between genuine packaging and 
these fakes include printing errors in boxes (including misalignment of letters or words), 
differences in font, spelling mistakes, and variable print quality. Figure 6.4 shows a map 
of the distribution of fake artesunate in relation to the fake packaging type. 
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Figure 6.4. Map of the distribution of fake artesunate, collected by Wellcome Trust-
University of Oxford SE Asian Tropical Medicine Research Program and Collaborators. 
Map drawn by Mr. Chongkham Phonekeo and reproduced with permission from 
Newton, et al.188 
 
6.5. Results of Palynological and Mineralogical Analyses 
Most of the spores and pollen identified during this survey have a distinct 
northern Asian temperate signature with evidence of plants such as firs, pines, cypresses, 
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sycamores, alders, wormwood, willows, elms, wattles, and fern spores. Figure 6.5 shows 





Figure 6.5. Photomicrographs of material found in fake artesunate tablets. (A) Debris, 
including charcoal fragments. (B) Pinus pollen grain. (C) Juglans pollen grain. (D) 
Acacia pollen grain with charcoal deposit. (E) Dermatophagoides mite nymph. 
 
The estimated origin of the samples includes northernmost Vietnam, southern 
China, and near the mountains bordering Myanmar and Vietnam. Some of the plant 
remains, such as Juglandaceae pollen (walnut), Carya (wing nut), and Pterocarya 
(hickory), suggest manufacture in southern China.304 In terms of botanical analysis for 
samples having different types of fake hologram/sticker, Type 2 differs from the others as 
it lacks fern spores, Type 1 contained little material but appeared similar to Type 3, and 
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Types 10, 11 and 12 had similar pollen signatures. Types 5 and 8 did not contain 
anything to enable comparisons to be made and Types 4, 6, 7, 9, 13 & 14 were not 
examined. 
In addition to plant remains, five samples contained invertebrates, including a 
Dermatophagoides mite nymph (from Type 11, Vietnam, Fig 6.5.E) which is commonly 
found in house dust and has a global distribution. All fake artesunate tablets contained 
charcoal fragments and black chips, broken up by the processing for pollen. In some 
samples, charcoal was so abundant that it suggested the source was an area suffering 
severe air pollution. 
XRD demonstrated great variability in tablet mineralogy. Although, maize starch 
is the main excipient in the genuine Guilin product, talc (hydrated magnesium silicate), 
calcite (calcium carbonate) and starch were the main excipients detected in the 
counterfeit tablets. Trace amounts of aragonite were present in two calcite-dominated 
fake tablets and traces of chlorite (iron-magnesium hydrosilicate) and quartz (silicon 
dioxide) were found in another two. Stable isotope analysis of the calcite fraction gave 
δ18O and δ13C values between -11 to +2% and +2 to + 25 %, respectively, as shown in 
Figure 6.6. 
 





Figure 6.6. Plot of δ13C and δ18O values, in % of carbonate in tablets. Approximate 
values expected from calcite in different geological environments (pink = igneous; 
yellow = metamorphosed; green = unaltered) is also plotted. Sample 05/17 is represented 
by the top right data point. 
 
Given the similar isotope signatures, the calcite in all (Types 2, 4, 5, 8, and 11) 
but one sample appears to come from the same source and is either hydrothermal or 
medical in origin. The one exception is sample 05/17 (Type 12) from southern Laos 
which, if the calcite is assumed to have been formed by natural geological processes, is 
typical of marine limestone. 
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6.6. DART and DESI Method Development for Screening Counterfeit 
Artesunate Antimalarials 
One common pitfall in the analysis of artesunate by MS is its labile nature, which 
makes detection of ions corresponding to the intact molecule difficult. As artesunate is 
acidic, it was anticipated that negative mode ionization would yield an intense [M-H]- 
peak, however, this was not the case as can be seen in Figure 6.7, which shows the 
negative DART mass spectrum of a genuine (Fig. 6.7.A) and a counterfeit (Fig. 6.7.B) 
artesunate tablet. 
 













Figure 6.7. Negative mode DART-MS mass spectra for a genuine (A) and counterfeit 
(B) artesunate tablet. The structure of artesunate and its dominant fragment ions are 
shown in (C). (1) = [M - H]-, (2) = [palmitic acid - H]-, (3) = [M - C4H4O3 - H]-, 
(4) = [M - C4H6O4 - CO - H]-, (5) = [stearic acid - H]-. 
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The mass spectrum shown in Fig. 6.7.A presents signals corresponding to the 
diagnostic [M-H]- artesunate anion (experimental m/z = 383.1702, theoretical 
m/z = 383.1711) and to palmitic acid, an ubiquitous contaminant. Artesunate fragment 
ions due to dissociation of the highly labile artesunate carboxylic side chain were also 
detected in this spectrum. The spectrum in Fig. 6.7.B, corresponding to a sample which 
had been classified as counterfeit by the Fast Red TR dye test,300, 301 does not contain 
signal corresponding to any artesunate species. Only palmitate and stearate anions were 
detected (calcium stearate is a common pharmaceutical excipient).  
As shown in Figure 6.7, negative ion mode DART-MS allows the rapid 
differentiation of counterfeit from genuine artesunate tablets. However, the high 
specificity of this DART ion mode prevents the detection of analytes that are not easily 
deprotonated. Not only is the absence of artesunate of concern in these tablets, but also 
the potential presence of other physiologically-AIs. These “wrong active ingredients” are 
sometimes added to counterfeit pharmaceuticals to either simulate alleviation of 
symptoms, or perhaps are waste powders left over from the manufacture of other 
pharmaceuticals.305 For this reason, an ionization mode that allows screening for 
artesunate and for other common drugs is highly desirable. 
To that end, positive ion mode DART-MS was performed, however, only a few 
artesunate fragment ions were detected. When the sample was exposed to ammonia 
vapors during DART ionization, the artesunate [M+NH4]+ ion was readily observed. 
Although the formation mechanism of this ion has yet to be studied, this doped-DART 
approach has proven to be extremely useful for analytical purposes. This approach is 
conceptually similar to the reactive DESI experiment performed by Takats, et al.37 and to 
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the method developed by Nyadong, et al. for the analysis of artesunate.171 Figure 6.8 
shows the mass spectra of a genuine artesunate tablet obtained using doped-DART 
ionization (Fig. 6.8.A) and DESI ionization (Fig. 6.8.B). 
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Figure 6.8. Screening of a genuine artesunate (M) tablet by (A) ammonia-doped 
DART-MS and (B) reagentless DESI-MS. (A = C4H6O4 and B = C4H4O3:  
1 = [M + NH4]+, 2 = [M – A + H]+, 3 = [M – A - H2O + H]+, 4 = [M – A – CO + H]+, 
5 = [M - A – CO - H2O + H]+, 6 = [M – A - C4H7O3 + H]+, 7 = [A - H2O + H]+, 
8 = [2M + K]+, 9 = [2M + Na]+, 10 = [2M + NH4]+, 11 = [2M – A – B + K]+, 
12 = [2M - A – B + Na]+, 13 = [2M – A – B + NH4]+, 14 = [2M – A – B - H2O + NH4]+, 
15 = [2M – A – B - H2O – CO + NH4]+, 16 = [M + K]+, 17 = [M + Na]+, 
18 = [M - B + K]+, 19 = [M – B + Na]+, 20 = [M – B + NH4]+, and 21 = [M - A + NH4]+.) 
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Reactive DART, as shown in Fig. 6.8.A, not only produced a diagnostic 
[M+NH4]+ ion, but also fingerprint fragment ions that could be assigned with an average 
error of 2.2 mmu. Together, the [M+NH4]+ and fragment ions accumulated 13.5 
identification points enabling the positive identification of the target analyte in excess of 
what is recommended by new EU guidelines.306, 307 
Both DESI and DART produced spectra with good S/N in five seconds, 
demonstrating an improvement of over two orders of magnitude in terms of sample 
throughput when compared to LC-MS. The DESI-MS mass spectrum also included 
several ions corresponding to adducts of the intact molecule (Fig. 6.8.B, insert), including 
[M+H]+, [M+Na]+ and [M+K]+, as well as ammoniated, sodiated and potassiated 
fragment and cluster ions. However, lower DESI jet flow rates caused the relative 
abundances of these species to change. Despite the low amount of IE believed to be 
deposited into the analyte ions during DESI, fragmentation was also observed – an 
indication of the lability of the [M+H]+ ion itself. A fragmentation pattern similar to 
6.8.B is also observed in pESI mass spectra of artesunate. 
 
6.7. Results of DART- and DESI-MS Screening 
The success of the DART- and DESI-MS methods for differentiation of genuine 
and counterfeit antimalarials enabled further investigation of the entire set of counterfeit 
artesunate antimalarials. Figure 6.9 shows the DART-MS mass spectra of counterfeit 
artesunate samples of increasing sophistication. 
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Figure 6.9. DART-MS spectra of sophisticated counterfeit artesunate samples collected 
from (A) Savannakhet, Laos, (B) Luang Nam tha, Laos, and (C) along the Thai-Myanmar 
border. (M = artesunate, N = arteminsinin, and A = C4H6O4:  1 = [N + NH4]+, 
2 = [N + H]+, 3 = [N - H2O + H]+, 4 = [N - H2O – CO + H]+, 5 = [N - H2O - 2CO + H]+, 
6 = [2N + NH4]+, 7 = [2N + H]+, 8 = [chloramphenicol + H]+, 9 = [metronidazole + H]+, 
10 = [paracetamol + H]+, 11 = [2 paracetamol + H]+, 12 = [M – A + H]+, 
13 = [M - A - CO + H]+, 14 = [M – A – CO - H2O + H]+, 15 = [A + H]+, 
and 16 = [A - H2O + H]+. 
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The sample shown in 6.9.A was collected in Savannakhet, Laos in June 2003 and 
had a type 7 fake hologram affixed to the blisterpack. Interestingly, this sample presented 
[M+H]+ and [M+NH4]+ ions consistent with artemisinin, the naturally-occurring 
precursor for artesunate synthesis that is found in Artemisia annua. Artemisinin may have 
been unintentionally added during the poor quality production process or may have been 
added in an attempt to confer some antimalarial properties to the fake sample. Figure 
6.9.B shows the DART-MS spectrum of a counterfeit sample collected in Luang Nam 
Tha, Laos in September 2004 with a well-crafted Type 6 fake hologram affixed to the 
blisterpack. The mass spectrum for this sample included peaks corresponding to 
chloramphenicol (C11H12Cl2N2O5, Δmass = 1.4 mmu) and metronidazole (C6H9N3O3, 
Δmass = 1.4 mmu), two commonly-used antibiotics. 
Figure 6.9.C corresponds to a counterfeit artesunate sample collected along the 
Thai-Myanmar border in March 2005. Although this sample had a sophisticated (but 
fake) type 9 hologram affixed to the blisterpack, it produced a positive result in the 
colorimetric Fast Red TR test. DART-MS analysis of this sample revealed not only the 
presence of paracetamol, but also low-intensity (5%) signals corresponding to artesunate 
fragment ions. This alarming finding was further confirmed by LC, which showed that 
this tablet contained 10 mg of artesunate per tablet (20% of the expected amount). It has 
been hypothesized that this latest “innovation” was introduced by counterfeiters in an 
attempt to deceive the colorimetric authentication tests currently used in the field. The 
implications of this finding are far-reaching, as the continued administration of low doses 
of artesunate could genetically select for artesunate-resistant parasite strains and render 
this last-resource antimalarial medicine ineffective. 
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HPLC and/or DART- and DESI-MS confirmed that all specimens (195/391, 
49.9%) thought to be counterfeit based on packaging analysis contained no, or very 
small, quantities of artesunate (up to 12 mg/tablet as opposed to 50mg per genuine 
tablet). One sample from Cambodia had apparently genuine packaging but contained only 
21 mg artesunate and was therefore either substandard or had deteriorated in transit 
and/or storage.297 Of 321 samples labeled as being manufactured by Guilin, 195 (61%) 
were counterfeit. A wide variety of unexpected “wrong” pharmaceuticals were also 
identified, including paracetamol (n = 24), sulphadoxine (n = 18), pyrimethamine (n = 
11), dimethylfumarate (n = 17), erythromycin (n = 88), erucamide (n = 5), safrole (n = 6), 
artemisinin (n = 10), metamizole (n = 10), an analgesic suspected of causing serious bone 
marrow disorders,308 2-mercaptobenzothiazole (n = 5), chloramphenicol (n = 4), 
metronidazole (n = 2) and chloroquine (n = 2), an early generation antimalarial that is 
now ineffective against multidrug-resistant P. falciparum parasites.296 
 
6.8. Interpretation of the Evidence 
Although at first glance, the pooling of chemical, botanical and packaging 
evidence suggests a wide diversity of fake artesunate in SE Asia with strikingly different 
fake holograms and chemical signatures, some generalization can be made. For example, 
palynological evidence suggests that all counterfeits were produced in temperate areas 
along the borders between China and neighboring countries in SE Asia. Inspection of 
maps of the geographical distribution of fake artesunate suggests that there may be two 
different origins of counterfeit artesunate, with similarities between the samples in 
Myanmar, northern Laos, and along the Thai-Myanmar border in a westerly group, and 
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similarities between those recovered in southern Laos, Vietnam and Cambodia in an 
easterly group (Fig. 6.4). A significantly higher proportion of counterfeit drugs were 
found in the east than in the west (41% (62/151) vs. 79% (133/168), p < 0001). Of 
samples collected in the westerly group, 73% (37/51) contained invalid batch numbers 
used were invalid whereas only 1.5% (2/128) of samples in the easterly group were 
invalid (χ2 = 107.8, p<0.0001). 
Fakes with stickers were only found in Vietnam and Cambodia while those with 
holograms were only found in Myanmar and along the Thai-Myanmar border. Both 
stickers and holograms were found in northern and southern Laos. All of the different 
fake holograms have mis-registration of the outer ring of the Guilin logo and although the 
errors differ between all Types, they have been made in the same way, suggesting the use 
of similar technology and machines. Types 2, 3, 5, 7, 11, and 12 were only found in the 
east while 6, 9, and 10 were only found in the west. Types 1, 4, and 8 were found in the 
east and the west but in varying proportions as 82% of Type 1, 17% of Type 4 and 25% 
of Type 8 were found in the west. With the exception of Type 4, all counterfeits 
containing calcite bore stickers and not fake holograms. However, the pollen signatures 
of Types 3, 11 & 12 (easterly) and 9 & 10 (westerly) were similar, suggesting that the 
manufacturing sites of these two groups may be in the same area of southern China, but 
that they are parts of separate operations having different distribution networks. Types 8, 
11, and 12 all contain an error in the upper case font for ‘Mfg’ and ‘Exp’ suggesting a 
link between the producers of these three types of counterfeits. Cross-mixing of different 
types of fake blisterpack packaging and boxes was also evident. Specifically, the 
occurrence of a Type 10 blisterpack in a Type 4 box and a Type 13 blisterpack in a Type 
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9 box suggested the presence of a link between the producers and/or distributors of these 
particular fakes. All of this evidence supports the ‘easterly’ and ‘westerly’ distribution 
hypothesis. 
The existence of two main sources is also suggested by DART- and DESI-MS 
analysis. Metronidazole and artesunate were only found in westerly group samples while 
sulphadoxine, pyrimethamine, erythromycin and erucamide were found only in the 
easterly group samples. Dimethylfumarate, 2-mercaptobenzothiazole, metamizole, 
safrole, paracetamol, and artemisinin were found predominantly in the east. Samples 
containing chloramphenicol, and chloroquine were in equal numbers in each 
geographical group. 
Counterfeit artesunate with type 14 packaging was shown to contain some 
artesunate of the exterior surface suggesting that the counterfeit tablets may have been 
contaminated with genuine artesunate in the tablet press left over from the manufacture 
of genuine product at an unknown location.171 The presence of sulphadoxine and 
pyrimethamine further suggests that the factory had been making, or had access to, 
sulphadoxine+pyrimethamine, an antimalarial combination therapy that is no longer 
effective in SE Asia. The discovery of safrole is of considerable concern and interest as it 
is a precursor in the synthesis of methylenedioxymethamphetamine (MDMA or Ecstasy) 
and is a banned chemical in the United Nations Convention Against Illicit Traffic in 
Narcotic Drugs and Psychotropic Substances.309 However, MDMA was not detected in or 
on the counterfeits. 
All of the counterfeits purchased from Vietnam, except for Type 12, contained 
calcite having stable isotope ratios that are consistent with what would be found in an 
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area being volcanic in origin rather than that originating from marine or terrestrial 
limestone or tap water precipitation. One such area having high temperature 
hydrothermal calcite is mined in an area west of Nanning, close to the Vietnam border 
(Fig. 6.4) and the calcite used in Types 2, 4, 5, 8 and 11 may have originated from these 
mines. 
This combination of excipient composition and palynology results therefore 
suggested that at least some of the counterfeit artesunate were coming from southern 
China or close to its border with Vietnam, Thailand and Myanmar. Furthermore, the 
evidence suggests that there are at least two distribution routes followed for these 
counterfeit products with westerly origins via Myanmar and easterly origins via Vietnam 
with Laos in the middle, an area of overlap afflicted by Types of both groups. 
The evidence described here was presented by the Secretary General of 
INTERPOL (Mr. Ronald K Noble) to the Assistant MPS (Mr. Zheng Shaodong) in 
March 2006 in Beijing, China. In response, a criminal investigation was carried out 
leading to the arrest of a native of Yunnan Province who, it was alleged, had bought 
240,000 blisterpacks of counterfeit artesunate (Fig. 6.10) from a native of Guangdong 
Province, China, which is thought to be the origin of these counterfeits. As Guilin 
Pharmaceutical Co. Ltd. exported 272,000 blisterpacks to Myanmar and Thailand during 
this time, an estimated 47% of artesunate available in the market was fake which is 
consistent with previous estimates of the proportion of fake artesunate in mainland SE 
Asian shops. 
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Figure 6.10. Counterfeit artesunate samples seized during arrests made after reporting of 
findings of Operation Jupiter to Chinese government officials. 
 
The seized samples appeared to be related to the more sophisticated westerly 
counterfeits found in Myanmar, Thai-Myanmar border and Laos bearing sophisticated 
holograms and without the plethora of wrong AIs (other than artemisinin). This assertion 
was also supported by the absence of calcite in these counterfeits. However, based upon 
the findings presented here, there is a strong possibility that there is a second trade route 
involving a different group of criminals distributing and/or manufacturing fake 
artesunate, with poor quality stickers and a variety of wrong ingredients with calcite, into 
Vietnam, Cambodia and southern Laos. If this hypothesis is correct, future examination 
of the prevalence of different types would be expected to demonstrate a reduction in the 
westerly distribution, but not that being fed by the easterly trade route. 
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6.9. Conclusion 
It has been estimated that almost half of the current supply of artesunate sold in 
SE Asia is counterfeit.188 Due to the widespread nature of this problem, an inter-
disciplinary approach must be taken to determine the source of these counterfeits and 
stop the inflow of counterfeits on the market. In particular, the use of novel analytical 
tools such as DART- and DESI-MS has been shown to facilitate the detection of 
counterfeit artesunate antimalarials. Reactive DART- and DESI-MS methods were 
developed and have been shown to provide sensitive, specific detection of artesunate 
while non-reactive mode analyses are useful for the identification of wrong AIs. Of 391 
tablets assayed using these methods, 196 (50.1%) were shown to be genuine artesunate 
samples while the remaining 195 samples contained AIs such as erythromycin, 
paracetamol, artemisinin, and safrole, as well as several other compounds. A 
collaborative effort by health workers, scientists, and law enforcement has prompted the 
Chinese Government to act quickly against the criminal traders identified in this work 
and has led to arrests and seizure of 240,000 blisterpacks containing counterfeit 
artesunate. 
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CHAPTER 7. CONCLUSIONS AND FUTURE OUTLOOK 
 
7.1. Abstract 
This chapter begins with a summary of the results of my work with AMUSE and 
DART. Specific challenges of these techniques, including limitations and possible 
solutions, are addressed. The chapter concludes with a discussion of the possible 
direction for continuation of this work and of applications that might benefit from the 
proposed improvements. 
 
7.2. AMUSE Ionization 
7.2.1. Summary of Accomplished Tasks in Development of the AMUSE Ionization 
Technique 
Since inception of the idea for the AMUSE ionization technique, the AMUSE ion 
source has undergone several design modifications. The current prototype incorporates an 
ejector array having 3-5 μm orifices, which has been shown to provide improved signal 
intensities for model compounds. This has been attributed to the concomitant reduction in 
droplet diameter132 which allows for more efficient desolvation. Incorporation of a 
Venturi device into the current setup provided a significant improvement in signal 
stability and intensity as shown in the low %RSDs of the MS signal for YGGFL during a 
30 minute ejection interval. 
Although comparison of the absolute signal intensities for ESI and AMUSE 
indicated that AMUSE absolute signal intensities are lower, an investigation of the 
baseline noise between these two ionization techniques showed that AMUSE spectra 
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have less noise. This was attributed to the use of much lower voltages than those typically 
used in pESI-based ionization techniques resulting in a corresponding reduction in 
solvent oxidation processes54 and ionization of volatile contaminants present in 
laboratory air.55 As a result of this cleaner baseline, S/N for peaks in AMUSE mass 
spectra are better than those for pESI mass spectra. 
Soft ionization of cytochrome C, a model protein commonly used in MS, was also 
demonstrated. However, the use of heated N2 flowing through the Venturi device was 
necessary to promote efficient desolvation. The average charge state in the cytochrome C 
charge state distributions observed for AMUSE, pESI and nESI was lowest for AMUSE 
suggesting that AMUSE ionization, which likely follows the charged residue ionization 
mechanism, is softer than either pESI or nESI and prompted an investigation of the mean 
IE deposited on AMUSE ions during the ionization process. 
Experiments using the SY method showed that AMUSE ionization is inherently 
softer than ESI. Increasing the Venturi device gas flow rate caused a miniscule increase 
in <E> for ESI but yielded a significant increase in <E> for AMUSE ionization. When 
ionizing solutions containing organic solvent and using optimized desolvating conditions, 
it was found that <E> for ESI and AMUSE were similar within experimental error. 
Ionization of aqueous solutions under optimum desolvating conditions produced AMUSE 
ions with a slightly lower <E> than ESI ions. 
Tuning of <E> of AMUSE and ESI ions was accomplished by modulating the 
Venturi gas flow rate and mass spectrometer capillary inlet temperature. An interesting 
observation arising from these experiments was that ESI ions with high <E> could be 
produced by either using high gas flow rates or high capillary temperatures. However, 
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AMUSE ions with high <E> could only be produced by conditions combining high gas 
flow rates and high capillary temperatures, demonstrating that AMUSE ionization is 
inherently softer than ESI. 
One potential application of the AMUSE ionization technique is as an ion source 
for LC-MS. It was speculated that AMUSE would be amenable to LC-MS applications 
for several reasons. First, due to decoupling of the droplet formation and charging 
processes, AMUSE ionization is not dependent upon solvent composition. Therefore, 
AMUSE should be compatible with a greater variety of solvent systems than current 
spray-based ionization methods, making it attractive for use with LC-MS. AMUSE-MS 
analyses have been shown to have good detection limits (femtomole to attomole), 
indicating that low abundant analytes in complex sample matrices may be detected by 
LC-AMUSE-MS. Furthermore, multiply charged cytochrome C charge states have been 
detected using AMUSE ionization suggesting that like ESI-MS, AMUSE-MS can ionize 
compounds spanning a large mass range – from small drugs and peptides to proteins. 
One phenomenon observed during AMUSE operation is the occurrence of 
electrowetting on the array surface, particularly in DC mode, which caused a concomitant 
reduction in signal stability. Silanization of the AMUSE ejector array increased the 
hydrophobicity of its surface causing a decrease in electrowetting and an increase in 
signal stability and signal intensities for both operational modes. LC-AMUSE-MS 
experiments using calpain inhibitors revealed that incompatibility between the sample 
injection volume and the reservoir volume resulted in a loss of fidelity of the 
chromatographic pulse. However, generation of a calibration curve using 
chromatographic areas calculated using SRM signal obtained over the entire LC-MS run, 
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rather than for individual chromatographic peaks, showed good correlation between the 
curve and experimental data suggesting that a reduction in reservoir volume should 
improve chromatographic fidelity. 
 
7.2.2. The Long and Difficult Road to Commercialization 
Critical proof-of-principle and characterization of the AMUSE setup has been 
accomplished. However, additional work must be performed to facilitate widespread 
acceptance and commercialization of this ionization technique. A retrospective 
examination of MS literature reveals the introduction of a plethora of ionization 
techniques over the last century – most of which have not been commercialized due to 
their difficulty of use or due to poor timing in their introduction in the market. 
The development of ESI provides a clear example of how each of these factors 
contribute to the successful commercialization of a given ionization technique.310 
Investigation into the electrospray phenomenon has occurred over long intervals starting 
with experiments by Lenard in 1892 who studied electrification in raindrops311 and 
followed by Chapman in 1930 who studied the electrification of liquids produced by 
spraying.312, 313 In 1966, Hines investigated the physics of the electrospray method during 
use in electrostatic painting and described the interdependence of the applied voltage, 
fluid flow rate and physical properties of the solvent.314 This was followed by the seminal 
work by Dole et al. in 1968 who was the first to recognize that large molecules could be 
analyzed by ESI.29 
Dole’s apparatus utilized a 70 cm AP desolvation chamber with an ESI needle at 
one end of a flange to a nozzle-skimmer system that was originally developed by 
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Kantrowitz and Grey315 and allowed pressure reduction so as not to overload the vacuum 
system. Detection was accomplished using a Faraday cup detector rather than with a mass 
spectrometer. Up to 30 kV was applied to the needle forcing the production of charged 
droplets that were propelled through the AP desolvation chamber due to the effects of the 
electric field and a concurrent flow of N2. Although Dole’s apparatus incorporated 
several parameters that could be varied to allow optimization, such as the distance 
between the needle and nozzle-skimmer inlet, gas flow rate, and applied potential, this 
system also exhibited signal instability due to charge accumulation on the walls of their 
glass chamber and clogging of their needle because of the high liquid flow rate used (80 
mL min-1). Due to the lack of mass spectrometers allowing efficient ion transfer from AP 
to the vacuum region of the mass analyzer, Dole’s findings remained largely unexploited 
for the next decade until 1972 when Evans and Hendrick introduced EHD,15 which also 
suffered from signal instability and required the use of volatile solvents as described in 
section 1.2. A decade after Dole’s work and nearly a century after the first reported 
studies of the electrospray phenomenon, Fenn and coworkers reignited interest in the ESI 
technique by demonstrating successful coupling of ESI to MS for the analysis of small 
organic molecules,30 salts30 and biomolecules.31 
Fenn’s apparatus used a liquid sample flowed at a rate of 10 μL min-1 through a 
needle held at 3 – 10 kV. A potential applied to a coaxial cylindrical electrode enclosing 
the needle was used to reduce spray divergence while a countercurrent gas flow of N2 
aided in desolvation and allowed the use of a shorter distance between the needle and the 
nozzle of the nozzle-skimmer interface used. One commercial version of Fenn’s source, 
the Ion Max® source from Thermo Electron, utilized an off-axis ESI spray with a heated 
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metal capillary inlet.316 Spraying off-axis prevented further transmission of large solvent 
clusters while lighter analyte ions entered the next vacuum stage because of the combined 
effect of suction and the potential gradient. The initial configuration of the IonSpray® ion 
source from PE/Sciex utilized a pESI source capable of handling high solution flow rates 
that was sprayed off-axis relative to the curtain gas API used in PE mass 
spectrometers.317 More recently, pESI sprayers that are oriented orthogonal to the mass 
spectrometer inlet have been introduced by most manufacturers.318 Many manufacturers 
have also employed either fused silica capillary or a metal hypodermic needle to enable 
low flow rate analyses, such as those required for protein MS analyses.319 Modified 
techniques related to ESI, such as nESI and microchip ESI have also been 
commercialized.310 
In order for AMUSE ionization to experience similar commercial success to ESI, 
several follow-up experiments should be performed to validate and test the robustness of 
this ionization technique. To that end, the following studies are recommended for future 
research: 
 
1. Due to the limited availability of ejector arrays resulting from difficulties 
during the challenging fabrication process, the effect of batch-to-batch 
variability on MS signal intensities has not been investigated. From 
preliminary work to compare the performance of 1st and 2nd generation arrays, 
it is clear that changes in the fabrication process have a large effect on the 
quality of MS signal obtained. However, it was also observed that there was a 
significant difference in performance between arrays of the same type. As an 
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example consider the work performed to determine IE deposition by AMUSE. 
Those experiments utilized a 2nd generation array having 5-μm nozzles having 
an optimal liquid flow rate of 20 μL min-1. LC-AMUSE-MS experiments 
were also performed using a 2nd generation array with 5-μm nozzles; however, 
it this case the optimal flow rate was 80 μL min-1. Therefore, it is suggested 
that further optimization of the batch fabrication process be conducted 
followed by rigorous testing of the reproducibility of AMUSE MS signal for 
the model compounds reserpine, YGGFL, and cytochrome C ionized using 
different batches and types of arrays. 
 
2. All AMUSE experiments were performed using a single array which was 
replaced if it became damaged during analysis. Damage to arrays assembled 
using protocol 1 generally occurred during device disassembly as the epoxy 
holding the device together needed to be completely removed. This particular 
issue was resolved by varying the assembly protocol. However, the large size 
of the current setup sets the minimum distance between the AMUSE and the 
Venturi/MS inlet. Therefore, it is recommended that a compression holder for 
the assembly be designed so that the array can be moved closer to the inlet. 
 
3. No attempt was made to improve the design of the Venturi device used in the 
current AMUSE setup. The commercial Venturi device allows adjustment of 
the size of the annular gap that constricts gas flow causing an increase in the 
linear velocity of the gas. However, it is unlikely that the dimensions of the 
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Venturi device are optimized for this particular application. For example, 
comparison of the droplet diameter at the inlet (1-2 μm larger than the orifice 
diameter132) and outlet (~2-3 x the orifice diameter135) of the Venturi device 
demonstrates the occurrence of droplet coalescence during transit through the 
relatively long Venturi device used in these studies. It is recommended that 
computer simulations modeling the Venturi gas flow, liquid flow, and 
AMUSE droplet stream focusing be performed to aid in determination of 
optimal dimensions for the Venturi device, keeping in mind the ultimate goal 
of utilizing the multiplexing capability of the AMUSE. Other methods of 
improving ion transmission, such as incorporation of flared inlet 
capillaries,212, 213 should also be explored. 
 
4. Previous experiments demonstrated the importance of consistent alignment of 
the Venturi-assisted AMUSE setup. Mounting the various components onto a 
breadboard allowed for consistent coarse adjustment of the AMUSE but 
manual fine adjustment was necessary to optimize alignment. Therefore, it is 
also suggested that the AMUSE holder be designed to attach to a computer-
controlled x,y-translational motion stage and that the entire assemblage, 
including the Venturi device, necessary electrical connections, and a digital 
camera, be packaged into a housing unit that also allows manual adjustment of 
the AMUSE in the z-direction. Utilizing computer control of the AMUSE 
position will likely allow for improved reproducibility of the AMUSE MS 
signal and will also provide the capability of optimizing the relative positions 
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of the MS inlet, Venturi device, and AMUSE. The AP-MALDI ion source 
offered by Masstech, Inc. (Columbia, MD) can serve as a model for the 
proposed AMUSE housing. 
 
5. Silanization of the surface provided a reduction in electrowetting of the array 
surface and improved signal stability for an aqueous solution ejected in DC- 
and RF-only AMUSE modes. However, tests to monitor the long-term 
stability of the silane layer have not been performed, nor have experiments 
using different solvent systems. Therefore, it is suggested that follow-up 
experiments designed to assess these parameters be performed. 
 
6. Several fundamental MS experiments also need to be performed to improve 
our understanding of how AMUSE ionization compares to more established 
techniques. 
a.  Extrapolated detection limits for reserpine using arrays having 3- and 5-
μm nozzles have been calculated but should be verified experimentally. 
b. One of the major challenges in the analysis of mixtures by ESI is the 
presence of ionization suppression due to a combination of charge 
competition and analyte partitioning within the droplet. Examination of 
AMUSE mass spectra obtained via analysis of an equimolar mixture of 
thermometer compounds showed evidence of some ionization suppression, 
most likely due to variation in the hydrophobicity of each compound. 
However, LC-MS analysis of a mixture of AK-295 and ZLAK-74 did not 
Hampton, C. Y.  208 
show evidence of ionization suppression such as that observed for 
matching experiments using pESI. Therefore, it is recommended that 
experiments be performed with the intention of determining if ionization 
suppression effects are prevalent in AMUSE ionization. This could be 
accomplished using the methods described by Tang et al. who investigate 
charge competition in ESI-MS.62 
c. The linear dynamic range of ESI is estimated to include analyte 
concentrations spanning three or four orders of magnitude. The minimum 
of the linear dynamic range for ESI is set by the detection limit for a given 
analyte while the maximum depends on the occurrence of ionization 
suppression and charge competition, which will have an adverse effect on 
signal for species that prefer to remain solvated in the droplet.320 AMUSE 
mass spectra have exhibited low baseline noise relative to that of ESI mass 
spectra, indicating that the detection limit by AMUSE may be lower. As 
mentioned in point 6b above, it is also possible that ionization suppression 
may not occur in AMUSE ionization to the same extent that it is observed 
during ESI. These observations suggest that the linear dynamic range in 
AMUSE may be wider than that of ESI. Therefore, it is recommended that 
the linear dynamic range of AMUSE (in both operating modes) be 
determined using model compounds. 
d. Mass spectra for the model compound reserpine revealed the presence of 
redox active species. It is well-known that ESI operates as a current-
controlled electrochemical cell. Thus, ESI analyses of reserpine show 
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peaks corresponding to the protonated molecule, water adducts, and also 
to a reduced form of reserpine at m/z 607.2. Reduction of reserpine in the 
AMUSE ion source is most likely due to electrochemical reactions 
occurring on the inner electrode of the piezo. It is recommended that 
experiments be performed to characterize the properties of this ionization 
technique using either cyclic voltammetry or chronoamperometry. The 
findings of these experiments may also enhance our understanding of the 
mechanism by which droplet charging occurs. 
 
7. Visual inspection of the AMUSE during ejection suggested that the ejection 
efficiency (number of nozzle ejecting a particular time) can range from 10 – 
25 % (40 – 100 nozzles). This relatively low value may be due to fabrication 
issues or may be due to the use of a RF resonant frequency that promotes the 
formation of a droplet stream rather than a continuous jet of solution. 
Meacham performed visualization studies which demonstrated that at 
distances close to the array surface (<100 μm), three ejection modes exist 
including times when no ejection occurred, ejection of a droplet stream 
(discrete-droplet mode), and ejection of a continuous jet (jet mode).131, 132 For 
a 2nd generation device with 5-mm nozzles, Meacham found that switching 
between these operating modes occurs over a 100 kHz range,132 thus, it is 
possible that the MS signal stability using AMUSE might be improved by 
switching to a different ejection mode. 
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8. Recently, Forbes et al. demonstrated successful operation of an AMUSE ion 
source having two droplet reservoirs having less than half of the volume of the 
current device.134 An investigation of the MS signal from this multiplexed 
using model compounds and for LC-MS studies of calpain inhibitors should 
be performed to assess the performance of this device – particularly with 
regards to retention of the chromatographic fidelity of LC-MS peaks. 
 
9. Finally, it has been demonstrated that AMUSE ionization is inherently softer 
than ESI. AMUSE analysis using cytochrome C showed that the average 
charge state by AMUSE was lower than that of ESI suggesting that the 
conformation of cytochrome C during analysis using AMUSE was tighter. 
One application which should be further explored is the use of AMUSE for 
the analysis of non-covalent complexes, such as myoglobin, and specific non-
covalent interactions such as antibody-antigen or enzyme-substrate 
interactions. 
 
7.3. DART Ionization of Pharmaceuticals 
7.3.1. Summary of Accomplished Tasks in Development and Applications of the DART 
Ionization Technique 
DART ionization has proven to be a useful screening technique and a powerful 
addition to the arsenal of analytical tools for forensic analyses of counterfeit 
pharmaceuticals. Experiments were performed to characterize the effect that varying the 
DART parameters has on the intensity for tablets of known composition. An 
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investigation of the effect of increasing the He gas flow rate or the grid voltage, which 
has been speculated to remove ions from the metastable stream, demonstrated that higher 
signal intensities for a paracetamol tablet was obtained using higher He gas flow rates 
and lower grid voltages. This was later verified by experiments and simulations 
performed by Harris.279 
The effect of increasing the He gas temperature was also investigated and it was 
found that the signal intensity of erythromycin generally increased with increasing 
temperature until thermal degradation induced fragmentation of the intact erythromycin 
signal, suggesting that the IE deposited on DART ions should be further investigated. 
Experiments to measure DART IE deposition are currently being pursued by two other 
graduate students in the Fernández research group using the methods and macros I 
generated during my investigation of the IE deposited on AMUSE ions. 
Although obtaining useful DART data was rapid, analysis of the data – 
particularly with regards to calibrating the spectra – was a lengthy process. To that end, 
an investigation of two methods to perform mass drift correction via either a single initial 
calibration or a time-dependent calibration was conducted and demonstrated that 
calibration of the mass spectral data should be performed using the time-dependent 
calibration method. 
Upon completion of these method development experiments, a collection of 50 
yaa chud containing a total of 254 tablets and capsules was subsequently analyzed by 
DART-TOF-MS. It was found that the majority of these pharmaceuticals contained 
paracetamol as the AI. Only 32 of the 50 yaa chud sampled contained an antimalarial 
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compound, however, none of the yaa chud contained an antimalarial that would be useful 
against P. falciparum malaria. 
DART-TOF-MS was also used to screen artesunate-containing pharmaceuticals as 
artesunate is a widely counterfeited drug that has been implicated in the deaths of patients 
with malaria patients.185 Preliminary screening of a set of 52 tablets using negative mode 
DART-TOF-MS demonstrated the capability of detecting genuine artesunate tablets from 
counterfeits. Expanding this screen to include an additional 339 tablets further 
demonstrated the validity of this method for detecting counterfeit artesunate and 
ultimately led to the dismantling of a ring of counterfeiters by Chinese law enforcement 
officials. 
 
7.3.2. Future Proposed Direction of DART Research 
Although DART was introduced in 2005,38 research into the fundamental 
physicochemical properties of this ionization technique, as described in section 5.3, have 
only recently been explored.173, 174, 279, 321, 322 However, there are some questions that have 
yet to be investigated. To that end, the following studies are proposed for future research: 
 
1. DART experiments were performed using either the commercial DART 
source or a home-built source. Both of these sources utilized an on-axis 
orientation of the gas exit of the DART with the mass spectrometer’s inlet 
orifice. However, it might be beneficial to explore other possible orientations, 
as that would increase the types of analyses and samples that are accessible 
via this technique. 
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2. One of the biggest challenges in DART-MS is the low upper mass limit 
accessible via this technique. This is likely due to inefficient desorption of the 
analyte from the surface being analyzed. Glenn Harris, a 2nd year graduate 
student in our group has begun preliminary experiments to try to decouple 
these effects to determine which possibility is contributing to the low upper 
mass limit of DART. In addition to the experiments he devised, it is 
recommended that a quartz crystal microbalance be used to measure the mass 
of the sample before and after analysis to determine the extent of desorption 
occurring. Other members of the Fernández research group are exploring the 
possibility of combining laser desorption or spray-based desorption with 
DART, however, acoustic desorption128 might be a better option as there are 
minimal surface interactions due to the mechanical desorption method used. 
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APPENDIX A. AK-295 DRUG ADME STUDIES 
 
A.1. Abstract 
This appendix presents results of LC-pESI-QiT studies for the quantitation of 
several calpain inhibitors including AK-295, benzyloxycarbonyl-leucine-4-aminobutyric 
acid-CONH-(CH2)3-adenine (ZLAK-3001), benzyloxycarbonyl-leucine-4-aminobutyric 
acid-CONH-(CH2)3-N-(1-methyl)piperazine (ZLAK-3002), and benzyloxycarbonyl-
leucine-phenylalanine-CONH-(CH2)3-N-(CH3)2 (ZLAK-3005). These compounds were 
synthesized by the Powers group as part of a series of syntheses designed to make 
analogs of AK-295 that inhibit calpain activity but also increase the probability that the 
compound will permeate the blood brain barrier. This chapter presents preliminary 
Adsorption, Distribution, Metabolism, Excretion (ADME) studies of these drugs. 
 
A.2. ADME Studies of Calpain Inhibitors 
As mentioned in Chapter 4, AK-295 is a calpain inhibitor compound synthesized 
by the Powers research group in the School of Chemistry & Biochemistry at the Georgia 
Institute of Technology262 that has been shown to prevent neuronal degeneration in rat 
models for stroke323 and brain injury.324 A quantitative LC-MS/MS method for detection 
of AK-295 in mouse plasma and tissue was developed with the aim of determining the 
permeability of this compound for crossing the blood brain barrier (BBB). This method 
was further extended to the analysis of several other analogs synthesized by the Powers 
group that have also shown to inhibit calpain activity.325 The names and formulas of these 
compounds are given in Table A.1 while the structures are provided in Figure A.1. 
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Table A.1. Acronyms, chemical names, and formulae for compounds tested by 
LC-MS/MS. (Z = Benzyloxycarbonyl, Leu = leucine, Abu = 4-aminobutyric acid, 
Nva = norvaline.) 
 
Acronym Compound Formula 
AK-295 Z-Leu-Abu-CONH(CH2)3-morpholine C26H40O6N4 
ZLAK-74 Z-Leu-Nva-CONH(CH2)3-morpholine C27H42O6N4 
ZLAK-3001 Z-Leu-Abu-CONH(CH2)3-adenine C27H36O5N5 
ZLAK-3002 Z-Leu-Abu-CONH(CH2)3-N-(1-methyl)piperazine C27H43N5O5 




Figure A.1. Structures of calpain inhibitors analyzed by LC-MS/MS. Structures of 
AK-295 and ZLAK-74 are given in Section 4.2. 
 
 
Hampton, C. Y.  216 
A.3. Experimental Details 
A.3.1 Materials 
HPLC-grade acetonitrile, methanol (EMD Chemicals, Inc., Gibbstown, NJ), and 
formic acid (88% by weight, Fisher Scientific, Hampton, NH) were purchased and used 
without additional purification. Stock solutions of all calpain inhibitors were provided by 
Dr. Asli Ovat of the Powers Research Group. These stocks were prepared by dissolving 1 
mg of each compound in methanol (1mg mL-1). Aliquots containing 50 μL of stock were 
pipetted into centrifuge vials and stored at -80 ºC until needed. Serum and tissue samples 
were prepared by Dr. Seneshaw A. Asress in the research group of Dr. Jonathan D. Glass 
at the Emory School of Medicine. Female C57BL/65 mice, aged 7 weeks, were dosed 
with the drug of interest (24 mg drug / kg body weight of mouse). Three methods of 
dosing were used: subcutaneous via a mini diffusion pump, oral gavage, and intravenous. 
After mice were sacrificed, their serum and tissues were collected and stored at -80 ºC 
until needed for analysis. 
 
A.3.2 Standard and Sample Preparation 
To eliminate possible matrix effects, control tissues from undosed mice were used 
to prepare calibration standards with concentrations of 0.10, 0.30, 0.50, and 1.00 μM for 
each compound investigated. Sample preparation for the spiked control tissues and the 
sample tissues was identical and was based on a protocol reported by Guo and 
coworkers.238 First, the tissues were homogenized with water in a 5% (weight/volume) 
ratio (i.e. 5 g tissue / mL water) and 100 μL aliquots of each homogenate were pipetted 
into centrifuge tubes and spiked with 1.00 μM ZLAK-74. The mixture was sonicated for 
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10 minutes to ensure homogeneity in the sample and 300 μL of 99.9:0.1 v/v 
acetonitrile:formic acid was added to precipitate proteins. The sample was briefly 
vortexed and sonicated for 15 minutes followed by centrifugation at 13,000 g for 30 
minutes. The supernatant was removed and evaporated at 45 ºC for 3 hours and the 
residue was reconstituted with 100 μL 30:69.9:0.1 v/v acetonitrile:water:formic acid. The 
final solution was filtered using a 0.45 μm syringe filter (Acrodisc, Pall) and analyzed by 
LC-MS/MS. 
 
A.3.3 LC-MS/MS Operation 
All measurements were carried out in an Agilent HPLC 1100 system coupled to a 
ThermoFinnigan LCQ Deca XP+ ion trap mass spectrometer using a pESI ion source 
operated in positive ion mode. For experiments with compound AK-295, an analytical 
Zorbax Extend® C18 column (1.0 x 150 mm, 5 μm particles, 80 Å pore size, Agilent) 
was used with the following gradient program: 0.0 min – 30% B, 0.5 min – 30% B, 0.7 
min – 85% B, 2.5 min – 85% B, 2.70 min – 30% B, 5.5 min – 30% B. 
For experiments using Zlak-3001, Zlak-3002, and Zlak-3005, an analytical 
Symmetry Shield® reverse-phase C18 column (1.0 x 150 mm, 3.5 μm particles, 100Å 
pore size; Waters) preceded by a Zorbax® RX-C18 guard column (4.6 mm x 12.5 mm, 
5.0 μm particles, 2 μm pore size; Agilent) was used for all remaining experiments. The 
solvent gradient program used was: 0.0 min – 30% B, 0.5 min – 30% B, 0.7 min – 100% 
B, 4.5 min – 100% B, 5.0 min – 30% B, 6.0 min – 30% B. 
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The mobile phases used for all separations were: A = 0.1 % formic acid in water 
and B = 0.1 % formic acid in acetonitrile. The flow rate was 80 μL min-1, with an 
injection volume of 15 μL. 
The QiT was operated in multiple reaction monitoring mode using the following 
precursor → fragment transitions: AK-295: m/z 505.2 → 443.2, ZLAK-74: m/z 519.2 → 
457.2, ZLAK-3001 : m/z 553.2 → 509.2, ZLAK-3002: m/z 518.3 → 410.3, and ZLAK-
3005: m/z 462.2 → 418.2. The QiT was set as follows: needle voltage +4.0 kV; sheath 
gas 15 arbitrary units (~0.6 L min-1); capillary temperature 275 ºC; capillary voltage 34 V 
(AK-295), 28 V (ZLAK-3001), 18 V (ZLAK-3002), 15 V (ZLAK-3005); capillary-
skimmer voltage 25 V (AK-295), 55 V (ZLAK-3001), 45 V (ZLAK-3002), 55 V (ZLAK-
3005). For all experiments, the mass analyzer was set with the automatic gain control on 
(1x107) with 2 microscans, 400 μs, 1.2 Da mass selection window and 34% normalized 
collision energy. 
 
A.3.4 Data Processing 
After acquisition, peak areas for the chromatographic peaks present in the 
extracted ion chromatograms for ZLAK-74 and the compound of interest were 
determined using the mass spectrometer software (Xcalibur 2.0, Thermofinnigan) with 
the Genesis peak detection algorithm (15 smoothing points, signal-to-noise ratio 
threshold = 3.0). The areas for the compound of interest and ZLAK-74 were exported to 
Excel and the ratio of the peak area of the compound of interest/peak area of ZLAK-74 
was calculated. The amount of compound present in each sample was determined by 
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correlating the area ratio to a concentration using the calibration curves obtained during 
each experiment. 
 
A.4. Results of Quantitation Studies 
In our initial studies demonstrating axonal protection in the animal model of 
peripheral neuropathy, AK-295 was delivered continuously from a subcutaneous mini 
diffusion pump at a dose of 24 mg/kg/day.263 These studies showed that AK-295 is an 
effective calpain inhibitor but subsequent LC-MS/MS experiments demonstrated that this 
compound does not penetrate into the brain 
Although AK-295 could not be detected in the brain tissues provided, it has since 
been discovered that oral and intravenous delivery of AK-295 at doses of 50 or 100 
mg/kg twice per day provides a similar degree of protection against axonal degeneration 
and clinical disease and at these levels, it is possible that AK-295 might be present in the 
brain. During initial studies using a dose of 24 mg/kg body weight, AK-295 was present 
in the liver, heart, kidney, and spleen at levels > 0.5µg/gram of tissue after a single 
subcutaneous dose as shown in Table A.2. 
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Table A.2. Amounts of AK-295 detected in the brain, heart, kidney, liver, spinal cord, 
serum, peripheral nerve, or spleen from mice dosed subcutaneously, orally, or 
intravenously with 24 mg AK-295/kg body weight. ND = not detected, 
NQ = not quantifiable. Each dosing study set included 2 mice. 
Tissue 
Subcutaneous 
(μg AK-295/g tissue) 
Oral 
(μg AK-295/g tissue) 
Intravenous 
(μg AK-295/g tissue) 
Brain ND ND ND 
Heart 0.541 ± 0.008 NQ 0.561 ± 0.036 
Kidney 0.936 ± 0.068 NQ 1.816 ± 0.161 
Liver 1.550 ± 0.068 NQ 0.943 ± 0.052 
Spinal Cord ND ND ND 
Serum 0.895 ± 0.196 NQ NQ 
Peripheral 
Nerve NQ NQ 0.333 ± 0.009 
Spleen 1.380 ± 0.174 NQ 1.316 ± 0.067 
 
 
As can be seen in Table A.2, AK-295 could not be detected in the brain for any of 
the dosing methods tested. Oral dosing provided the lowest levels of AK-295 detected but 
most of the LC-MS/MS signal intensity was too low to be quantified using the calibration 
curve created during the run. However, intravenous dosing provided quantifiable signal 
intensities for most of the tissue samples tested. Interestingly, after intravenous dosing, 
levels of 0.333 ± 0.009 µg AK-295/g tissue were detected in the peripheral nerve (Fig. 
A.2). This confirms that AK-295 is present in the target organ of interest, and is able to 
prevent axonal degeneration in the peripheral nerve, supporting its potential as a 
treatment to reduce axonal degeneration. 
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Figure A.2. Extracted ion chromatogram obtained using LC-MS/MS showing 
chromatographic peak from sciatic nerve of mouse dosed intravenously with 
24 mg AK-295/kg body weight. 
 
Early data from inhibitors ZLAK-3001, ZLAK-3002, and ZLAK-3005 
demonstrated that ZLAK-3001 and ZLAK-3002 do penetrate into the brain but that 
ZLAK-3005 does not (Fig. A.3). The amounts of ZLAK-3001 and ZLAK-3002 
quantified in the brain tissue sampled were 1.17 ± 0.01 μg/g tissue and 1.14 ± 0.02 μg/g 
tissue, respectively. 
 



























Figure A.3. Extracted ion chromatograms obtained using LC-MS/MS showing 
chromatographic peaks from brain tissue of mice dosed subcutaneously with 24 mg/kg 
body weight for compounds (A) ZLAK-3001, (B) ZLAK-3002, or (C) ZLAK-3005. 
 
A.5. Conclusion 
Work performed so far has demonstrated that AK-295 can cross the BBB, but 
only with limited efficiency, and appears to be primarily passed through the excretory 
system. Since then, several new drugs in the same family as AK-295 have been 
synthesized to find a compound that can penetrate the brain. Three of these compounds, 
ZLAK-3001, ZLAK-3002, and ZLAK-3005 have been analyzed using our quantitative 
method. ZLAK-3001 and ZLAK-3002 have been shown to have therapeutically useful 
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concentrations in the brain of mice that received a single subcutaneous dose, 
demonstrating the ability of these compounds to cross the blood brain barrier and 
suggesting that these compounds should be further investigated to determine their 
concentrations in other tissue types and with different dosing strategies. 
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Efforts to discover potential biomarkers for ovarian cancer have been primarily 
focused on identifying diagnostic proteins to improve the predictive power of current 
diagnostics tests. Metabolomics, the study of metabolic changes in biological systems, 
can be used to provide characteristic small molecule fingerprints (profiles) related to 
disease states. In this chapter, results are presented for the mining of potential metabolic 
biomarkers from LC-MS analyses of a small group of patients with ovarian cancer and 
controls, who may have benign tumors on their ovaries or may have another form of 
cancer. 
 
B.2. Biomarker Discovery Efforts for Ovarian Cancer 
In the U.S. ovarian cancer is the fifth most common cancer in women and is the 
leading cause of deaths from gynecological malignancies with estimates of more than 
21,500 new cases diagnosed in 2009 and more than 14,600 deaths.326 The high mortality 
rate is a direct consequence of the lack of effective early detection diagnostic tests. Due 
to the asymptomatic nature of the disease, most new cases involve women in the 
advanced stages of the disease (Stage III/IV) when the 5-year survival rate is less than 
20%.327 Current assays for ovarian cancer detection are based on examination using 
ultrasound or Doppler imaging of the ovaries or on measuring the physiological level of 
cancer antigen 125 (CA125), the only FDA-approved diagnostic test for ovarian cancer 
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detection. However, abnormally high CA125 levels are only present in 82% of advance 
stage patients while fewer than 50% of early stage patients show elevated levels.328 As a 
result of this variability, the overall predictive value of CA125 has been reported to be 
less than 10%.329 Despite the high degree of active research being conducted to screen for 
diagnostic ovarian cancer biomarkers, which has been on-going since the early 1970’s,330 
no new biomarkers have been implemented in screening tests. 
Most biomarker discovery studies reported in literature are based on the 
univariate or multivariate comparison of the high-throughput analyses that are focused on 
investigating qualitative or quantitative changes of large biomolecules such as DNA, 
RNA, glycans, or proteins.331 In particular, researchers have focused on identifying 
changes in the concentrations or biotransformations such as methylation or glycosylation 
on these biomolecules. In contrast, metabolic biomarker discovery efforts (molecules < 1 
kDa) have received considerably less attention and comprise ~6% of all reported 
potential ovarian cancer biomarkers.327 
As metabolites are the end products of cellular regulator processes, their 
physiological concentrations can be correlated to genetic, pathophysiological or 
environmental stressors.332 Therefore, human serum metabolic profiling, as defined by 
Fiehn and Kind,333 can reflect the pathological state of various organs and may be useful 
in the search for early detection assays for ovarian cancer. For example, lysophosphatidic 
acid334-336 and lipid associated sialic acid,337-341 are two metabolic biomarkers identified 
using 1H nuclear magnetic resonance (NMR) spectroscopy as being possible biomarker 
candidates for ovarian cancer detection. 
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On challenge in performing broadband metabolomic studies, which is aimed at 
simultaneously screening relative changes in the concentrations of thousands of 
metabolites, is the wide variation in concentrations and chemical properties of 
metabolites. Due to the wide dynamic range, reproducible quantitative properties,342 and 
large peak capacity,343 MS is an ideal tool for detecting these metabolic changes. MS has 
been successfully applied to the discovery of proteomic biomarker panels using either 
MALDI344, 345 or a related technique, surface-enhanced laser desorption/ionization 
(SELDI),329, 344, 346-349 which is similar to MALDI but uses functionalized target plates 
that promote sample clean-up and preferential protein binding, rather than the stainless 
steel target plates that are commonly used for MALDI. However, LC-MS technologies 
for probing the metabolome have not been as widely used as they are still evolving,350 as 
are the bioinformatics techniques for the analysis of the resulting data.351 
Denkert, et al. recently used GC-MS to investigate metabolic changes in ovarian 
tumor tissues and identified 51 metabolites that were significantly different between their 
control and patient groups.352 Despite the promise of this approach, the limited accessible 
mass range in GC-MS, which more suitable for the detection of metabolites with m/z < 
~350 Da, reduces the applicability of GC-MS for use in metabolite profiling experiments. 
However, LC-MS is widely used for the separation of complex biological samples and 
allows for the sensitive detection of compounds over a wide mass range.353, 354 Recent 
technological advances in separation techniques for metabolomics such as 
ultraperformance liquid chromatography (UPLC),355 capillary LC,356 2D-LC,357 and drift 
tube ion mobility gas-phase separations,358 which are all characterized by having high 
speed separations with improved peak capacity, have further expanded the capability of 
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MS combined with separation techniques for metabolomics. However, the difficulty in 
extracting useful diagnostic data from these massive datasets remains challenging and has 
only recently begun to be overcome by applying chemometric techniques to this data.351 
Historically, principal component analysis (PCA),359, 360 which identifies useful 
spectral features from the dataset by using principal components that capture the most 
relevant variance between disease and control populations, and partial least squares 
discriminant analysis (PLSDA),335 which extracts the variation in the data as latent 
variables and uses discriminant analysis to generate a model that classifies the data as 
being part of the disease or control groups, have been applied to the analysis of 
metabolomic datasets. However, it has long been recognized that feature reduction 
improves the model quality as it eliminates non-informative data, makes the diagnostic 
process cheaper and targeted, and reduces the number of potential biomarkers, which aids 
in interpreting their biological significance. To that end, feature selection tools such as 
genetic algorithms (GA)361-364 and recursive feature elimination (RFE)365 have been 
combined to generate high classification models with good predictive ability. 
Recently, support vector machines (SVMs)366 have also been successfully applied 
to the classification of cancer vs. control sample sets obtained using SELDI-MS367-369 and 
MALDI-MS.344, 345 SVMs treat the input data (retention time (tR) and m/z vs. intensity) as 
two vectors in space and optimize the classification performance of the system by 
maximizing the distance between any two neighboring points on these vectors using a 
hyperplane. 
In this work, results from RFE feature selection combined with a nonlinear SVM 
for classifying LC-MS data of serum samples from ovarian cancer patients and controls 
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are presented. Panels of metabolic spectral features that are potentially useful in diagnosis 
are identified and chemical assignment of these biomarkers to endogenous human 
metabolites is attempted based on accurate mass measurements. 
 
B.3. Experimental Details 
B.3.1. Materials 
Serum samples were collected by Benedict B. Benigno, of the Ovarian Cancer 
Institute, Atlanta, GA, and L. DeEtte Walker and John F. MacDonald, who are both 
affiliated with the Ovarian Cancer Institutes and the School of Biology at the Georgia 
Institute of Technology. 
Serum samples for LC-MS metabolomics analysis were obtained from 37 patients 
with papillary serous ovarian cancer (mean age 60 years, range 43-79, stages I – II (9), 
stages III – IV (28)) and 35 controls (mean age 54 years, range 32-84). The control 
population consisted of patients with histology considered normal within limits (NWL) 
and women with non-cancerous ovarian conditions. All serum samples were obtained 
from the Ovarian Cancer Institute (OCI, Atlanta, GA) after approval by the Institutional 
Review Board (IRB). All donors were required to fast and to avoid medicine and alcohol 
for 12 hours prior to sampling, except for certain allowable medications, for instance, 
diabetics were allowed insulin. Following informed consent by donors, 5 mL of whole 
blood were collected at Northside Hospital (Atlanta, GA) by venipuncture from each 
donor into evacuated blood collection tubes that contained no anticoagulant. Serum was 
obtained by centrifugation at 5000 rpm for 5 min at 4 ºC. Two hundred and fifty μL 
aliquots of serum samples were frozen with dry ice immediately after centrifugation, and 
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stored at -80 ºC for further use. The sample collection and storage procedures for both 
ovarian cancer patients and healthy individuals were identical. All chemicals were 
obtained from Sigma-Aldrich (St. Louis, MO) and used without further purification. All 
aqueous solutions were prepared with nanopure water from a Nanopure Diamond 
laboratory water system (Barnstead International, Dubuque, Iowa). 
 
B.3.2. Serum Sample Pretreatment and LC-MS Analysis 
Serum samples were prepared and analyzed by Dr. Manshui Zhou, a post-doc in 
the Fernández research group. LC-MS data processing was done by Dr. Manshui Zhou, 
Dr. Facundo M. Fernández, and Christina Y. Hampton. 
A stock sample of human serum purchased from Sigma (S7023, St. Louis, MO) 
was used during the development of the serum sample pretreatment and LC-MS analysis 
protocols. Upon arrival, the frozen stock sample was thawed and separated into 250 μL 
aliquots that were stored at -80 ºC for further use.  
Serum samples were thawed, and proteins precipitated by addition of acetonitrile 
to the serum sample in a 5:1 ratio (1000 μL acetonitrile + 200 μL serum). The mixture 
was vortexed for 1 minute and incubated at room temperature for 40 minutes, then the 
sample was centrifuged at 13,000 x g for 15 minutes and the supernatant retained. The 
supernatant was vacuum-evaporated and the residue reconstituted in 80% 
acetonitrile/0.1% TFA. 
LC-MS analyses were performed on a JEOL AccuTOF mass spectrometer 
coupled to an Agilent 1100 Series LC system (Santa Clara, CA) via a pESI source. The 
TOF resolving power measured at FWHM was 6000 and the observed mass accuracies 
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ranged from 5-15 ppm, depending on the S/N of the particular ion investigated. The 
injection volume was 15 μL in all cases. Reverse phase separation of serum samples was 
performed using a Symmetry® C18 column (3.5 μm, 2.1 mm x 150 mm, pore size 100 Å; 
Waters, Milford, MA) at a flow rate of 150 μL min-1. The analytical column was 
preceded by a Zorbax® RX-C18 guard column (5.0 μm, 4.6 mm x 12.5 mm, pore size 2 
μm; Agilent). The LC solvent mixtures used were: A = 0.1% formic acid in water and 
B = 0.1% formic acid in acetonitrile. After a pre-run equilibration with 5% B for 5 
minutes, data acquisition was started and the solvent composition was varied according to 
the solvent program described in the Table B.1. After analysis of a given serum 
specimen, a 0.20mM sodium trifluoroacetate standard (NaTFA) was run for mass drift 
compensation purposes. For NaTFA analysis, 100% B at a flow rate of 300 μL min-1 was 
used and data was acquired for 10 minutes. After injection of the drift correction 
standard, the column was washed with 100% B for 30 minutes. 
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(acetonitrile/0.1% formic acid) 
Flow Rate 
(μLmin-1) 
Pre-Run Column Equilibration 
0.0 100 300 
10.0 5 150 
15.0 5 150 
Sample Run 
0.0 5 150 
5.0 5 150 
10.0 20 150 
20.0 25 150 
28.0 30 150 
38.0 35 150 
50.0 40 150 
90.0 45 150 
100.0 50 150 
110.0 60 150 
120.0 75 150 
130.0 85 150 
160.0 95 150 
180.0 100 150 
Post-Run Column Wash 
0.0 100 300 
30.0 100 300 
NaTFA Standard Run 
0.0 100 300 
10.0 100 300 
Post-Run Column Wash 
0.0 100 300 
30.0 100 300 
 
Spectral data was collected in the 100-1750 m/z range with a spectral recording 
interval of 1.5 s and a data sampling interval of 0.5 ns for both positive ion mode pESI 
(+pESI) and negative ion mode pESI (-pESI). The settings for the TOF mass 
spectrometer for +pESI or -pESI were as follows: needle voltage: +/- 2000 V, ring lens: 
+8 V or -9 V, orifice 1: +30 V or -69 V, orifice 2: +6 V or -8 V, desolvation chamber 
Hampton, C. Y.  232 
temperature: 250 ºC, orifice 1 temperature: 80 ºC, nebulizing gas flow rate: 1.0 L min-1, 
desolvation gas flow rate 2.5 L min-1, and detector voltage +/- 2800 V. The TOF analyzer 
pressure was 4.8x10-6 Pa during analysis. The RF ion guide voltage amplitude was swept 
to ensure adequate transmission of analytes in a wide range of m/z values. The sweep 
parameters were as follows: initial peaks voltage: 700 V, initial time: 20%, sweep time: 
50%, final peaks voltage: 2500 V. After LC-MS data was collected, it was centroided, 
mass drift corrected using the NaTFA reference spectrum, and exported into NetCDF 
format for further mining. 
To ensure maximum reproducibility in metabolomic experiments, all serum 
specimens were run consecutively within a 2.5 month period. Every cancer sample was 
randomly paired with a normal sample and run on the same day to ensure that no 
temporal bias was introduced in the way samples were analyzed. Sample pairs were run 
in random order and in duplicate. 
 
B.3.3. LC-MS Data Mining 
Data mining was performed by Dr. Manshui Zhou, Dr. Facundo M. Fernández, 
and Christina Y. Hampton. 
All data were mined identically and simultaneously. Data mining was performed 
by loading NetCDF files into mzMine.370 The data mining parameters were selected by 
visual inspection of their effect on the spectral features extracted. Data were smoothed by 
chromatographic median filtering with a tolerance in m/z of 0.1, and one-sided scan 
window length of 3 s. Peaks were picked with a m/z bin size of 0.15, chromatographic 
threshold level of 0%, absolute noise level of 200, absolute minimum peak height of 250, 
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minimum peak duration of 5 s, tolerance for m/z variation of 0.06, and tolerance for 
intensity variation of 50%. The method for de-isotoping was to assume +1 charge states, 
and monotonic isotopic patterns. The tR tolerance for de-isotoping was 65 s and the m/z 
tolerance was 0.07. The chromatographic peak alignment m/z tolerance was 0.2, and the 
tR tolerance was 12%, with a balance between m/z and tR of 30. The minimum number of 
detections for rare peak filtering in the alignment results was set to 41. Spectral features 
not initially detected by the peak detection algorithm were subsequently added by a gap 
filling method using an intensity tolerance of 30%, m/z tolerance size of 0.2, and tR 
tolerance size of 12%. Systematic drift in intensity levels between different data files was 
corrected for by linear intensity normalization using the total raw signal. 
After the normalized alignment file containing all peak intensities was created, 
peak areas were exported to Excel and peaks of contaminants, dimers, redundant adducts, 
and isotopes not adequately detected were removed. Approximately 37% of the peaks 
from +pESI and 18% of the peaks from -pESI were eliminated after this filtering. Peak 
areas from duplicate runs were then averaged, and the mass spectral data were exported 
as ASCII files into Matlab (R2007a, The Mathworks, Natick, MA). 
 
B.3.4. Feature Selection, Model Building, and Model Validation 
Data processing, including feature selection, model building and model validation 
were performed by Wei Guan and Dr. Alexander Gray in the College of Computer 
Science, Georgia Institute of Technology. 
Feature selection was performed using iterative RFE whereby an SVM is first 
trained with the currently selected feature set. The features are individually evaluated to 
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determine their importance and less important features are dropped from the feature set. 
The process is iteratively repeated until the smallest feature set that achieved the highest 
training accuracy is selected. The prediction performance was evaluated using leave-one-
out-cross-validation (LOOCV, one sample is removed from the set of 72 samples, the 
model is built with the training set (N=71) and tested with the test set (M=1)), 12-fold-
cross-validation (12-fold CV, 12 samples are excluded, the model is built with the 
training set (N=12) and tested with the test set (M=60)), and 52-20 split-validation (52-20 
Split, 20 samples are excluded (N=52), the model is built using the training set (N=52) 
and tested with the test set (M=20)). 
 
B.3.5. Metabolite Identification Protocol 
Metabolite identification was performed by Dr. Manshui Zhou and Christina Y. 
Hampton. Compound identification was attempted only for those spectral features 
remaining after the feature selection process. Due to the biological complexity of serum 
samples, adduct ion analysis was first performed to ensure the unambiguous assignment 
of the signal of interest in each mass spectrum. Adducts formed in +pESI usually include 
[M+H]+, [M+NH4]+, [M+Na]+, [M+K]+, [M-H2O+H]+, and [2M+H]+ species; while 
adduct and dimer formation in -pESI include [M-H]-, [M+CH3COO]-, [M+Cl]-, 
[M+HCOO]-, and [2M-H]-. Adducts in centroided mass spectra corresponding to 
SVM-RFE-selected variables were identified by manually calculating the differences 
between the exact m/z values of peaks within the spectrum and comparing these 
differences to those between the common adduct species mentioned above. For spectra in 
which multiple adducts were not present, the accurate mass of the candidate neutral 
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molecule was calculated based on the assumption that the peak of interest corresponded 
to either [M+H]+, [M+Na]+, or [M+NH4]+ in +pESI or [M-H]-, [M+CH3COO]-, 
[M+HCOO]-, or [M-CH3]- (for glycerophosphocholines) in -pESI yielding multiple 
possible neutral molecular masses for each m/z value. 
Elemental formulae were estimated from the accurate mass spectra using a freely-
distributed system of macros333 that relies on a series of heuristic rules to identify 
possible formulae based on the mass accuracy of the peak of interest and the 
corresponding isotopic ratios. The mass of the neutral molecule and relative isotopic 
abundances were imported directly into the “seven golden rules” Excel spreadsheet.371 
The mass accuracy was set to 15 ppm, and the threshold for error in the relative isotopic 
abundance was set to 10%. The list of elements to include in the search was constrained 
to include C, H, N, O, P, S, Cl, and Br. The probability of a given formulae being the 
“correct” one is provided as a score calculated from the error rates in satisfying the 
aforementioned rules. The top hits in the list of filtered elemental formulae and accurate 
mass values obtained were searched in the following databases: Metlin,372 KEGG,373 
HMDB,374 MMCD,375 and Lipid Maps (LM),376 to determine the greatest possible 
number of candidate molecules. The criteria used for the assignment of a tentative 
chemical structure were: 1) a mass difference with the simulated formula lower than 15 
ppm, 2) isotope abundance errors less than 10%, and 3) that the candidate found in the 
database corresponded to an endogenous metabolite (i.e. a small molecule that 
participates in cellular metabolism as an intermediate or product). 
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B.4. Results of LC-MS-Based Metabolomic Analysis of Human Serum 
Samples 
Metabolomic investigation of LC-MS data from sera of patients with ovarian 
cancer and controls revealed 576 features (each feature represents a particular m/z value 
observed at a specific tR) extracted by mzMine in +pESI and 280 in -pESI (giving a total 
of 856 features in the multimode feature set, which combines all +pESI and -pESI 
features). Detailed manual analysis of the entire dataset revealed the presence of 
additional redundant species (dimer, adducts, and isotopes) that were removed, thus 
reducing the final number of features (n) used to n = 360 +pESI, n = 232 -pESI, and 
n = 592 multimode features. 
A 3-D serum metabolic profile for a typical stage III ovarian cancer serum sample 
is displayed in Figure B.1.A showing the capability of LC-MS to resolve hundreds of 
compounds in a wide mass range within 180 minutes. Despite the shallow solvent 
gradient chosen for the LC run, there is still evidence of co-elution as evidenced by the 
projection of Figure B.1.A onto the chromatographic axis (Fig. B.1.B). However, the 
high resolving power of the TOF mass analyzer allowed in most cases to resolve these 
signals by their selected monoisotopic ion chromatograms as shown in Figure B.1.C for 
an ion with m/z = 443.26 at a window width of 0.05 Da. The corresponding centroided 
negative ion mode spectrum obtained at tR = 91 minutes is shown in Figure B.1.D.  
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Figure B.1. Sample data obtained by –pESI-LC-MS analysis of a stage III ovarian 
cancer serum sample including (A) 3D intensity matrix, (B) total ion chromatogram 
(TIC), (C) selected ion chromatogram for the feature at m/z 443.26, and (D) mass 
spectrum at tR = 91 minutes. 
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Due to the obvious complexity of these samples, the reproducibility of the LC-MS 
approach was tested in early experiments to rule out column memory effects. Lipids, fatty 
acids and other hydrophobic components in sera that are easily adsorbed onto the reverse 
phase column can act as a new stationary phase, causing a change of selectivity, memory 
effects and shifting retention times. If sufficient contamination occurs, backpressure 
increase or even complete blockage of the column may occur. Figure B.2 shows total ion 
chromatograms corresponding to 4 identical samples prepared in an identical fashion and 
analyzed by +ESI (Fig. B.2.A) and -ESI (Fig. B.2.B). 
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Figure B.2. Total ion chromatograms (TIC) of 4 aliquots of stock serum prepared in an 
identical fashion and analyzed by (A) +pESI and (B) -pESI. 
 
The results indicate that good reproducibility was possible following the 30-
minute washing step. Compound identification was not pursued at this stage, as in LC-
MS experiments this is a more time-intensive task than in GC-MS experiments, where 
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automatic identification is accomplished in an unsupervised way by direct comparison of 
each EI spectra with existing databases, such as the one available from NIST. This 
difference in identification procedures arises from two fundamental properties of ESI that 
are different than for EI: (a) the formation of various adducts and dimers with varying 
abundances, which is a function of the LC solvents and the desolvation conditions used, 
and (b) the different extent to which different ESI sources impart varying degrees of IE to 
desolvated ions. This last property of ESI lends to producing varying degrees of 
fragmentation of labile species, most commonly dehydration, by in-source CID. Instead, 
compound identification was attempted a posteriori, for spectral features observed to be 
significant in SVM-RFE models. 
 
B.5. Evaluation of Model Performance 
The prediction performance for each dataset (+pESI, -pESI, and multimode) was 
evaluated for the SVM-RFE model. The results are summarized in Table B.2. 
 
Table B.2. Prediction performance (%) evaluated for each dataset using LOOCV, 12-fold 
CV, and 52-20 Split. 
Dataset LOOCV 12-fold CV 52-20 Split 
Multimode 
(n=592) 80.6 74.0 71.6 
+pESI 
(n=360) 66.7 71.4 66.5 
-pESI 
(n=232) 73.6 74.3 69.1 
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As can be seen in Table B.2, the prediction performance of the multimode dataset 
model was better than that of the +pESI and -pESI datasets for LOOCV and 52-20 Split 
validation. However, for 12-fold CV, the prediction performance of the -pESI dataset 
model is slightly better than that for the multimode dataset. The average number of 
features selected for the multimode, +pESI, and -pESI datasets was 32, 26, and 35 
features, respectively. The sensitivity (how well cancer patients can be detected) and 
specificity (how well controls can be detected) of these models are summarized in Table 
B.3. 
 
Table B.3. Sensitivity and specificity (%) for LOOCV validation. 
Dataset Sensitivity Specificity 
Multimode 
(n=592) 83.8 77.1 
+pESI 
(n=360) 73.0 60.0 
-pESI 
(n=232) 78.4 68.6 
 
Although it is difficult to pinpoint which of the three models, multimode, +pESI, 
or -pESI, has the best prediction performance using the results in Table B.2, it is clear 
from Table B.3 that the multimode dataset provides a model having the best sensitivity 
and specificity. Therefore, we attempted to identify metabolites corresponding to the 
features selected in the SVM-RFE model of the multimode dataset. 
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B.6. Metabolite Identification 
The calculated neutral masses, species investigated, and tR’s of the +pESI and -
pESI features used by the multimode SVM-RFE model, as well as their corresponding 
chemical formulae, mass differences (∆m), and matching scores, are reported in Tables 
B.4 and B.5, while the corresponding mass spectra are shown in Figures B.3 and B.4. 
This model consists of the relatively stable features (threshold 54%) obtained over 
the LOOCV validation as described above. Adduct analysis of the 18 and 27 features 
selected from +pESI and -pESI, respectively, provided 29 neutral masses to search 
against the databases as 16 features were found to be redundant. 
Five of the SVM-RFE-selected +pESI features from the multimode dataset were 
tentatively identified as glycophospholipids. Due to the inability of single stage MS 
analysis to distinguish between isomeric compounds (compounds having identical 
chemical formulae but different structures), the features could not be definitively 
assigned to a particular glycophospholipid isomer. As such, all of the possible isomers 
corresponding to each feature are listed in Table B.4. The chemical formulae 
corresponding to these five features yielded 106 possible compounds with the total 
number of isomers attributed to each feature ranging from 3-32, mass accuracies between 
0.4-11.6 ppm and matching scores between 42.6-99.0%. Examples of compounds that 
could be tentatively matched to the elemental formulae obtained in this investigation 
include LysoPC (18:2 (9Z, 12Z), PE-NMe (18:1 (19E) /18:1 (9E)), PC (14:0/20:1 (11Z)), 
PC (14:0/22:4 (7Z, 10Z, 13Z, 16Z)), and PC (14:0/22:1 (13Z)). 
Nine of the SVM-RFE-selected -pESI features were tentatively identified as 
endogenous carboxylic acids, peptides, glycerophospholipids, and hormones. The total 
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number of isomers for these nine features ranged from 1 – 16 yielding 65 possible 
compounds with mass accuracies between 1.4 – 14.9 ppm and matching scores between 
82.7 – 99.3%. One of the identified features could not be assigned to a single chemical 
formulae due to the absence of additional supporting adduct ions in the mass spectrum. 
This feature was attributed to either lithocholic acid glycine conjugate or any of 8 
glycerophosphocholine isomers, such as PC (P-16:0/0:0). Potential matches for the 
possible identities of the selected features include palmitic acid, 12-hydroxy-8E,10E-
heptadecadienoic acid, stearic acid, GlnHisAla, DHEA sulfate, PC (10:4/4:0), 
PE (9:0/10:0) and glycoursodeoxycholic acid 3-sulfate. 
Although metabolites such as lysophosphatidic acid and lipid associated sialic 
acid have been investigated as metabolic biomarkers for ovarian cancer in literature, 
these were not identified during this study. However, the presence of several endogenous 
lipids as well as other endogenous metabolites in the set of selected features suggests that 
this approach has merit and should be further explored. 
The wide variation in mass accuracies and scores observed can be attributed to 
two major factors: 1) ambient temperature variations during the lengthy LC analysis time 
affecting both the output of the TOF mass spectrometer power supplies and the length of 
the flight tube, and 2) low signal intensity of some of the features selected. The software 
provided by the mass spectrometer manufacturer provides two methods to perform post-
analysis correction of the m/z values obtained – mass drift compensation and mass 
calibration. Mass drift compensation, which is typically used to correct for temporal drift 
during long analysis times, was found to be insufficient to accurately calibrate the entire 
run. Instead, a full recalibration of the sample run using a calibration curve generated 
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from the NaTFA standard run immediately after the sample was performed and provided 
a marked improvement in mass accuracy. It was further observed that inclusion of the 
isotope matching rule had a positive impact on decreasing the number of false-positive or 
negative entries on the hit lists. Confirmation of the annotation of these eighteen 
metabolites and identification of remaining features selected by SVM-RFE will require 
additional accurate mass MS/MS and 1H-NMR experiments, and exceeds the scope of 
this study. 
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Table B.4. Tentative identifications of SVM-RFE-selected features from multimode dataset detected in +pESI. Matches to identified 
compounds were made using accurate mass measurements and isotope cluster matching. For species which could not be matched 
against metabolite databases, the top-five matching formulae (according to score) are listed (for features matching fewer than five 












Tentative Identification Source Spectra
148.0129 [M+H]+ 116.8812 C4N6O, C5H9OPS, C4H8N2S2 0.1-11.7 99.5-90.1 B.3 (a)
204.0695 [M+H]+ 116.8743
C12H13OP, C6H12N4O2S, C14H8N2, 
C11H12N2S










1.1-13.7 99.7-98.8 B.3 (d)
519.3330 [M+H]+ 100.1739 C26H50NO7P 1.0 99.0




757.5678 [M+H]+ 127.8454 C42H80NO8P 7.5 83.3




759.5775 D [M+Na]+ 138.3808 C42H82NO8P 0.4 42.6




781.5595 D [M+H]+ 138.3808 C44H80NO8P 3.4 46





787.6000 G [M+Na]+ 136.6754 C44H86NO8P 11.6 74.6








1.0-13.5 97.3-96.6 B.3 (i)
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Table B.4, cont’d. Tentative identifications for SVM-RFE-selected features from multimode dataset detected in +pESI. 
(A) For species having multiple isomers the following nomenclature is given:  # isomers found including name of isomer [source (cross-
listed source, if any)]. 
 
(B) 3 isomers found including PC(18:2/0:0) [LMGP 01050036 (HMDB 10386), 01050034, and 01050035]. 
 
(C) 31 isomers found including PE-NMe(18:1/18:1) [LMGP 02010331 (MMCD cq_17959), 02010333, 02010338, 02010350], 
PC(16:0/18:2) [LMGP 01010585, 01010586, 01010587, 01010588, 01010589, 01010590, 01010591, 01010592, 01010593, 01010594, 
01010595, 01010596], PC(16:1/18:1) [LMGP 01010678, 01010680, 01010687, 01010688, 01010689],  PC(17:1/17:1) [LMGP 
01010726, 01010727, 01010728], PC(18:0/16:2(2E,4E)) [LMGP 01010745], PC(18:1/16:1) [LMGP 01010886, 01010887], 
PC(18:2/16:0) [LMGP 01010920, 01010926, 01010932, 01010933]. 
 
(D) Adduct analysis yielded several possible ion species for the selected feature. Only species having tentative matches are listed. 
 
(E) 18 isomers found including PC(14:0/20:1(11Z)) [HMDB 07879], PC(16:0/18:1) [LMGP 01010005, 01010575, 01010576, 01010577, 
01010578, 01010579, 01010580, 01010581, 01010582, 01010583, 01010584], PC(16:1/18:0) [LMGP 01010679, 01010686],  
PC(18:0/16:1(9Z)) [LMGP 01010744], PC(18:1/16:0) [LMGP 01010874, 01010884, 01010885]. 
 
(F) 32 isomers found including PC(14:0/22:4(7Z,10Z,13Z,16Z)) [HMDB 07889], PC(16:0/20:4) [LMGP 01010007, 01010629, 01010630, 
01010631], PC(18:0/18:4) [LMGP 01010772, 01010773, 01010774, 01010775, 01010776], PC(18:1/18:3) [LMGP 01010897, 
01010898, 01010899], PC(18:2/18:2) [LMGP 01010918, 01010919, 01010921, 01010922, 01010923, 01010924, 01010925, 01010927, 
01010928, 01010929, 01010930, 01010937, 01010938, 01010939], PC(18:3/18:1) [LMGP 01010949, 01010955], PC(20:4/16:0) 
[LMGP 01011049, 01011050, 01011056]. 
 
(G) Adduct analysis yielded several possible ion species for the selected feature. Only 1 species could be tentatively identified.  
 
(H) 22 isomers found including PC(14:0/22:1(13Z)) [HMDB 07887], PC(16:0/20:1(11Z)) [LMGP 01010618], PC(18:0/18:1) [LMGP 
01010749, 01010750, 01010751, 01010752, 01010753,01010754, 01010755, 01010756, 01010757, 01010758, 01010759, 01010760, 
01010761, 01010762, 01010763], PC(18:1/18:0) [LMGP 01010840, 01010875, 01010888, 01010889], PC(20:1(11Z)/16:0)[U] [LMGP 
01011037]. 
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Figure B.3. Mass spectra for SVM-RFE-selected features from multimode dataset detected in +pESI (structure and name of 1st isomer 
listed in Table B.4 is included as inset in spectra for those features that were matched to compounds). 
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Figure B.3, cont’d. Mass spectra for SVM-RFE-selected features from multimode dataset detected in +pESI. 
m/z
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Figure B.3, cont’d. Mass spectra for SVM-RFE-selected features from multimode dataset detected in +pESI. 
m/z
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Table B.5. Tentative identifications for SVM-RFE-selected features from multimode dataset detected in -pESI. Matches to identified 
compounds were made using accurate mass measurements and isotope cluster matching. For species which could not be matched 
against metabolite databases, the top-five matching formulae (according to score) are listed (for features matching fewer than five 













256.2398 [M-H]- 104.6898 C16H32O2 1.7 96.3









1.8-14.3 99.0-95.2 B.4 (b)
280.2446 [M-H]- 133.2433 C15H38P2, C15H36O2S, C11H32N6S 0.9-13.2 93.7-91.4 B.4 (c) 
280.2460 [M-H]- 98.8490 C15H38P2, C15H36O2S 4.1-8.6 95.0-94.4 B.4 (d)






284.2701 D [M-H]- 123.8672 C18H36O2 5.0 96.1






C20H38P2, C20H37O2P, C22H32N2O, 
C17H32N4O3, C16H33N6P
4.3-12.4 98.1-95.4 B.4 (g)








384.2831 I [M+CH3COO]- 90.7391
C26H40S, C23H44S2, C21H40N2O2S, 
C29H36, C18H44N2O2S2
3.4-13.9 94.0-85.9 B.4 (j)
398.2982 I [M+HCOO]- 90.7391
C27H42S, C24H46S2, C22H42N2O2S, 
C25H38N2O2, C19H46N2O2S2
3.8-14 94.0-86.9 B.4 (j)








0.45-13.0 94.1-91.9 B.4 (j)
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479.3310 J [M-H]- 91.9683 C24H50NO6P 13.7 96.6





481.2835 [M-H]- 106.0719 C22H44NO8P 6.3 90.4



















0.9-12.1 99.5-97.9 B.4 (o)









0.1-12.8 97.3-96.2 B.4 (p)
509.3156 [M-H]- 121.2736 C24H48NO8P 7.6 91.8









1.7-14.2 93.3-92.8 B.4 (s)
529.2699 [M-H]- 105.7854 C26H43NO8S 1.9 82.7
3 carboxylic acid isomers (e.g. 
glycoursodeoxycholic acid 3-sulfate)
see footnote 
(P) B.4 (r) 




2.7-10.2 94.0-93.0 B.4 (s)
Hampton, C. Y.  251 

















0.1-14.7 88.7-87.9 B.4 (t)




2.7-14.5 88.6-88.1 B.4 (t)




1.6-14.7 88.7-88.2 B.4 (t)




4.8-14.5 88.8-88.2 B.4 (t)
 
 
(A) For species having multiple isomers the following nomenclature is given:  # isomers found including name of isomer [source (cross-
listed source, if any)]. 
 
(B) 16 isomers found including palmitic acid [LMFA 01010001 (HMDB 00220)], isopalmitic acid [LMFA 01020010], 2,6-dimethyl-
tetradecanoic acid [LMFA 01020038], 2,8-dimethyl-tetradecanoic acid [LMFA 01020039], 3-methyl-pentadecanoic acid [LMFA 
01020164], 2-propyl-tridecanoic acid [LMFA 01020165], 2-hexyl-decanoic acid [LMFA 01020166],  3-ethyl-3-methyl-tridecanoic 
acid [LMFA 01020167], 2-heptyl-nonanoic acid [LMFA 01020168], 6-ethyl-tetradecanoic acid [LMFA 01020169],  2,4-dimethyl-
tetradecanoic acid [LMFA 01020170], 3,5-dimethyl-tetradecanoic acid [LMFA 01020171], 4-hexyl-decanoic acid [LMFA 
01020172],  2-ethyl-2-butyl-decanoic acid [LMFA 01020173],  13-methyl-pentadecanoic acid [LMFA 01020192], 4,8,12-trimethyl-
tridecanoic acid [LMFA 01020249]. 
 
(C) Adduct analysis yielded multiple possible ion species for this feature. Only 1 species could be tentatively identified. 
 
(D) Adduct analysis yielded multiple possible ion species for this feature. Only 1 species could be tentatively identified. 
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Table B.5, cont’d. Tentative identifications for SVM-RFE-selected features from multimode dataset detected in -pESI. 
(E) 12 isomers found including stearic acid [HMDB 00827 (LMFA 01010018, MID 189, MMCD cq_00998)], 10-methyl-heptadecanoic 
acid [MID 4292 (LMFA 01020013)],  (+)-isostearic acid [MID 4293 (LMFA 01020014)], 2,6-dimethyl-hexadecanoic acid [MID 
4324 (LMFA 01020042)], 4,8-dimethyl-hexadecanoic acid [MID 4325 (LMFA 01020043)], 2,14-dimethyl-hexadecanoic acid [MID 
4326 (LMFA 01020044)], 4,14-dimethyl-hexadecanoic acid [MID 4327 (LMFA 01020045)], 6,14-dimethyl-hexadecanoic acid [MID 
4328 (LMFA 01020046)], lambda isostearic acid [MID 4493 (LMFA 01020093)], neostearic acid [MID 4620 (LMFA 01020094)], 
11,15-dimethyl-hexadecanoic acid [MID 34604 (LMFA 01020175)], 15-methyl-heptadecanoic acid [MID 34632 (LMFA 
01020205)].  
 
 (F) 6 isomers found including Gln His Ala [MID 23091], Gln Ala His [MID 22217], Ala His Gln [MID 21229], Ala Gln His [MID 
16023], His Gln Ala [MID 20595], His Ala Gln [MID 18707]. 
 
(G) Adduct analysis yielded multiple possible ion species for this feature. Only 1 species could be tentatively identified. 
 
(H) 2 isomers found including DHEA sulfate [HMDB 01032 (LMST 05020010)], testosterone sulfate [HMDB 02833]. 
 
(I) Adduct analysis yielded multiple possible ion species for this feature. All are listed as none could be matched against the databases. 
 
(J) Adduct analysis yielded multiple possible ion species for this feature. Only species that could be tentatively identified are listed. 
 
(K) Cross-listed as MMCD cq-10750 and MID 5666. 
 
(L) 8 isomers found including PC(P-16:0/0:0) [HMDB 10407 (LMGP 01070006)], PC(O-16:1/0:0) [LMGP 01050100, 01050101, 
01050102, 01050103, 01050104, 01070004, 01070005]. 
 
(M) 10 isomers found including PC(10:0/4:0) [LMGP 01010403], PC(12:0/2:0) [LMGP 01010443], PC(6:0/8:0) [LMGP 01011233, 
01011234], PC(7:0/7:0) [LMGP 01011238, 01011239, 01011240], PC(8:0/6:0) [LMGP 01011248, 01011249], PC(9:0/5:0) [LMGP 
01011269]. 
 
(N) Adduct analysis yielded multiple possible ion species for this feature. All are listed as none could be matched against the databases. 
 
(O) 6 isomers found including PE(9:0/10:0)[U] [MID 40490 (LMGP 02010091)],  PE(10:0/9:0)[U] [MID 40669 (LMGP 02010272)], 
PC(14:0/2:0) [LMGP 01010504], PC(8:0/8:0) [LMGP 01011251, 01011252, 01011253]. 
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Table B.5, cont’d. Tentative identifications for SVM-RFE-selected features from multimode dataset detected in -pESI. 
 
(P) 3 isomers found including glycoursodeoxycholic acid 3-sulfate [HMDB 02409 (MMCD cq_17361, MID 6670)], glycochendeoxycholic 
acid 7-sulfate [HMDB 02496 (MMCD cq_17159, MID 6692)], glycochendeoxycholate-3-sulfate [HMDB 02497 (MMCD cq_17507, 
MID 6702)]. 
 
(Q) Adduct analysis yielded multiple possible ion species for this feature. All are listed as none could be matched against the databases. 
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Figure B.4. Mass spectra for SVM-RFE-selected features from multimode dataset detected in -pESI (structure and 
name of 1st isomer listed is included as inset in spectra for those features that were matched to compounds). 
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Figure B.4, cont’d. Mass spectra for SVM-RFE-selected features from multimode dataset detected in -pESI. 
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Figure B.4, cont’d. Mass spectra for SVM-RFE-selected features from multimode dataset detected in -pESI. 
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Figure B.4, cont’d. Mass spectra for SVM-RFE-selected features from multimode dataset detected in -pESI. 
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B.7. Conclusions 
The results presented here demonstrate that LC-MS-based serum metabolomic 
experiments combined with state-of-the-art machine learning methods have the potential 
to generate metabolic profiles of ovarian cancer with possible application to the problem 
of developing accurate, effective diagnostic assays for disease. Using SVM-RFE, a model 
was built having a prediction accuracy of 80.6% with sensitivity and selectivity results of 
83.8% and 77.1%, respectively. Adduct analysis of the 45 features selected by this model 
yielded 29 chemical formulae to search against human metabolite databases. This search 
led to the identification of 171 possible isomeric matches for these formulae and includes 
compounds such as glycerophospholipids, peptides, fatty acids, and hormones. These 
promising findings provide justification for continued investigation of this issue. 
However, future studies should include examination of a larger sample set, which will 
likely improve the figures of merit for the model, and the use of more sophisticated 
analytical tools such as UPLC and accurate mass MS/MS analyses. Inclusion of these 
tools will provide improved throughput and utility, and will also enable generation of 
fragmentation data that can aid in identification of these metabolites by allowing for 
differentiation between isomers. 
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